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Summary 
Liposomes have established roles in drug delivery and 
cell membrane studies. Amongst other applications; they 
can also be used as analytical reagents, particularly in 
immunoassays. Liposomal immunoassays have potential 
advantages over alternatives; including sensitivity, 
speed, simplicity and relative reagent stability. The aim 
of these studies was to develop and evaluate novel 
examples of these assays. 
When liposomes entrapped the dye, Sulphorhodamine B, a 
shift in its maximum absorption wavelength compared to 
free dye was observed. This was attributed to 
dimerization of the dye at high concentrations. If the 
liposomes were disrupted, the released dye was diluted 
into the external buffer, and the dye's absorption 
spectrum reverted to that of free dye. 
After optimization of dye entrapment, immunoassays were 
developed using these liposomes. Albumin-coated 
liposomes were used in a model assay to measure serum 
albumin. This assay employed complement-mediated 
immunolysis, commonly used in liposomal immunoassays. 
The liposomes were lysed by anti-albumin and complement, 
and this could be competitively inhibited by serum 
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albumin. 
To improve sensitivity, Fab' anti-albumin liposomes were 
prepared. These enabled measurement of urinary albumin 
by a complement-mediated immunoassay, but using a 
sandwich technique. 
Anti-albumin (intact) liposomes were shown to precipitate 
on gentle centrifugation after reaction with albumin. 
They were applied as a solid phase reagent in an 
heterogeneous immunoassay, using radioimmunoassay for 
urinary microalbumin as a model assay. 
Liposomes containing Sulphorhodamine B were also used in 
a more novel assay; for serum anticardiolipin antibodies. 
Cardiolipin-containing liposomes were prepared. These 
were lysable using magnesium ions. Anticardiolipin 
antibodies (IgG) were found to augment this lysis, 
enabling their estimation. Similar imprecision and 
acceptable correlation with a commercial enzyme-linked 
immunosorbent assay (ELISA) were obtained. 
The findings demonstrate Sulphorhodamine B release can be 
used as a marker in homogeneous colorimetric liposomal 
immunoassays; both in model assays and in potentially 
more useful clinical biochemistry applications. 
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Materials 
Lipids (of the highest purity available unless otherwise 
stated), purified albumin (essentially fatty acid and 
globulin free) and the dye, Sulphorhodamine B were 
supplied by Sigma Chemical Company Ltd., Poole, Dorset. 
This dye was used throughout except when stated a Kodak 
dye supplied by Phase Separations Sales, Deeside, Clwyd, 
Wales was used. 
Cholesterol was measured using a colorimetric procedure 
('CHOD-PAP method, BDH Ltd, Poole, Dorset) using an EPOS 
analyser (BDH Ltd. ) 
Protein was measured using a manual Coomassie blue assay 
(Biorad Laboratories Ltd, Watford, Hertfordshire). 
BM-Test 3 or BM-Test 5 were used in the initial 
assessment of urine samples for protein and pH 
(Boehringer Mannheim Ltd, Lewes, East Sussex). 
Other chemicals and AnalaR grade reagents were supplied 
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by BDH Ltd. 
Gel filtration materials and N-succinimidyl 3-(2- 
pyridyldithio) propionate (SPDP) were supplied by 
Pharmacia Ltd, Milton Keynes, Buckinghamshire. 
Phosphate buffer, 0.05M, pH7.4 was used throughout except 
when varied experimentally as stated. 
"L Buffer" contained 10 mm N-(2-hydroxyethyl) 
piperazine-N'-(2-ethanosulphonic acid) (HEPES) and 145 MM 
sodium chloride, pH 8.0 . 
"Buffer All contained 50 mM tris titrated to pH 7.5 with 
HC1 and containing 0.15 M NaCl, 0.5 MM MgCl 2 and 0.15 mM 
CaCl 2* 
A radioactive marker, 1-125 labelled bleomycin, was 
kindly donated by Dr GB Firth, Princess Royal Hospital, 
Haywards Heath. 
Radioactive 1-125 labelled human albumin (specific 
activity 16.4 uCi/ug) was supplied by North East Thames 
Regional Immunoassay, London (NETRIA). 
Polyclonal anti-human albumin antiserum (batch 608, 
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purified immunoglobulin G fraction), normal animal sera 
and donkey anti-sheep antiserum were obtained from 
Guildhay Antisera Ltd., Guildford, Surrey. 
Fab' fragments of their sheep anti-human albumin 
antiserum were prepared by Immunogen International Ltd, 
Liandysul, Dyfed; by papein digest, dialysed into 
phosphate buffer. 
Animal complement was obtained from Sera-lab Ltd., 
Crawley Down, Sussex. Human complement was supplied by 
Sigma Chemical Company. 
Anticardiolipin Reference Sera (1100 GPL units) was 
kindly donated by Dr J Faux, Churchill Hospital, Oxford. 
Other anticardiolipin positive samples were kindly 
supplied by the following Immunology Departments; Kings 
College Hospital, London; Royal Hallamshire Hospital, 
Sheffield; Royal Sussex County Hospital, Brighton and St. 
Helier Hospital, Carshalton, Surrey. 
Anticardiolipin antibody enzyme-linked immunosorbent 
assay (ELISA) kits were supplied by Cambridge Life 
Science Ltd, Ely, Cambridgeshire 
xiii 
Equipment 
Sonication was achieved by a Soniprep 150 probe sonicator 
(MSE Scientific Instruments Ltd, Crawley, West Sussex). 
An LKB-Wallac Clinigamma counter (Pharmacia Ltd) was used 
to measure radioactivity. 
Gel filtration was performed using 0.7 mm x 20 cm 'Econo 
Columns' (Bio-Rad Laboratories Ltd). 
Dialysis employed dialysis tubing supplied by Medicell 
International Ltd, London. This was 18/32 inch size 
unless otherwise stated. 
Liposomes were filtered using 200 nm 'Minisart NML' 
filters (Sartorious Ltd, Epsom, Surrey). 
Spectrophotometric scans and absorbance measurements were 
made using a Pye Unicam SP1800 spectrophotometer (Philips 
Scientific, Cambridge, Cambridgeshire) and an Hitachi U- 
2000 spectrophotometer (Hitachi Scientific Instruments, 
Wokingham, Berkshire) or using a Cobas Bio automated 
analyser (Roche Products, Welwyn Garden City, Herts). 
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Fluorescence measurements were made using a Perkin Elmer 
scanning fluorescence spectrophotometer (Perkin Elmer 
Ltd, Beakonsfield, Buckinghamsire). A solution of 2x 
10-6M Sulphorhodamine B was used to set the scale reading 
to 100% (scale 4) which equals 900 arbitrary fluorescence 
units (excitation wavelength 400 nm, emission wavelength 
580 nm). 
ELISA plates were read using a Multiscan MCC/340 plate 
reader, supplied by Labsystems Ltd, Basingstoke, 
Hampshire. 
Centrifugation employed a Burkhard Koolspin centrifuge 
(Uxbridge, Middlesex) and a MSE Mistral 61 (Crawley, West 
Sussex). 
The rotary evaporator used was type 349/2 from Corning 
Ltd, Stone, Staffordshire. 
The following methods were used to measure urinary 
analytes as described by the manufacturer, (Bayer P. L. C., 
Basingstoke, Hampshire) using a Bayer Axon analyser: 
phosphate, ammonium molybdate; magnesium, xylidyl blue; 
and calcium, cresolthalein. 
xv 
Urinary sodium and potassium were analysed using a flame 
photometer (Instrumentation Laboratory 943, Warrington, 
Cheshire). 
A Corning-Eel model 10 pH meter was used to measure pH 
(Corning Ltd). 
Light microscopy photographs were obtained using a 
Leitz Diaplan microscope with a 35 mm film magazine 
(Leica, Milton Keynes). 
Electron micrographs were kindly produced by Ms Dawn 
Chescoe, School of Materials Sciences, University of 
Surrey, Guildford. 
Statistical calculations were performed using an Amstatl 
parametric statistics package on an Amstrad PCW 9512 
computer (Amstrad plc, Brentwood, Essex); except that 
regression equations were calculated using Deming's 
method as described by Cornbleat and Gochman (1). 
LP3 and LP4 plastic tubes were supplied by Luckhams Ltd, 
Burgess Hill, Sussex. 
xvi 
The following hand pipettes were used; Eppendorf, Oxford 
Scientific Instruments; SMI hand pipettes, Alpha 
Laboratories Ltd, Eastleigh, Hampshire. 
xvii 
Chapter 1 
Introduction 
1.1 Nature and Applications of Liposomes 
Liposomes are synthetic spheroidal vesicles consisting 
of a lipid bilayer membrane, usually composed 
mainly of phospholipids, enclosing an aqueous interior. A 
variety of materials including lipids or proteins can be 
incorporated into or attached to the membrane, while 
water soluble substances such as drugs, enzymes or dyes 
can be entrapped in the aqueous interior. 
Thermodynamically unstable structures, liposomes do not 
form spontaneously when amphiphilic molecules (e. g. 
phospholipids) are brought into contact with an aqueous 
phase. In theory, they eventually will always tend to 
convert to more stable phases such as lamellar or 
hexagonal structures (2). However in practical terms; 
liposomes can be very stable, readily formed by a 
variety of techniques and often lose their integrity only 
slowly. These considerations, together with the ease and 
subtlety with which their composition can be altered, has 
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led to their application in a number of fields. These 
have ranged from their use as models of cell membranes 
and as a means of studying the physical chemistry of 
lipid-lipid and lipid-protein interactions, to their 
role as carriers of drugs or other therapeutic agents. 
These applications have been extensively reviewed (2-6). 
Liposomes have recently become familiar as ingredients of 
cosmetics (7). The potential of liposomes as analytical 
tools, the subject of this thesis, is another 
comparatively recent area of study. 
1.2 Immunoassays - the Search for Improved Labels 
Since the development of radioimmunoassay (RIA) by Yalow 
and Bersen (8) in the early 1960s; the technique has held 
a central importance in the measurement of analytes at 
low concentration, despite there being inherent 
disadvantages of the use of a radionucleotide as the 
label in the immunoassay. These include the limited shelf 
life, the need for specialised counting equipment, the 
need to incorporate a separation stage of the 
antibody-bound label from the free label and the health 
and safety risks of the use and disposal of radioactive 
materials. While radioimmunoassay is still popular there 
has been a gradual move to safer, stabler and more 
2 
convenient labels. The various alternatives have been 
reviewed and compared (9), and the impetus to improve 
labels shows no sign of abating (10). 
An ideal label would retain the advantages of 
radioimmunoassay while avoiding its disadvantages. No 
single label to date has fulfilled this aim completely, 
perhaps explaining why there are now so many alternative 
immunoassay techniques available. 
Radiolabels can be counted with a high degree of 
sensitivity leading to low limits of analyte detection. 
Some of the alternatives have approached this 
sensitivity, for example enzyme linked immunosorbent 
assay (ELISA) (11). This techique achieves sensitivity, 
however, by an enzymatic reaction step which can be time 
consuming and involves reagents with limited stability. 
Under certain circumstances assays can be constructed 
that avoid the separation stage of radioimmunoassay (e. g. 
enzyme multiplied immunoassay (EMIT) (11) or plane 
polarised fluorescence immunoassay (12)). However these 
tend to lack sensitivity, cannot usually be developed by 
the user (unlike radioimmunoassay), generally apply only 
to small analytes such as drugs or non-protein hormones 
and are expensive. 
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Some assay techniques such as fluorescence (12) or 
chemiluminescence (13) assays require equipment that is 
not readily available in all laboratories. 
These considerations, together with improvements in 
radiolabelled assay performance such as the development 
of immunoradiometric assays (IRMAS) (14) and the use of 
affinity purified or monoclonal antibodies (15) have 
ensured that radiolabels are still widely used. New 
developments however, particularly in the commercial 
field, tend to utilize alternative non-isotopic labels 
(10). 
The possibility of using liposomes as carriers of labels 
for immunoassays has received a limited, though growing, 
consideration. Liposomes are potentially very versatile 
as label-carriers since they can be made to entrap a wide 
range of measurable substances. These can include 
enzymes, fluorophors, colorimetric dyes, chemi- 
luminescent molecules and potentiometrically measurable 
ions (16). Antigen or antibody can be incorporated 
within the lipid membrane or attached to the liposome 
surface. It may be possible to measure the signal in 
intact liposomes although more usually the liposome is 
lysed, for example by detergent, enabling the 
encapsulated substance to be measured. 
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1.3 Liposome Classification and Methods of Synthesis 
Liposomes fall into three main categories depending on 
their size. These were defined by the New York Academy of 
Science (17) as multilamellar large vesicles (MLVs), of 
sizes ranging between 0.1-5 um; small unilamellar 
vesicles (SUVs), size range 20-50 nm and large 
unilamellar vesicles (LUV)s, size range above 60 nm 
(typically 200 nm -1 um (18)). Giant and "cell size" 
liposomes have also been synthesized (19,20). Each 
synthetic method tends to produce a certain type of 
liposome, though often with a small proportion of other 
types. 
When a mixture of lipids including phospholipid is 
deposited on the wall of a vessel by evaporation of the 
organic solvent and then shaken with an aqueous solution 
liposomes are formed. They consist of large concentric 
layers of lipid enclosing aqueous solution centrally and 
between each layer. These are multilamellar large 
vesicles and are of the type first described by Bangham 
and Horne in 1964 (21). While very useful, for example in 
membrane studies, these liposomes are less suited to 
immunoassay applications because of their heterogeneity 
and low aqueous capture volume. 
5 
Small unilamellar vesicles (22) are formed if 
multilamellar large vesicles are sonicated, usually for a 
few minutes. Although relatively homogeneous these also 
have a low capture volume. 
A better capture has been achieved using large 
unilamellar vesicles. A convenient method for their 
synthesis was described by Szoka and Papahadjopoulos 
(18). This involves first sonication for a few minutes of 
a mixture of an organic phase, containing lipid, and an 
aqueous phase which usually contains the material to be 
entrapped. Sonication produces a water-in-oil emulsion. 
This is followed by rotary evaporation under reduced 
pressure. As the organic phase evaporates the mixture 
becomes viscous and usually briefly forms a gel. The gel 
suddenly collapses, often violently, and disperses, 
resulting in the creation of bilayered large unilamellar 
lip osomes (LUVS). These liposomes are also known as 
reverse phase evaporation vesicles (REVs). 
A more homogeneous preparation of the reverse evaporation 
vesicles is obtainable by filtration through suitable 
sized, usually polycarbonate, filters (e. g. 200 nm pore 
size) (23). 
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Consideration of surface area/volume ratios would suggest 
a greater entrapment of aqueous phase by large 
unilamellar vesicles compared with small unilamellar 
vesicles or multilamellar large vesicles. This seems 
generally to be the case. Szoka and Papahadjopoulos (18) 
reported between approximately 24 and 60% of the 
aqueous volume was entrapped within large unilamellar 
vesicles (8.1-15.6 1/mg of lipid) compared with 
approximately 16.5% (4.1 1/mg of lipid) for multilamellar 
large vesicles and 1.8% (0.5 1/mg of lipid) for small 
unilamellar vesicles. 
Large unilamellar vesicles are likely, therefore, to be 
the liposomes of choice for high encapsulation. This may 
be desirable for liposomes used as immunoassay labels; as 
it will increase the signal (e. g. release of entrapped 
dye or enzyme) produced by the lysis of a given number of 
antigen or antibody-coupled liposomes. However it is 
possible that the signal strength of an assay might not 
be a significant consideration. Alternatively, the amount 
of lysis may be dependent on high amounts of coupled 
antibody or antigen. In those circumstances small 
unilamellar vesicles, with their increased surface area 
to volume ratio, may be preferable. 
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Small unilamellar vesicle (and multilamellar large 
vesicle) preparations have the advantage that there is 
virtually no risk of contact between organic solvent 
and labile antigens or antibodies which could cause 
denaturation. However this is not a major disadvantage of 
large unilamellar liposomes, since a variety of coupling 
procedures enable attachment of proteins to large 
unilamellar vesicles subsequent to their synthesis and 
organic solvent removal (see Section 1.5.2). 
There are a number of other techniques to prepare 
liposomes (2-4,24). For large unilamellar vesicles, 
reverse evaporation is probably the method of choice 
(24), particularly for small experimental batches. A 
detergent dialysis technique has been claimed to have the 
advantage of producing liposomes of greater homogeneity 
and more easily controlled size (25-300nm, i. e. 
intermediate between small unilamellar vesicles and large 
unilamellar vesicles) (25). Lipid is dissolved using a 
detergent such as sodium cholate to form mixed 
lipid/detergent micelles. The detergent is then reduced 
in concentration by dialysis, either using a dialysis bag 
or commercially available equipment (25). When the 
detergent concentration falls below a critical level 
liposomes are formed. The technique has the advantage of 
avoiding potentially damaging organic solvents. However 
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it is not easily applicable to retaining dialysable 
material (e. g. dyes) within the liposomes. 
Solvent injection methods have also been used. In these 
techniques vesicles are formed by the injection of lipid 
in organic solvent into a large aqueous volume. The 
ethanol injection technique of Batzri and Korn (26) is a 
simple method but produces small unilamellar vesicles of 
low encapsulation. The ether infusion method of Deamer 
and Bangham (27), involving the injection of organic 
mixture into aqueous solution at 55-650 C or under 
reduced pressure at 300 C, does produce large unilamellar 
vesicles. However it suffers from the potential 
disadvantage of denaturation of organic or heat sensitive 
molecules and of producing liposomes of heterogeneous 
size (28). 
Papahadjopoulos et. al. (29) have used a calcium infusion 
method to prepare liposomes from acidic phospholipids. By 
the addition of calcium to certain types of small 
unilamellar vesicles multilamellar structures termed 
cochleate cylinders are formed. Addition of EDTA coverts 
these to large unilamellar vesicles. Despite the 
restriction to certain types of lipid this method has the 
advantage of using gentle reaction conditions. 
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Another method which produces liposomes of LUV dimensions 
which are oligo and multilamellar has been described by 
Kirby and Gregoriardis (30). This involves dehydration, 
typically by freeze drying, followed by controlled 
rehydration and is claimed to be a simple method giving 
high entrapment yields. Ligands can be coupled to 
liposomal surfaces prior to entrapment of material within 
the liposome using this method. This might have 
advantages if the entrapped material is sensitive to 
coupling reagents (31). 
Liposomes of desired characteristics, e. g. homogeneity, 
can be formed by reducing the size of large liposomes by 
passing through a small orifice. Hamilton et. al. (32) 
used a French press to convert multilamellar large 
vesicles to small unilamellar vesicles. It is also a 
common practice to use filtration through polycarbonate 
membranes to improve the homogeneity of large unilamellar 
vesicles (23). A similar technique can be used for 
multilamellar large vesicles to produce smaller more 
homogeneous preparations (33). 
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1.4 Methods of Purification and Characterization 
Once liposomes are 
used to separate 
aqueous phase as 
choices of methods 
nature of the li] 
material. 
formed, physical methods are usually 
the liposomes from unencapsulated 
well as un-incorporated lipid. The 
used vary depending on the size and 
posomes and the type of entrapped 
Gel filtration, for example using Sepharose 4B or 
Sepharose 6B, is widely used. Large unilamellar vesicles 
normally elute in the void volume in these gels, while 
small unilamellar vesicles often are separated into two 
peaks, one in the void volume and one that is filtered 
more slowly. A potential problem with gel filtration 
techniques is absorption of lipid onto the gel 
column (34). 
Recently an alternative physical separation method, high 
pressure liquid chromatography, has also been used. This 
was shown to have advantages over gel filtration, 
including small sample size and rapid run times (35). 
Dialysis is another technique which is useful if the 
entrapped material is dialysable and can give an 
indication of liposome leakage rate. 
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Centrifugation techniques are also available. 
Ultracentrifugation can be used to separate liposomes, 
both from impurities and according to size. In addition, 
centrifugation can be used to precipitate out large 
liposomes and sonication probe fragments from small 
unilamellar vesicle preparations (36). 
A useful alternative which can avoid high centrifugation 
forces is to use a density gradient medium such as 
Ficoll-Paque (T. M. Pharmacia) (37). Since liposomes are 
less dense than this medium they float above it and can 
be separated from other components which remain in the 
aqueous phase or are precipitated. Alternatively the 
density gradient medium could be added to the 
encapsulated solution to increase the liposome's density 
and facilitate their centrifugation. 
An assessment of the physical properties of the prepared 
liposomes is usually desirable. If liposomes are to be 
used analytically this will include assessing their 
instability. While many liposome preparations do not show 
appreciable loss of their contents over several months 
this is not always the case (see Section 1.5.1). Loss of 
internal contents can be by leakage or rupture (38). The 
term "lysis" strictly speaking implies liposomal rupture. 
However it is often used to indicate release of contents 
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from liposomes without implying knowledge of the specific 
mechanisms involved. "Lysis" will be used as a term in 
this general sense throughout this report. 
A convenient method to assess instability is by dialysis, 
provided an encapsulated component is dialysable. A 
sophisticated mathematical treatment has been applied to 
obtain accurate measurements of liposome 
permeability (24). Dialysis can also be used, however, 
to simply estimate the stability of a liposomal 
preparation. 
Another approach to the assessment of liposome 
instability; which, like dialysis, can also be used to 
assess the amount of encapsulation of aqueous phase 
material, is the measurement of the degree of quenching 
of an encapsulated fluorophor. Carboxyfluorescein (38,39) 
and calcein (40) have been used for this technique. It 
is based on the observation that when, a fluorophor is 
incorporated at a concentration sufficient to cause 
self-quenching (by an inner filter effect) the fluorophor 
within the liposome remains quenched and the liposomes do 
not fluoresce. However if the liposomes are lysed, for 
example by detergent, the fluorophor is diluted and 
fluoresces. The increase in fluorescence upon lysis of a 
sample of a preparation (for example by detergent) can be 
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used to calculate the percentage incorporation of 
fluorophor, while the gradual increase in fluorescence 
of a liposome preparation (in absence of detergent) can 
be used to assess the stability. Since the kinetics of 
quenching loss is different if liposomes leak than if 
they rupture, this technique can be used to 
differentiate between the two types of loss of 
contents(39). 
The size of a liposome preparation and its homogeneity 
can be assessed by several techniques. Electron 
microscopy has been widely used, negative staining being 
more commonly used to assess size (23) while freeze 
fracture techniques are more useful to assess 
morphology (41). While electron microscopy is applicable 
to large unilamellar vesicles- or small unilamellar 
vesicles; multilamellar large vesicles are large enough 
to be assessed by light microscopy, for example by the 
inclusion of a hydrophobic fluorescent probe into the 
bilayer (42). Light scattering studies have been used to 
assess liposome sizes and can be used to estimate the 
degree of contamination of a preparation by large 
liposomes (43-45). Thin layer chromatography has also 
been used to provide an approximate estimate of liposome 
size (46). Kirkland et. al. (47) used the centrifugal 
technique of sedimentation field flow fractionation to 
14 
size liposomes. This is based on the differential flow 
rates of different sized particles through a narrow 
orifice under centrifugal force. Another approach is the 
use of a Coulter 
TM 
particle analyser (48). 
The size of the liposome, together with an estimate of 
the encapsulation ratio (litres aqueous phase entrapped / 
mol lipid), can be used to calculate the number of 
liposomes in a preparation and their surface area (49). 
The lipid content of a liposome preparation can usually 
be assessed by measurement of phosphate or cholesterol. 
Alternatively a radiolabelled tracer (e. g. 
14Carbon 
labelled phospholipid) could be used to assess lipid 
recovery. 
Finally, free-flow electrophoresis has been used to study 
the surface charge density of liposomes (50). 
1.5 Varying Liposome composition 
1.5.1 Lipids and Internal Aqueous Phase 
Although liposomes formed from single chain amphiphiles 
such as dodecanol/sodium dodecylsulphate, octadecyl 
sulphate or octadecylphosphate have been reported(51), 
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the large majority of 
phospholipid liposomes. 
one or a mixture of 
dipalmitoyl phosphatidyl 
other lipids, proteins 
substances. There is 
compositions which can 
liposomal properties suc: 
and stability. 
liposome studies have involved 
Their lipid membranes contain 
phospholipids, often including 
choline (DPPC), sometimes with 
and perhaps various other 
clearly a wide choice of 
be used and will affect the 
h as size, encapsulation volumes 
Liposome membranes can exist in two states, a gel state 
at lower temperatures and a more fluid liquid crystalline 
state at higher temperatures. Above the phase transition 
temperature liposomes become very leaky. Hence liposomes 
are generally maintained below their phase transition 
temperature, although higher temperatures may be used 
during their formation, as is the case in the reverse 
evaporation method (18). The phase transition temperature 
is 20-250 C for most lipids but 450 C for DPPC. Mixed 
lipid liposomes may not have a single phase change but 
may have a more gradual transition, consisting of mixed 
phase localized demains. 
Various physical techniques can be used to determine 
fluidity, including nuclear magnetic resonance (NMR), 
electron spin resonance (ESR), fluorescence spectroscopy 
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or Raman spectroscopy (52). It is generally desirable to 
reduce fluidity in order to increase stability (i. e. to 
reduce leakage). Physical studies (52) indicate a 
potentially complex effect of the fatty acyl groups on 
fluidity; in terms of their length, number of double 
bonds and the presence or absence of cis-double bonds, 
which pack less compactly than trans-double bonds. The 
phospholipid head groups also affect the fluidity; as 
does cholesterol, which reduces membrane fluidity by 
perpendicular "wedge like" packing at a level just below 
the head groups. Cholesterol tends to reduce the 
permeability of the membrane up to a molar ratio of 1-1, 
above which it may have the reverse effect. 
The in-vivo fluidity of membranes is thought to have 
important biological effects; most cellular membranes 
existing predominantly in the gel state with fluid 
domains around membrane proteins, many of which function 
better with greater mobility. 
The addition of lipids of net positive or negative charge 
can alter the rate of incorporation or subsequent loss of 
charged molecules. Stearylamine is often added to produce 
positively charged liposomes and phosphatidic acid to 
produce negatively charged liposomes. Positively charged 
liposomes tend to be impermeable to cations whilst 
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negatively charged liposomes are generally freely 
permeable to cations. Anions, however, tend to diffuse 
through liposomes irrespective of their charge. The 
permeability of all charges of liposome membranes to 
protons is generally low. This may be helpful if a pH 
gradient must be maintained. 
The incorporation of specific non-lipids can have effects 
on structure and permeability. For example, the 
permeability to specific ions can be selectively 
increased by the incorporation of valinomycin , certain 
antibiotics or cyclic peptides (53). Various substances, 
including glycophorin, a transmembrane protein (54) and 
acylated antibody (55), can act to stabilize unsaturated 
phosphatidylethanolamine liposomes. These are otherwise 
unstable at physiological conditions, rapidly 
transforming to non-bilayer, hexagonal II phase, 
structures with the release of their aqueous contents 
(56). 
The lipid type can influence 
affect the encapsulation rats 
at a molar ratio of 1-1 with 
to increase incorporation 
arabinoside, an effect which 
the liposomes (18). 
the liposome 
a. For examp; 
phospholipid 
of sucrose 
was related 
size and hence 
Le, cholesterol 
has been shown 
and cytosine 
to the size of 
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The degree of encapsulation of an aqueous substance and 
the subsequent stability of the liposome depends not only 
on the choice of membrane components and the synthetic 
technique but also to a degree on the aqueous phase. In 
addition to the relationship between the permeability to 
ionic species and the lipid charge, the ionic strength 
of the solution has an effect. In general encapsulation 
is increased at low ionic strengths (18). 
An example of the importance of the aqueous phase is seen 
in the specific effects produced by calcium ions. These 
can induce fusion of small unilamellar vesicles 
containing acidic phospholipids to form multilamellar 
cochleate cylinders (28). Studies at the molecular level 
indicate that calcium ions can draw together negatively 
charged phospholipid groups and can also produce a 
localised phase change from fluid to gel state with close 
packing of fatty acyl chains. This may be a mechanism by 
which calcium ions exert an influence on cell fusion in 
vivo (52,57). 
In the case of cardiolipin, the neutralization of 
negative charges on the head groups by divalent cations 
seem to draw them together and induce a phase change from 
lamellar to hexagonal (II) phase. Hexagonal (II) phases 
are rod like structures based on reverse micelles (i. e 
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monolayers with the fatty acyl 
outwards) (2). Their formation can 
destabilizing liposomes, releasing 
Cardiolipin is -concentrated in 
hexagonal (II) structures may have a 
in providing pores in mitochondrial 
channels for the passage of proteins 
chains protruding 
have the effect of 
their contents. 
mitochondria, and 
biological function 
membranes creating 
(58). 
Liposomes can be destabilized by a number of other 
aqueous phase substances which could be internal or 
external to the liposomes. The addition of general 
anaesthetics such as ether or chloroform have been shown 
to induce cation leakage (59). The addition of certain 
proteins to liposome preparations induces anion and 
glucose leakage. These include lysozyme (60), myelin 
basic protein (61) and immunoglobulins (62). 
Complement will cause the release of the contents of 
liposomes which have first undergone an antibody reaction 
against membrane components such as cardiolipin (63). 
Leakage seems to be the mechanism, shown by analysis of 
the fluorescence quenching effects as marker is released 
(64). Leakage of calcein from small unilamellar vesicles 
was induced in vitro by calf serum (65), and both the 
complement system and lipoproteins have been implicated 
in lysis of liposomes in vivo (66). While these 
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observations have implications to the success of 
liposomes as delivery systems in vivo they should not 
generally cause excessive problems at the dilutions used 
for in vitro analytical techniques. 
Liposomes can readily be lysed by detergents such as 
Triton X100 or by high concentrations of organic solvents 
such as ethanol or methanol. Care must be taken to avoid 
contamination of glassware, particularly by detergents as 
this may lyse liposomes and lead to erratic experimental 
results. 
Because of the potential complex interaction of aqueous 
phase and lipid phase it is often difficult to predict 
on theoretical grounds the optimum conditions for 
entrapment of a particular aqueous material. It is 
generally necessary to combine predictions from previous 
experimental results with a degree of trial and error. 
1.5.2 Protein Coupling Methods 
The earliest attempts to incorporate proteins into 
liposome membranes involved non-covalent bonding which 
occurs due to electrostatic and hydrophobic interactions. 
This was demonstrated in multilamellar large vesicles 
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(67) and examined in small unilamellar vesicles(68), in 
which it was greater in liposomes containing anionic 
phospholipids. However, little study has been reported on 
the reproducibility of this method, the irreversibility 
of the coupling or the stability of the coupled 
liposomes. The majority of more recent studies have 
centred on the use of covalent coupling methods. 
Methods to chemically couple proteins to liposomes have 
been extensively reviewed (34,37). This can be attributed 
to the importance of coupling macromolecules such as 
antibodies or protein antigens to liposomes. An advantage 
of these techniques is their transferability, i. e. the 
applicability of individual methods to a large number of 
different proteins. 
Protein coupling methods fall into two main categories. 
The first involves attachment of protein directly to 
preformed liposomes by a chemical reaction with a lipid 
species, commonly the primary amine group of 
phosphatidylethanolamine. The second approach involves 
the prior modification of the protein with a hydrophobic 
"anchor" such as a fatty acid which can then be 
intercalated into liposomes, either at their preparation 
or subsequently. 
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The major advantage of the first approach is that 
liposomes can be preformed under conditions that have 
been optimized for entrapment, stability and other 
variables. Another advantage is the avoidance of 
preparative conditions which might denature the protein, 
such as the presence of organic solvents or high 
temperatures. The methods may involve comparatively few 
analytical steps and it may be easier to define and 
control the protein/lipid ratio. 
The second approach, i. e coupling the protein to lipid 
prior to liposome formation, has an advantage of avoiding 
the likelihood of liposome-liposome or protein-protein 
coupling which are certainly a potential problem in some 
of the earlier direct methods. It may also be desirable 
in some applications to be able to isolate and 
characterize the protein-conjugate prior to inclusion in 
the liposomes. The approach suffers however from the 
restrictions it imposes on the method of formation of the 
liposomes which must include the fatty acyl-protein 
derivative and which must avoid denaturing the protein. 
There is also the possibility of reduced exposure of 
incorporated protein if it is positioned on the inner 
surface of the membrane. 
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The main application of this approach has been by Huang 
et. al. (69). Their method involves the coupling of 
protein (e. g. antibody) to the N-hydroxysuccinimide ester 
of palmitic acid(NHSP) (which is first formed by a 
condensation reaction of palmitic acid and N-hydroxy 
succinimide). This method has been successfully used for 
small unilamellar vesicle coupling (70). 
The method's use for coupling to large unilamellar 
vesicles commonly utilizes the detergent dialysis 
technique. Although this is a valuable technique for 
encapsulating macromolecules it is less suited to 
entrapping small dialysable materials such as dyes. A 
reverse-phase evaporation method has been reported (69) 
This involves addition of the modified protein at a stage 
after the evaporation but in the presence of a small 
amount of organic solvent. After mixing and standing for 
two hours in the presence of detergent, the mixture is 
dialysed. This technique is, therefore, in effect to some 
extent a hybrid of the reverse evaporation and detergent 
dialysis methods and may suffer the same limitation 
regarding the entrapment of small molecules. 
The earliest methods which covalently coupled protein 
directly to preformed liposomes utilized bifunctional 
crosslinking reagents. These include glutaraldehyde (71), 
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carbodiimide (normally the water soluble 1-ethyl-3-(3- 
dimethylamino)-propylcarbodiimide (EDCI)(62) and dimethyl 
superimidate (72). These couple to amino groups on the 
protein and on the liposome, usually introduced through 
the incorporation of phosphatidylethanolamine. The 
methods are particularly susceptible to cross linkage, 
producing protein-protein bonding which may form large 
aggregates that can be difficult to separate from 
liposomes using gel chromatography or centrifugation. 
These reagents are also limited in the extent of their 
reaction. 
Other techniques have been 
problem of protein-protein 
contains carbohydrate resit 
peroxidase, these can be 
aldehyde groups that 
phosphatidylethanolamine 
liposomes (73). 
developed which circumvent the 
crosslinkage. If the protein 
dues, for example horse radish 
oxidized to provide reactive 
can then be coupled to 
or stearylamine containing 
The requirement of this approach for carbohydrate 
residues in the protein was removed by an alternative 
method of oxidizing glycosphingolipids incorporated into 
the liposome membrane (74) which could then react with 
amino groups on the lysyl residues of the protein. 
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Coupling through thiol groups has given rise to a number 
of useful methods based on the development of 
heterobifunctional reagents that can react both with 
amino and thiol groups. An examples of these reagents is 
m-maleimidobenzoyl-N-hydroxysuccimide ester (MBS) (75). 
Thiol groups on the protein can be reacted with 
phosphatidylethanolamine incorporated into 1iposome 
membrane using this reagent (37). This technique gives 
high levels of coupling but requires the formation of 
unstable free thiol groups on the protein which must be 
conjugated immediately. 
Another heterobifunctional reagent, N-succinimidyl 3-(2- 
pyridyldithio) propionate (SPDP) (76) has been used in a 
similar way to MBS to couple, for example, Fab' fragments 
of immunoglobulin to liposomes (77). The particular 
strength of SPDP is its ability to form a linkage between 
amino groups on the lipid membrane (e. g. phosphatidyl 
ethanolamine) and on the protein. 
SPDP can be reacted with phosphatidyl ethanolamine prior 
to liposome synthesis to give a molecule containing a 
protected, relatively stable, thiol group; N-(3-(2- 
pyridyldithio)propionyl)phosphatidyl-ethanolamine (DTP- 
PE). The DTP-PE can then be incorporated into liposomes. 
SPDP is then reacted with the protein to give another 
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protected thiol group. Conjugation is achieved by first 
cleaving the disulphide group in the derivatized protein 
using dithiothreitol and mixing the protein and 
liposomes. The 2-pyridyl disulphide group on the 
phospholipid undergoes a thiol disulphide exchange 
producing a covalent dipropionyl-disulphide linkage 
between the phospholipid and the protein. 
This technique is relatively straightforward to perform, 
uses moderate reaction conditions, produces a high degree 
of coupling and has the advantage that the reagent is 
commercially available (78). A potential disadvantage, 
however, of dipyridyldithiol reagents is the 
susceptibility of the disulphide bond to reduction. 
Martin and Papadjopoulos (79) have used N-succinimidyl 
4-(p-maleimidophenyl)butyrate (SMPB) to activate 
phosphatidyl-ethanolamine which can then be incorporated 
within liposomes and reacted with either the endogenous 
thiols of rabbit Fab'(69) or with thiols introduced into 
monoclonal antibodies by SPDP (80). The latter approach 
introduces a more stable bond than that produced by SPDP 
alone while avoiding the difficulties associated with the 
instability of free endogenous sulphide groups. A similar 
approach has been used with the reagent, N- 
succinimidyliodoacetic acid (81). 
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Finally the versatility of recent indirect conjugation 
techniques, utilising either protein A or the avidin- 
biotin reaction, has been extended to liposome-protein 
conjugation. Liposomes can be coupled to protein A which 
can then be used to bind to the Fc portion of 
antibodies (82). 
The avidin-biotin system can be used in several 
ways (83-86). Avidin can be conjugated to liposomes 
which will then bind to biotinylated antibody. 
Alternatively biotinylated antibody can be coupled to 
biotinylated phosphatidyl ethanolamine through an avidin 
bridge. The potential of these techniques is that a 
"universal" liposome preparation could be made which 
could react with a range of antibodies or other proteins. 
However careful optimization of reaction conditions is 
necessary to prevent unwanted cross-linkage reactions. 
Once coupled it is necessary to separate the liposomes 
from the unreacted reagents and assess their 
characteristics. Many of the techniques used to purify 
liposomes and assess their stability can equally be 
applied to this stage. It is important to ensure that 
protein-protein aggregates do not separate with the 
liposome fraction during purification. This can best be 
assessed by the inclusion of appropriate control 
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experiments. The use of density gradient medium 
centrifugation techniques can be useful in the 
separation of protein aggregates from liposomes (37). 
In order to assess the efficiency of coupling, the 
protein/lipid ratio can be measured. A convenient method 
to assess bound protein is to use a labelled protein as a 
tracer (37). Heath et. al. (74) studied the effects of 
varying protein/lipid concentration ratios and found 
that, using the technique of periodate oxidation of 
membrane bound glycosphingolipid, the bound 
protein/lipid ratio was dependent on the protein 
concentration in the reaction mixture much more than the 
lipid concentration. 
It will also be necessary to investigate whether the 
bound protein is still active. The immune reactivity of a 
protein can be assessed by its binding to a radio- 
labelled antibody or antigen, as assessed by association 
of the radioactivity with the liposomes on physical 
separation (e. g. gel filtration or density gradient 
centrifugation). This may be adequate for application in 
an in vitro assay but may not indicate biological 
activity, which can be affected by alterations in, for 
example, antibody valency. It has been reported that 
enhanced antibody affinity can occur derived from an 
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increase in effective antibody valency when it is 
conjugated to liposomes (85). 
1.5.3 Coupling Methods for Non-Protein Molecules 
While hydrophobic substances can be incorporated into 
membranes as part of the liposome preparation by 
incorporation with the lipid in the organic phase, it may 
be necessary to couple small molecules such as haptens or 
other non-protein to lipid either before or after 
liposome formation. 
Liposomes can bind by electrostatic or hydrophobic forces 
to a variety of polymers, such as dextrans (87) or 
polyamino acids (88). Both types of molecule can induce 
aggregation (88,89) and certain polyamino acids alter 
liposome permeability (72). 
Electron spin resonance is a technique that has been 
applied to the study of membrane components at the 
molecular level (90). Spin labels can be introduced into 
liposome membranes. The probe TEMPO, for example, 
associates non-covalently with lipid (91). It is also 
possible to introduce probes by chemical coupling to 
phospholipid fatty acyl chains (92). 
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A number of haptens have been coupled to liposomes for in 
vitro or in vivo immunological uses. Thyroxine (T4) can 
be coupled to dipalmitoyl phosphatidylethanolamine prior 
to large unilamellar vesicle formation. This involves the 
reaction of the phospholipid with succinic anhydride and 
triethylamine to form a hemisuccinimide derivative which 
is then able to react with the thyroxine (93). Tan et 
al. (94) used an alternative procedure to synthesise 5- 
N-thyroxine-2,4-dinitrophenyl phosphatidylethanolamine. 
Since, due to their sugar moiety, digoxin conjugates 
often are unstable, O'Connell et al. (48) used the 
aglycone of digoxin, digoxigenin, to form liposomes with 
the same antigenic determinants. They made use of the 
reactive amino group of phosphatidylethanolamine to 
couple it to 3-ketodigoxinogen prior to large unilamellar 
vesicle formation. 
Canova-Davis et al. (95) synthesized a theophylline 
derivative of phosphatidylethanolamine, again prior to 
large unilamellar vesicle formation. This involved the 
reaction of glutaric anhydride and 4,5-diamino-1,3- 
dimethylpyrimidine-2,6-dione, followed by thionyl 
chloride to form the hydrochloride of 8-(3- 
carboxypropyl)-theophylline which then was coupled with 
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dipalmitoyl phophatidylethanolamine through a peptide 
linkage. 
Six et al. (96) and Urema et al. (97) have reported 
methods for synthesizing dinitrophenylated 
phosphatidylethanolamine for model studies of antibody 
and complement reactions with liposomes. 
As a final example, Ligler et al. (98) reported a method 
for coupling mycotoxin T-2 (hydroxydiacetoxyisovaler- 
oxyepoxytrichothecene) to phosphatidylethanolamine prior 
to liposome formation. T-2 was first succinylated, 
converted to its acid chloride and then coupled to the 
amino group of phosphatidylethanolamine. 
1.6 Liposome Applications in Immunoassay 
1.6.1 The Use of Liposomes and Choice of Encapsulated 
Marker 
In most conventional immunoassays, it is usual for a 
single molecule of label (e. g. fluorophor) to be linked 
to a single molecule of either antigen or antibody. The 
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immunoassay is based on the ability to measure the label 
with adequate sensitivity. 
Liposomal immunoassays can be designed, in contrast, in 
which many molecules of a label are entrapped within a 
liposome, and antibody or antigen can be coupled to the 
membrane surface. If the labels conventionally produce 
sensitive assays (e. g. fluorophors), the liposomes can be 
used to amplify the signal and result in even greater 
sensitivity. 
Coupling a single chromogenic molecule to an antibody or 
antigen would be unlikely to produce a measurable signal 
in an immunoassay. In the case of a liposomal chromogenic 
assay, however, the amplification can be used to provide 
sufficient sensitivity to produce a measurable 
spectrophotometric signal. The advantage in this case 
might be assay speed and simplicity, rather than extreme 
sensitivity. 
In clinical biochemistry laboratories, chemical analyses 
of common analytes (e. g. enzymes, glucose, urea etc. ) are 
generally performed by spectrophotometric analysers. 
These almost always use liquid reagents which are 
optimized to avoid separation stages, and enable rapid 
analysis of large numbers of samples. To be performed, on 
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these analysers, immunoassays require colorimetric 
markers and generally must be homogeneous (i. e. without a 
separation step). 
Immunoassays are at present usually performed on separate 
dedicated instruments (e. g. by radioimmunoassay (RIA) 
(5), fluoroimmunoassay (8), chemiluminescence immunoassay 
(9) or enzyme-linked immunosorbent assay (ELISA) (7)). 
They can be homogeneous (e. g. using fluorescence 
polarization immunoassays (8)) or heterogeneous, 
requiring a separation step (e. g. ELISA (7)). 
The development of homogeneous immunoassays with 
spectrophotometric detection might enable both chemical 
assays and immunoassays to be performed on a single 
spectrophotometric analyser. This would be likely to 
confer considerable organizational benefits. 
There are a limited number of alternative homogeneous 
immunoassays which allow colorimetric detection. 
Immunoturbidimetry (99) is one example. It is based on 
light scatter resulting from antibody-antigen reactions 
and is primarily restricted to large antigens (usually 
proteins). The performance of this technique may be 
compromised because of interference due to light 
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scattering by biological fluids and dust particles in 
reagents. 
Immunoturbidimetry is generally less sensitive than 
alternative immunoassay techniques (e. g. RIA). It is 
usually used to measure proteins of relatively high serum 
concentration, e. g. immunoglobulins, (approximately 0.5 
- 30 g/1). Urinary microalbumin (molecular weight 69000 
D), probably represents close to the limits of the basic 
technique, with respect both to molecular size and also 
to limit of detection (approximately 5- 20 mg/1). 
Although the basic immunoturidimetric technique is 
limited, particle enhancement (i. e. coupling of antibody 
or antigen to particles) can improve sensitivity (100). 
Latex is commonly used, although gold sols and 
erythrocytes have also been applied (100). Modifications 
to the technique also allow the measurement of smaller 
antigens, including drugs such as gentamycin and small 
hormones such as thyroxine. One such approach 
(manufacturered by Bayer plc) (101) involves linkage of 
the antigen to Ficoll (TMPharmacia). Ficoll has a high 
density, (it is also used as a density gradient medium), 
and agglutinates with microparticle-bound antibody in the 
absence of free antigen. The agglutination is inhibited 
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by the presence of free antigen, which competes for the 
antibody binding sites. 
There are a few other homogeneous immunoassay techniques 
which can be performed using spectrophotometric 
analysers, particularly for small molecules such as drugs 
(e. g. enzyme-multiplied immunoassay technique (EMIT) 
(TMSyva) (7) and CEDIA (TMMicrogenics)(102)). 
Although these alternative spectrophotometric assays are 
successful, none has become the established method of 
choice. They employ expensive reagents, and, because of 
the complexity of reagent composition, (and sometimes 
patent restrictions), it is not normally feasible for 
users to themselves develop new assays by these 
techniques. 
EMIT is generally based on inhibition of an enzyme's 
binding site by antibody in the absence of antigen. CEDIA 
involves the binding of two inactive portions of an 
enzyme; one of which is covalently bound to an analyte. 
Antibody binding to this conjugate inhibits activation of 
the enzyme, except in the presence of free antigen. 
In both assays, therefore, enzymes are used as the 
marker. The enzymes produce products which can be 
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measured spectrophotometrically. The enzymatic reaction 
is a further step which usually adds to the assay time 
and adds more components to the reaction mixture (e. g. 
substrates and co-factors). Some of these components, 
including the enzymes, may limit reagent shelf-life. 
A liposomal chromogenic marker, on the other hand, can 
produce a rapid signal (usually only depending on the 
rate of chromogen release), and the reagents will usually 
be simpler and more stable. 
The choice of liposomal marker may depend on several 
considerations and may not be the same for all 
applications. Aspects which may be important include 
technical feasibility and convenience, both in the assay 
and the availability or synthesis of reagents; safety, 
sensitivity, speed of analysis, matrix affects of the 
medium to be analysed, transferability of methods and the 
cost, both of reagents and equipment. 
1.6.2 Early Markers - Glucose and Electron Spin Labels 
The ability of complement to lyse antibody-coated 
liposomes was an early observation (103). IgM antibodies 
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were found to be more effective than IgG in initiating 
complement damage. These studies, mainly in the 1970s, 
used glucose as a marker (96,103) of complement-mediated 
lysis. The increase in absorbance at 340nm after reaction 
with hexokinase, glucose-6-phosphate dehydrogenase and 
NADP was measured. This only occurred if the glucose was 
released from the liposomes. It was thus unnecessary to 
separate the free glucose from the intact liposomes. This 
formed the basis of an approach later developed for 
homogeneous liposome immunoassays. Glucose is not an 
ideal marker because of its presence in a range of 
biological fluids. Nevertheless complement-mediated 
release of glucose has been used to test for specific 
immune reactions against lipids (104) and lipopoly- 
saccarides (105) incorporated into liposome membranes. 
Another early approach (92) involved the use of 
electron paramagnetic resonance spin labels to study 
liposomal membrane properties (90). Humphries and 
McConnell, (106,107) incorporated the water soluble 
electron resonance spin label, tempocholine, into 
liposomes. The encapsulated label produced a broad 
paramagnetic resonance signal of low amplitude. This was 
due to the close proximity of the spin molecules which 
could exchange signals. On release by complement- 
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mediated damage, the tempocholine was diluted and the 
signal alteration measured. M 
A similar spin label technique was used to measure 
thyroxine chemically coupled to liposomal membrane (94). 
Complement-mediated lysis was competitively inhibited by 
thyroxine in the sample. 
The use of spin labels has some advantages. Since they 
are not measured optically, they are less susceptible to 
some matrix effects of biological fluids, such as colour, 
turbidity or fluorescence. Spin resonance markers are 
also likely to have good sensitivity. However a limiting 
factor in its application is the need for sophisticated 
and expensive equipment which is not widely available. 
1.6.3 Enzymes, Chromophors and Fluorophors as Markers 
It was not until the mid-1980s that a series of 
publications began to appear using liposomes containing 
markers that might be more suited to routine analytical 
use, for example in clinical biochemistry laboratories. 
The main liposomal markers have been enzymes, 
fluorophors or chromophors (generally dyes). Each type of 
marker has its own particular potential advantages. 
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Enzymes have a capacity for sensitivity due to the 
amplification afforded by the enzyme reaction. However 
the need for the additional stages of the enzymic 
reaction may be disadvantagous compared to chromophors 
or fluorophors which can be read instantly. Fluorophors 
are probably capable of greater sensitivity than 
chromophors; however chromophors have the advantage of 
being measurable using the ubiquitous spectrophotometer. 
Assays using these various markers have been developed 
concurrently in recent years. Usually large unilamellar 
liposomes have been used. Some assays have been 
homogeneous (e. g. complement-mediated lysis) and some 
have been heterogeneous (e. g. coated tube) type assays. 
1.6.4 Assay Using Cardiolipin Antibodies and Arsenazo III 
In 1983, Janoff et al. reported an assay for the 
autoantibodies which are found in the sera of patients 
with systemic lupus erythematosus (108). These antibodies 
react with cardiolipin. When cardiolipin is incorporated 
into liposomal membranes, it can be induced to re-arrange 
from a lamellar to hexagonal (II) phase by divalent 
ions. In the technique, magnesium (II) ions were used to 
destablize and lyse the liposomal membranes. The presence 
of systemic lupus erythematosus serum prevented this re- 
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arrangement. The marker used was the dye, Arsenazo III. 
This dye undergoes a colour change from red to blue on 
release from the liposomes due to sensitivity to the 
divalent cations in the extra-liposomal solution 
(109). The method required only a one minute incubation 
at room temperature. Although developed as a method for 
qualitative screening of sera, the colour change was 
claimed to be quantitatively measurable. 
1.6.5 Complement-Mediated Assays Using Enzymes 
In 1984 applications using alkaline phosphatase as the 
enzyme marker and based on guinea-pig complement-mediated 
damage were reported for thyroxine and immunoglobulin G 
(IgG) (93). These were both homogeneous, "one stage" 
immunoassays (although sodium hydroxide was added to 
terminate the enzyme reaction). 
The assay for thyroxine involved a competition of 
thyroxine in the patients sample and thyroxine coupled to 
the liposomal membrane for free antithyroxine antibody. 
The antibody which became bound to the liposomes was 
inversely related to the concentration of the thyroxine 
in the sample. Complement in the solution invoked lysis 
and the released alkaline phosphatase was measured by its 
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action on the substrate, p-nitrophenylphosphate. The 
reaction was terminated by sodium hydroxide after thirty 
minutes and the absorbance at 410nm used to calculate the 
thyroxine in the sample. 
The assay for immunoglobulin G was also competitive and 
made use of the competition for complement of IgG in 
patients' sera and liposomal membrane coupled human IgG 
F(ab')2 fragments. The reaction conditions and timing 
were similar to those for the thyroxine assay. Both 
methods correlated well with existing methodologies. It 
should be pointed out, however, that the IgG assay made 
use of the special property of immunoglobulin for 
binding to complement. The assay is not universally 
applicable in its described form to other macromolecules 
which do not bind to complement. Since 1984, several 
assays using complement have been reported but most have 
measured small molecules. 
In 1986 Canova-Davis et al. (95) measured theophylline by 
a similar approach to that for thyroxine (93); a 
theophylline derivative of diphosphatidylethanolamine 
being incorporated into the liposomal membrane. This was 
used to induce lysis by antitheophylline antibody and 
complement. Lysis was inhibited by free theophylline from 
the patient's sample. The technique used glucose-6- 
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phosphate dehydrogenase as a marker. This had an 
advantage over alkaline phosphatase that it is not 
present in large amounts in serum. The enzymatic 
reaction was coupled with a dye, 2,6- 
dichlorophenolindophenol. The absorption of the dye at 
610nm was reduced by the presence of NADH, avoiding 
problems of absorption of reaction components (e. g. 
complement) in the ultra-violet range. The reagents, some 
in lyophilized form, were shown to be stable for at 
least four months at 5oC. 
In the same year (1986), Bowden et al. (64) used the 
complement reaction against antibody-sensitized liposomes 
to measure complement activity itself. Liposomes were 
produced incorporating a dinitrophenol derivative and 
reacted with antidinitrophenol antiserum and complement. 
The results obtained correlated with the haemolytic 
complement test (correlation coefficient(r) = 0.80) and 
also with complement components C3 (r=0.62) and C4 
(r=0.74). Alkaline phosphatase was used as the liposomal 
marker. The test was claimed to have the advantages of 
stability of reagents, simplicity and speed compared to 
other techniques to measure complement. 
Alkaline phosphatase was also used subsequently as a 
marker to demonstrate that albumin-coated liposomes 
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could be lysed by antialbumin antiserum and complement 
110,111). Competitive complement-mediated assays for 
phenytoin, phenobarbital and carbemazepine have also been 
described, using entrapped glucose-6-phosphate 
dehydrogenase (112). 
1.6.6 Complement-Mediated Assays Using Chromophors and 
Fluorophors 
Fluorescent markers become quenched if incorporated into 
liposomes at high enough concentration. The fluorescence 
increases as the fluoprophor is diluted on lysis of the 
liposomes (38-40,113,114). 
Umeda et al., in 1986, (115) reported a sandwich 
liposomal immunolysis assay for C-reactive protein using 
complement and carboxyfluorescein as marker. The assay 
is of interest as one of the few examples of a 
complement-mediated assay for a protein. Antibody to C- 
reactive protein was coupled to the surface of 
multilamellar liposomes. Incubation with C-reactive 
protein and unbound antibody caused complement-mediated 
lysis. 
In the following year Ligler et al. (98) produced a 
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competitive assay for the mycotoxin T-2 
(hydroxydiacetoxyisovaleroxyepoxytrichothecene) from 
Fusarium using a complement-mediated assay. This also 
used the fluorescent marker, carboxyfluorescein. 
Liposomes incorporating membrane-coupled T-2 were 
employed. These activated complement if incubated with a 
monoclonal anti T-2 antibody, but only in the presence of 
polyclonal anti-mouse immunoglobulin as a second 
antibody. In the presence of free T-2 toxin the lysis was 
reduced. This assay, which required only a thirty minute 
incubation, was claimed to be approximately ten times 
more sensitive than a conventional enzyme immunoassay 
which used the same antibodies. 
The same group subsequently described the coupling of 
Fab' fragments to liposomes using the method of Martin 
and Papahadjopoulos (with SMBP reagent) (79). They 
suggested these liposomes could be used in sandwich-type 
assays for large molecules but did not present supportive 
data (116). 
Nomura et. al. (117) showed that thyroxine can be 
measured by the inhibition of complement-mediated lysis 
using a colourimetric label. (Thyroxine had been measured 
earlier with an enzyme marker(83)). The label which was 
used was 2-(2-thiazolylazo)-4-methyl-5-(sulpho(-) 
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methylamino) benzoic acid (TAMSMB), which was 
encapsulated within small unilamellar liposomes. This 
reagent became coloured in the presence of cobalt(III) 
ions which were added to the reaction mixture at levels 
high enough to prevent interference from metal ions in 
the patient's sample. A good sensitivity (limit of 
detection almost 10-10mol/1) was claimed using this 
approach. 
More recently, fluorescence release has been used to 
measure levels of antibodies to cytochrome C and 
myoglobin. Complement-mediated lysis was induced in the 
presence of the respective antibodies. Carboxy- 
fluorescein-containing liposomes coated in antigen were 
employed (118). Gelonin, a polypeptide plant toxin, has 
also been estimated by a competitive complement-mediated 
assay, using gelonin-coated liposomes containing calcein 
(119). 
1.6.7 Melittin-Mediated Immunoassays 
Freytag et al. (113,114), in 1984, reported an assay for 
digoxin which was not dependent on complement. In this 
assay antidigoxin antibody competitively reacts with 
digoxin from the patient's sample and an ouabain- 
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melittin conjugate. (Ouabain was substituted for digoxin 
because of greater solubility). 
Melittin is a biological cytolysin which can lyse 
liposomes. If the ouabain-melittin conjugate is bound 
to its antiserum it loses lytic activity. This binding is 
competitively reduced by free digoxin (from the 
patient). The release of encapsulated alkaline 
phosphatase was monitored by the absorbance after 
reaction with p-nitrophenylphosphate. Although no assay 
performance data was presented this approach seems to 
offer the basis of a simple and rapid homogeneous assay 
for small molecules. It has the advantage that the 
liposomes used did not have to be modified by 
conjugation. 
A similar melittin-mediated assay for digoxin has since 
been reported, based on a chemiluminescence detection of 
released glucose oxidase, by measuring the enzymatically 
produced hydrogen peroxide using isoluminol (120). 
1.6.7 Assays Using Stabilized Liposomes 
Ho and Huang (54), in 1985, reported an approach that was 
innovative in two major respects. Firstly, it was the 
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first practical application of the reduction in quenching 
of a fluorophor, in their case calcein, as it is 
diluted as a marker in an immunoassay. Fluorescence 
quenching loss had been used five years earlier to 
assess the serum induced leakage of liposomes (65). 
The second innovation was the use of stabilized dioleoyl 
phosphatidylethanolamine(DOPE) liposomes. DOPE does not 
form stable liposomes at neutral pH and room temperature. 
However if certain materials such as the derivatives 
N- (dinitophenylaminocaproyl)- phosphatidylethanolamine 
(DNP-cap-PE) or glycophorin A, a glycoprotein, are 
incorporated into the membranes the liposomes can be 
stabilized. Ho and Huang (54) showed that if stabilized 
liposomes are incubated with immobilized antibody to 
either dinitrophenol or glycophorin A, the liposomes are 
destabilized and lysis occurs. This can be explained by 
the rapid random diffusion of antigen to the immobilized 
antibody where it is bound. Thus a lateral phase 
separation of membrane components leads to a localized 
relative depletion of the stabilizing antigen in a 
portion of the liposome. When this happens, the DOPE 
converts to an hexagonal (HII) phase and the liposomes 
lyse. 
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In the presence of free antigen or antibody the solid 
phase immunoreaction was inhibited and lysis was reduced. 
This formed the basis of an immunoassay for either 
antigen or antibody. The assays described had some 
practical limitations. The antigens (dinitrophenol and 
glycophorin A) are of restricted practical application. 
Also small unilamellar vesicles were used, (facilitating 
the incorporating of the stabilizing substances at the 
time of liposome synthesis). Finally the assay design 
was inconvenient (coated glass slides being used as a 
solid phase). Nevertheless the report was a novel and 
innovative immunoassay approach. 
The-same group subsequently reported a technique to 
detect cells infected with Herpes Simplex virus 
(HSV) (121). Again unsaturated phosphatidylethanolamine 
liposomes were used, but in this case stabilized by 
acylated-antibody against the virus. The antibody 
stabilized the liposomes until it bound to the virus 
membrane, when destablization occurred, probably by the 
mechanism described in the earlier report. The assay 
avoided the inconvenient solid phase of the previous 
study by, in effect, using the virus as a solid phase. 
Calcein and alkaline phosphatase were both used as 
markers. 
49 
1.6.8 Solid Phase Liposomal Immunoassay 
O'Connell et al. (48), in 1985, used antibody-coated 
tubes in an immunoassay for digoxin. Polypropylene tubes 
were coated with digoxin antiserum in glycine buffer 
(pH9.6). These were used in a competitive solid phase 
immunoassay, free digoxin from patients' samples 
competing with digoxinogen-coupled liposomes for binding 
to the tubes. (Digoxinogen is the aglycone of digoxin 
which is immunologically similar and is used because of 
greater stability). After a thirty minute incubation; the 
tubes were drained, rinsed and their contents released by 
lysis with detergent. The marker in this assay was the 
dye Sulphorhodamine B which was encapsulated in large 
unilamellar liposomes and which could be measured by its 
absorbance at 565nm. The liposomes showed good stability 
over six months; and the assay correlated well with 
radioimmunoassay and had acceptable precision. 
In a brief poster presentation (122), Vonk et al. 
entrapped a europium complex within liposomes in-order to 
detect the signal by time-resolved fluorescence. They 
claimed good sensitivity in micro-titre plate solid phase 
assays for human chorionic gonadotrophin and for 
thyrotropin. 
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One of the few commercially available liposomal 
immunoassays is a qualitative test based on a solid 
phased assay. In the Q Test for Group A Streptococci 
(TMBeckton Dickinson), throat swabs are inoculated onto a 
membrane impregnated with antibodies specific to the 
bacterial antigens. Specific antibody-coated liposomes 
are then added, together with a wash liquid. Liposomes 
remain bound to the centre of the membrane only in the 
presence of bacterial antigen (123). 
1.6.9 Potentiometric Detection of Liposomal Markers 
Monroe (16), in 1988, described the use of potentiometric 
detection of the components released from lysed 
liposomes. Ions which were impermeable to liposome 
membranes (e. g trimethylphenylammonium or tetraphenyl- 
ammonium ions (124) ) were able to be detected directly 
by ion selective electrodes. In an alternative approach, 
released markers such as enzymes (125) or glucose (126) 
could participate in reactions producing detectable 
species such as oxygen. This could confer an 
amplification to the signal. While requiring a degree of 
technical complexity, this approach has some advantages, 
such as the lack of interferences by turbidity of serum 
samples. 
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A procedure to measure theophylline has been reported 
using complement lysis of theophylline-coated liposomes 
and antiserum; in which horseradish peroxidase was used 
as the enzyme marker. The lysis was inhibited 
competitively by free theophylline from patients' 
samples. Once released the enzyme produced oxygen from 
hydrogen peroxide, which was detected by an oxygen 
microelectrode (125). A thirty minute incubation was 
sufficient to allow complement-mediated lysis and 
electrode equilibration. An alternative approach (16) 
used melittin conjugates to detect theophylline, (as 
described earlier (113,114)), and also used horseradish 
peroxidase to produce an oxygen electrode signal. 
1.6.10 Other Immunological Applications 
Durst et. al. (127) reported a liposome-enhanced flow 
injection immunoanalysis system. This was designed to 
allow competition between immobilised Fab' antibody 
fractions, antigen-coated liposomes encapsulating 
carboxyfluorescein, and free antigen from samples. The 
liposomes and sample were fed into an immunoreactor 
containing the F(ab)' fragments coupled to glass beads. 
The unbound liposomes then flowed into a chamber where 
they were lysed by surfactant injection and the released 
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contents passed 
measurement. The 
related directly 
sample. Critical 
hydrodynamics of 
same group, (128 
for theophylline 
to a fluorescence detector for 
strength of signal was claimed to be 
to the amount of free antigen from the 
aspects of this technique, such as the 
liposome flow, have been studied by the 
who have developed a competitive assay 
using this approach. 
Antibody-coated liposomes have been widely applied as 
means to target cells containing antigenic determinants 
of interest; either to enhance histological staining, 
for cell-biological studies or to assess the 
therapeutic potential of targeted liposomes prior to in- 
vivo use (36,37,129). Truneh et al. (36) applied mixed 
populations of two different antibody-coated liposomes, 
one type containing sulphorhodamine and one 
carboxyfluorescein, as multicolour immunofluorescence 
markers for both flow cytometry and fluorescence 
microscopy. A flow-cytometric assay for anticardiolipin 
antibodies has also been described (130), based on 
altered light scattering when the antibodies reacted with 
cardiolipin-containing liposomes. 
Antibody-bearing liposomes can also be used to enhance 
latex agglutination assays. An application for the 
detection of human rheumatoid factor has been 
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reported (131). Human rheumatoid factors are a class of 
immunoglobulin, predominantly immunoglobulin M. which 
binds heat-denatured immunoglobulin G. The conventional 
latex agglutination technique involves the agglutination 
of latex beads coated with heat-denatured immunoglobulin 
G by samples containing rheumatoid factor. The addition 
of liposomes coupled at their surface with anti-human 
immunoglobulin M, which bind to the rheumatoid factor 
sensitized latex, increases the speed and sensitivity of 
the latex agglutination. This enhancement seems to rely 
on the membrane characteristics of the liposomes since 
anti-human immunoglobulin M-coated latex particles do not 
themselves enhance agglutination. 
1.7 Non-Immunological Liposome Applications 
Not all the analytical applications of liposomes involve 
immunological techniques. One of the earliest 
applications, based on the loss of quenching of 
carboxyfluorescin following the lysis of liposomes, 
measured the lytic enzymatic activity of phospholipase C. 
an enzyme produced by C. welchii (132). The method 
involved a thirty minute incubation. It was claimed to 
be more sensitive, rapid and convenient than the 
conventional method which involves the digestion of a 
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lecithin dispersion followed by titrimetric estimation of 
the released fatty acids. A similar release of 
fluorescence was seen with phospholipases from other 
sources. 
Depending on the site of cleavage of the phospholipid 
molecule, other phospholipases may give similar release 
of liposomal contents. Phospholipase A is of clinical 
interest, since its concentration is raised in acute 
pancreatitis. Since a product of phospholipase A is 
lysophosphatidyl choline which has a detergent action, a 
degree of liposomal lysis seems likely. The 
phospholipases have been conventionally measured by 
titrimetry. Although simpler enzymic methods are now 
available (133), these still involve additions of several 
reagents. Liposomal assays might be considerably simpler 
and quicker. 
Another application is interesting since it made use of 
chemiluminescence (13), which has also been used as label 
in liposomal immunoassays. The application employed 
unusual small unilamellar vesicles made from the 
heterophilic compound, didodecyldimethylammonium bromide, 
which in combination with uranine and sodium hydroxide 
forms a chemiluminescent system (134). This system is 
sensitive to free cyanide ions, which could be measured 
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at levels much lower than can be obtained by conventional 
spectrophotometric or ion selective electrode methods. 
The sensitivity is thought to be due to an enhanced 
quantum efficiency and/or energy transfer efficiency in 
the ordered environment of the liposomal membrane. 
The effects of free radicals are another possible non- 
immunological area for liposomal assay development. 
Liposomes can be used to study or measure the effects of 
lipid peroxidation. This is a topical area; in light of 
the interest in free radical reactions, particularly 
relating to ageing processes, and in the therapeutic 
effects of anti-oxidants. Lipid peroxidation has been 
studied by analysis of the effects of factors such as 
ultra-violet light on the lipid composition of liposome 
membranes (135). An additional effect is the release of 
liposomal contents by membrane perturbation. This has 
been shown for liposomes containing glucose in response 
to chemical peroxidation by ferrous ions and ascorbate 
(136) and to ultra-violet light (137). It has also been 
demonstrated using chromium ion-containing liposomes in 
response to superoxide anions (138). A difficulty in this 
approach is the lack of stability of unsaturated 
phospholipids on storage. If this could be overcome; 
liposomes might provide a straightforward test for free 
radical reactions and anti-oxidant activity, perhaps by 
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dye release, as well as shedding light on the molecular 
and cellular processes involved. 
Two final applications suggest a role for liposomes in 
enhancing the performance of reagents used in other 
analytical techniques. In the first, Ullman et al. (139) 
used liposomes to compartment mutually reactive reagents 
within a stable single mixture. They applied this 
approach to an homogeneous EMIT (enzyme multiplied 
immunoassay technique) for theophylline. This normally 
requires separate addition of antitheophylline antibody 
and theophylline-glucose-6-phosphatase conjugate to the 
sample; premature mixing rapidly causing inhibition of 
the conjugate by the antibody. The authors encapsulated 
the conjugate within liposomes and found that more than 
92% of the conjugate activity was still present after one 
year in the presence of the antibody. At the time of 
assay, the liposomes were lysed by detergent in the 
buffer used to dilute the samples. The approach of 
combining reactive reagents using liposomes may have 
practical benefits for other techniques that use mutually 
reactive reagents. 
Another application of liposomes was an homogeneous 
signal amplification system (140). Dioleoylphosphatidyl- 
ethanolamine liposomes were stabilized by incorporation 
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of ganglioside GM1 (an alternative to glycophorin or 
dinitrophenol as used by Ho and Huang (54)). Ganglioside 
GM1 is a substrate for J-galactosidase, an enzyme used in 
some immunoassays. On exposure to ß-galactosidase the 
liposomes were destabilized and lysis occurred. This 
released entrapped glucose-6-phosphate dehydrogenase, 
which could be measured with a degree of amplification 
over the signal produced by ß-galactosidase. 
The ß-galactosidase produced by the CEDIA (TMMicrogenic) 
assay for digoxin was used to lyse the stabilized 
liposomes. This resulted in enhanced sensitivity due to 
signal amplification. Although the increase in 
sensitivity in this particular application was probably 
of limited clinical use, liposomes were demonstrated to 
have a role as secondary reagents to enhance the 
sensitivity of other immunoassays. 
1.8 Summary of the Analytical Applications of Liposomes 
Although the use of liposomes as analytical tools is 
quite a recent development there are already a number of 
reported applications. 
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A range of small molecules or "haptens" have been 
analysed including thyroxine (93,94,117), theophylline 
(16,95,128), digoxin (48,113,114) and mycotoxin T2 (98). 
Cyanide has also been measured by a non-immunoassay 
technique (134). 
Assays for antibodies against membrane components have 
also been relatively numerous, including assays for 
antibodies against cardiolipin (108), dinitrophenol and 
glycophorin A derivatives (54) and other membrane lipids 
or lipopolysaccharides (105-107). These assays either 
utilize complement-mediated lysis (105-107) or rely on 
the delocalization of stabilizing liposomal components 
(54). The latter technique was also applied to the 
measurement of Herpes Simplex Virus (121). 
There have been suprisingly few methods to measure 
protein antigens, despite the relative ease of protein 
conjugation methods and the theoretical simplicity of 
certain methods (e. g. coated tube techniques). 
No applications of either the membrane destabilization 
techniques (54,105-107,121) or melittin-induced lysis 
(113,114) have been reported for the measurement of 
proteins. Perhaps surprisingly, the solid-phase coated- 
tube technique (48) has not been widely used for 
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macromolecular antigens; although the only commercial 
application has been a qualitative solid phase assay for 
Group A Streptococcal antigens (123). 
Complement-mediated lysis has also been used to measure 
complement itself (64) and to assay immunoglobulin G, 
where the immunoglobulin competed for complement with 
membrane-bound immunoglobulin fragments. The enzymatic 
estimation of phospholipase C (132) and the augmentation 
of the latex agglutination method for rheumatoid 
factor(131) have also been reported. 
Assays involving complement-mediated lysis of liposomes 
have tended to measure either small molecules 
incorporated in the membrane or other lipid components. 
They have been shown to be a means of measuring the 
concentrations of antibodies specific to protein antigens 
on the liposomal surface (110,111,118). The plant 
polypeptide, gelonin, has been measured by a competitive, 
complement-mediated assay (119). 
There have been very few reports that antibody-coated 
liposomes can react with antigen and free antibody to 
induce complement-mediated lysis. This type of sandwich 
technique would be a simple and attractive means to 
measure protein antigens. One report has claimed success 
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in this approach, using liposomes coated with intact 
antibodies to CRP in a sandwich-type assay for C-reactive 
protein (115). 
Despite the limited number of published examples of 
its use to measure protein antigens, complement-mediated 
lysis is the most frequently adopted approach to 
liposomal immunoassays. 
1.9 Aims of the Project 
The primary aim of this project is to design liposomal 
assays and to examine their role in measuring analytes of 
clinical biochemical interest. Their advantages and 
disadvantages, relative to the wide range of alternative 
techniques available, will be examined. 
The choice of the encapsulated marker is necessarily a 
compromise between various advantages and disadvantages. 
The use of Sulphorhodamine B as a liposomal marker will 
be investigated. This dye can be measured 
spectrophotometrically, giving the possibility of assays 
easily applicable on readily available equipment; and 
also fluorimetrically, with the possibility of greater 
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sensitivity. It has the advantages of a high absorbance 
coefficient and is also highly soluble in aqueous 
solutions. 
An attempt to develop homogeneous liposomal immunoassays 
using Sulphorhodamine B will be undertaken. If 
Sulphorhodamine B is a useful marker it will be applied 
to model complement-mediated assays, since these are the 
commonest homogeneous type of liposomal assay and have 
been shown to be applicable to a wide range of analytes. 
The possibility of developing homogeneous complement- 
mediated assays for protein antigens will also be 
examined. Despite the potential usefulness of this 
approach, there have been few reports of successful 
assays of this type. 
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Chapter 2 
Preparation of Liposomes; Optimization of Sulphorhodamine 
B Incorporation and Spectrophotometric and Fluorimetric 
Properties of the Free and Encapsulated Dye 
2.1 Introduction 
A wide range of substances have been encapsulated within 
liposomes. Maximum incorporation is dependent on 
physical considerations such as size and charge of the 
encapsulated "marker". Despite this, it is usually 
difficult to make an accurate prediction of the 
conditions likely to optimize incorporation of a given 
marker because of. the number of variables involved. It is 
necessary to assess factors such as the types and 
combinations of lipids used, buffer pH and ionic strength 
in order to optimize incorporation. Consideration is also 
required as to whether these factors are most appropriate 
to produce liposomes with the desired characteristics 
for a given application; such as their stability under 
conditions both of storage and of use. 
The relative merits of differing types of liposomes in 
immunoassays was discussed in chapter 1 (section 1.6.1). 
63 
The reverse evaporation method is a convenient technique 
which produces large unilamellar vesicles (LUVs). These 
tend to have a higher capacity to incorporate aqueous 
material than other types of liposomes (section 1.3). 
The dye Sulphorhodamine B was considered as a potential 
aqueous "marker" to be incorporated into the 
liposomes. It has both a high absorbance coefficient and 
also a high aqueous solubility. These properties are 
predictable from the dye's structure (figure 2.1). The 
amino group is characteristic of the group of rhodamine 
dyes, which tend to be basic in character. However the 
presence of sulphite groups render Sulphorhodamine weakly 
acidic, with a net negative charge in near neutral pH 
solutions. The heterocyclic aromatic structure stabilizes 
the otherwise unstable pyrylium cation (-0+-). These ring 
structures are characteristically highly coloured . 
2.2 Preparation of Liposomes Incorporating 
125Iodine- 
Labelled Bleomycin 
Radiolabelled bleomycin was incorporated into liposomes. 
This was to obtain information of entrapment using the 
reverse evaporation method; with a view to its use as a 
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Figure 2.1 
Chemical Structure of Sulphorhodamine B 
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reference with which to compare subsequent incorporation 
of Sulphorhodamine B. 
A total of 66 umol of purified lipid consisting of 
PC/Chol/PTA (molar ratio 10: 2: 1) was dissolved in 2ml 
chloroform and 2m1 petroleum ether. 1 ml of phosphate 
buffer containing 1-125 bleomycin was added and the 
mixture sonicated for 2 minutes in a cold water bath at 
an amplitude of 10um. A further iml of phosphate buffer 
was then added and the suspension transferred to a long 
neck evaporating flask warmed in a water bath to 45°C. 
The organic solvent was removed by evaporation under 
reduced pressure. The suspension rapidly formed a gel 
which then collapsed to. produce an opalescent aqueous 
suspension containing liposomes. The liposomes were 
immediately purified by separation using Sepharose 4B gel 
filtration. 
Liposome preparation (0.5 ml) was applied to a 0.7 mm x 
20 cm gel filtration column containing Sepharose 4B, 
which had been pre-equilibrated with phosphate buffer. 
Fractions (1 ml) were collected using an automated 
fraction collector. 
The radioactivity of each fraction was counted over 100s 
in a gamma counter (figure 2.2). The liposomes eluted in 
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Figure 2.2 
Separation of Bleomycin-Containing Liposomes from Free Bleomycin 
Using Gel Filtration 
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Radioactive bleomycin-containing liposomes were formed by the reverse 
evaporation procedure and then separated using a Sepharose 4B gel filtration 
column. Fractions (1ml) were collected and their radioactivity measured (as 
described in section 2.2). 
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the void volume, as clearly seen by opalescence in these 
fractions, while the free bleomycin was retarded by the 
gel and formed a second peak of radioactivity. The 
radioactive counts in the liposomal fractions were 
divided by the counts in both peaks. This indicated a 30% 
incorporation of the radioactive bleomycin into the 
liposome fraction, which was similar to the incorporation 
of bleomycin obtained previously using a similar 
procedure (141). 
2.3 Examination of the Spectrophotometric and 
Fluorimetric Properties of Sulphorhodamine B in Aqueous 
Solution 
Solutions (0.1 mol/1) of Sulphorhodamine B supplied by 
Sigma was prepared both in distilled water and phosphate 
buffer. The impurities of the Sigma dye (30% by weight) 
were stated by the manufacturer to be non-chromogenic 
material, although the impurities could not be 
identified. They were not included in the molarity 
calculation. A confirmation that the impurities were 
non-chromogenic was obtained by comparing absorbances and 
scans with solutions of dye from Kodak which was more 
than 99% pure. Both solutions were diluted as 
appropriate, scanned spectrophotometrically and the 
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absorbance coefficient of the dye and their absorbance 
maxima determined. The spectrophotometric scans (figure 
2.3) and the molar absorptivity for both dyes appeared to 
be the same, discounting the sigma impurities. This was 
calculated to be 1.13x105 1 mol-1 cm -l at a wavelength 
maximum of 565 nm. At this wavelength Beer's law was 
found to be obeyed up to a concentration of approximately 
1.5x10-5 mol/l. Use of either distilled water or 
phosphate buffer did not alter the optical properties 
significantly. 
The dye solutions were found to fluoresce. The 
fluorimetric characteristics of the dye were examined 
and are described in appendix 2. 
There were no detectable fluorimetric differences 
between the two sources of dye, whether distilled water 
or phosphate buffer was used as a solvent, using an 
excitation maximum of 400 nm with an emission peak at 580 
nm. These wavelengths were selected as a means of 
measuring dye concentrations in subsequent studies. Using 
these wavelengths; the fluorescence of the dye was 
linearly related to dye concentration up to approximately 
6x10-6 mol/1, but above this concentration showed a 
quenching effect characteristic of fluorophors (figure 
2.4). 
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Figure 2.4 
Effect of Concentration of Sulphorhodamine B on Fluoresence Intensity 
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The fluorescence of Sulphorhodamine B was measured at various 
concentrations in distilled water. The excitation wavelength was 400 nm and 
the emission wavelength was 580 nm. A definition of fluorescence arbitrary 
units has been given in the materials and methods section. 
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As the properties of the two manufactures' dyes were 
similar the Sigma dye was used subsequently (except in 
later experiments to confirm similar liposomal entrapment 
of the two sources of dye (secton 2.11)). 
As the units of fluorescence were arbitrary, the 
fluorimeter was calibrated so that a2x 10-6 M dilution 
of Sulphorhodamine B produced 900 arbitrary units; using 
10 nm excitation and emission band widths. Under these 
conditions (ex. 400nm; em. 580nm), 4 arbitrary 
fluorescence units was approximately equivalent to an 
absorbance of 1 mA at 565 nm. However the fluorescence 
sensitivity could be increased by widening the band 
widths (as described in appendix 2). 
To examine the effect of pH on the absorption and 
fluorescence of the dye, 0.05M phosphate buffers were 
made up between pH2 and pH12 at pH2 intervals 
(using a phosphoric acid, phosphate salts and sodium 
hydroxide as appropriate). The spectra of the dye 
solutions were examined by both spectrophotometry and 
spectrofluorimetry. The effect of varying buffer strength 
was also examined by preparing a range of buffers of 
between 0 and 0.5M at 0.1M intervals. Neither alteration 
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of pH or buffer concentration between these limits had 
any detectable effect on the spectrophotometric or 
fluorimetric properties of the dye solutions. 
The effect of adding either ethanol or Triton X-100, both 
of which can be used to release the contents of 
liposomes, to solutions of dye was examined. Neither 
ethanol or Triton X-100 had any detectable effect on the 
spectrophotometric or fluorimetric properties of the dye 
at the maximum concentrations used in subsequent 
experiments (dilutions of 1: 50 for Triton X-100, and 1: 10 
for ethanol). 
2 .4 Procedure for Prep ari ng Liposomes Encapsulating 
Sulphorhodamine B by Rever se Evaporation Method 
Liposomes were prepared as described above (section 2.2) 
incorporating iml of 0.1 mol/1 Sulphorhodamine B in 0.05M 
phosphate buffer as the aqueous phase (rather than 
bleomycin). The incorporation was assessed using 
Sepharose 4B. A small volume (20 ul) of eluted 0.5ml 
aliquots was mixed with 100ul ethanol (to release 
entrapped dye from liposomes), then diluted in phosphate 
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buffer to give a measurable absorbance (total dilution 
usually 1/1000). Good separation of the liposomal and 
free dye peaks was obtained by Sepharose 4B 
chromatography (figure 2.5), the liposomes eluting in the 
void volume. The percentages of dye in the liposomal 
fractions were calculated to be 8.9% and 9.3% in 
consecutive preparations under these conditions. 
When, as a control, diluted free dye alone was applied to 
the column no detectable dye eluted in, the void volume. 
As a further control, the reverse evaporation technique 
was performed with free dye but without lipid. The 
position of the free dye peak was unaltered, indicating 
that the liposomal peak was not an artifact due to an 
effect of the procedure on the dye. The fractions 
containing liposomes were collected and stored at 4°C for 
further investigation. 
Ion exchange chromatography was carried out for 
comparison to gel filtration. The liposome preparation 
was eluted through a column containing Sepharose 4B- 
DEAE-CL. As in the case of Sepharose 4B the liposomes 
were eluted in the void volume and the percentage of the 
total dye in this fraction (elution of two preparations, 
7.8% and 9.5% respectively) was similar to Sepharose 4B. 
However the free dye could only be eluted using 6M HCl 
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Figure 2.5 
Separation of Sulphorhodamine B-Containing Liposomes from Free 
Sulphorhodamine B Using Gel Filtration 
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Sulphorhodamine B dye-containing liposomes were prepared by the reverse 
evaporation method and then separated from free dye usind a sepharose 4B gel 
filtration column. Fractions (0.5m1) were collected and measured 
spectrophotometrically (as described in section 2.4). 
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which was less practical and this technique was not 
pursued further. 
The presence of liposomes was confirmed by several means. 
Firstly, on microscopic examination of the liposomal 
fraction under high magnification (x400), liposomes were 
clearly visible as minute red coloured spheres 
(appendix 1). The liposomal fraction, although very red, 
was noticeably more turbid than the free dye fraction. 
The turbidity cleared on addition of ethanol or Triton 
X-100, which was presumed to be due to liposome lysis. 
It was found difficult to directly measure the amount of 
lipid eluted to establish that most was present in the 
void volume, in order to confirm this to be the liposomal 
fraction, because of the high absorbance of dye present. 
To provide evidence that this was the case, a separate 
identical liposome preparation was prepared in which the 
dye was replaced by phosphate buffer. The cholesterol was 
measured using a cholesterol oxidase procedure and 
compared to that included in the liposome preparation. 
90% of the added cholesterol was calculated to be eluted 
in the liposomal fraction (i. e. in the void volume). 
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2.5 Dialysis as a Means to Assess Liposome Stability 
The stability of liposomes can be defined as their 
resistance to loss of encapsulated material. As 
referred to in section 1.4, the term "lysis" is used to 
describe the process leading to release of this material, 
although the loss could be either by leakage or by 
rupture. 
To assess liposome stability the rate of dye loss from 
the liposome fraction obtained from Sepharose 4B 
filtration was measured. The fraction was dialysed 
against 40 times its volume in phosphate buffer at room 
temperature with rotary mixing. The absorbance of the 
dialysed dye was measured at frequent intervals. 
Under these conditions there was an initial rapid rate of 
dye dialysis. This decreased in an exponential manner 
towards equilibrium in 2-4 hours using 9/16 inch 
diameter dialysis tubing; or approximately 12 hours using 
1/4 inch diameter dialysis tubing. This was mainly 
attributable to dialysis of free dye present in the 
liposomal fraction. To show this free dye alone was 
dialysed and the dye completely equilibrated with the 
dialysis buffer within these time periods. Typically 
approximately 10% (range 5% to 20%) of the dye present in 
77 
the liposome fraction was found to be released at this 
stage. 
There followed a slower release of dye which was usually 
at a rate of less than 1% per 24 hours. This was 
attributed to the release of entrapped dye from the 
liposomes (Figure 2.6). This secondary slow rate gave an 
indication of the length of time a preparation would be 
usable as a reagent. To assess this, the dialysate 
absorbance was measured at least once a day over at 
least two weeks. The rate of release was found to be 
approximately linear over this period. Stabilities of 
liposomal preparations could be compared by calculating 
the percentage of the dye within the dialysis tubing 
released per 24 hours. The first 24 hours was excluded to 
reduce the effect of dialysis of free dye from the 
preparation. 
Similar experiments were conducted at 4°C to assess the 
stability of the liposomes under refrigerated storage 
conditions. For practical reasons, daily mixing was used 
rather than continuous mixing. At 4°C, the secondary rate 
of dye release was either very low (typically <0.1% per 
day) or immeasurable over a period of up to six months. 
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Figure 2.6 
Absorbance Changes in Dialysate of Sulphorhodamine B-Containing 
Liposomes 
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The absorbance of the dialysate was measured periodically, when 
Sulphorhodamine B liposomes (fraction from sepharose 4B) were dialysed 
against phosphate buffer (x40 volume) at room temperature (as described in 
section 2.5). The symbols on the graph refer to the following: (a) = period of 
release of free dye from within the dialysis tubing; (b) = period of release of 
liposome-encapsulated dye; (x) = extrapolated absorbance deduced to be due 
to free dye present at the initiation of dialysis. 
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2.6 Fluorescence Que nching of Liposome Preparations and 
its Use in Estimatin g Amount of Dye Entrapment 
The spectrofluorimetric properties of the free dye have 
been described in section 2.3. At the dye concentration 
incorporated into the liposomes the fluorescence was 
quenched (figure 2.4). The fluorescence remained quenched 
even when the intact liposomes were diluted since the 
concentration within the liposomes remained high. On 
lysis of the liposomes, the dye became sufficiently 
dilute that the solution fluoresced. This phenomenon, 
referred to as quenched fluorescence release, has been 
applied as a marker in immunoassays, as described in 
sections 1.4 and 1.6.6. 
Provided the entrapped dye is completely quenched and the 
liposomes are diluted sufficiently that on lysis there is 
no quenching, an estimate of the percentage of dye that 
is encapsulated in a preparation can be calculated. The 
following formulae, derived from the work of Weistein and 
Ralston (38) on the fluorophor, carboxyfluorescein, were 
applied to the prepared liposomes. 
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Fraction of dye in the liposomes = 
(1 - f/ft)/Qv (1) 
f= fluorescence before lysis 
ft = fluorescence after lysis 
Qv = Quenching Coefficient 
Qv =1- av (2) 
av = fluorescence of dye in liposomes (3) 
fluorescence of same concentration without quenching 
If the concentration is sufficiently high, av will be 0, 
in which case; 
%encapsulation = (1 - f/ft) x 100% (4) 
To estimate encapsulation in practice, a small amount of 
a liposome preparation (e. g. 20u1) was diluted in five 
times its volume of ethanol (e. g. 100ul), then vortexed 
briefly. A second aliquot was diluted to the same degree 
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in phosphate buffer. The mixtures were then both diluted 
in phosphate buffer to give fluorescences in the linear 
range (usually at least 1000 fold). The ratio of the two 
fluorescences were applied to formula (4) to calculate 
the percentage entrapment. (Duplicates were measured to 
minimise pipetting errors. ) 
It follows from equation (4) that the amount of 
fluorophor-release from a liposome preparation can also 
be estimated from the change in fluorescence. This can be 
calculated using equation (5), as long as the liposomes 
contained quenched fluorophor and the released fluorophor 
is sufficiently dilute not to be quenched. 
fluorophor-release (%) = 
(final fluorescence - initial fluorescence) x100% 
(maximum fluorescence (ft) - initial fluorescence) (5) 
The entrapments of dye in two liposome preparations 
(prepared as in section 2.5, but prior to gel fitration) 
were calculated from equation (4). This indicated 
slightly higher entrapments of 12.5% and 11.2% 
respectively, compared to 9.6% and 8.9% respectively for 
entrapments calculated by gel fitration. 
The validity of the technique depends on the absence of 
light scatter effects. This was assessed by extensive 
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dialysis of the preparations obtained by gel filtration 
(dialysed three times, each for 24 hours at 4°C, against 
fresh phosphate buffer) to remove free dye. The amount 
of dye release in the final dialysis was less than 0.1% 
of the total. The fluorescences of a dilution of 1/1000 
of the dialysed preparations were 2 and 4 arbitrary units 
respectively, while after lysis the fluorescences were 
450 and 459 respectively. This indicated an entrapment of 
over 99% in the dialysed preparation. The low 
fluorescence of the liposomes in the near absence of free 
dye suggested a lack of interference by light scatter 
from the liposomes. 
2.7 Comparison of Gel Filtration and Dialysis as Means of 
Purifying Liposome Preparations 
For several preparations, the entrapment calculated by 
gel filtration and dialysis were compared. In order to 
ensure the complete removal of the large amount of free 
dye from the liposome preparations (not subjected to gel 
filtration), they were each dialysed for two hours at 4° 
C against 40 times their volume of phosphate buffer, then 
dialysed three times more, each for 24 hours at 4°C 
against fresh phosphate buffer. 
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A higher percentage entrapment using the dialysis data 
was found (12.5% and 11.5%) compared to gel filtration 
data (9.6% and 8.9% respectively). Lack of complete 
dialysis seemed unlikely in view of the low release of 
dye in the final dialysis. Furthermore; fluorescence 
quenching release calculations of the level of entrapment 
(section 2.6) agreed quite closely with the dialysis 
data, and indicated greater than 99% encapsulation of dye 
in the final dialysed preparations. 
The apparent relative underestimation by gel fitration of 
entrapped dye in the liposome fractions, compared to 
dialysis or fluorescence quenching data, might appear to 
contradict the observation in section 2.5 that the 
post- gel filtration liposome fractions contain free 
dye. However, the two observations can be reconciled, by 
disruption of liposomes in passage through the column 
resulting in loss of entrapped dye from the liposome 
fraction. This would explain the lower calculated dye 
entrapment using gel filtration compared to the other 
techniques. The free dye in the liposome fraction 
suggests further destabilization of the liposome 
fraction resulting in further dye release at or soon 
after its elution from the column. 
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To investigate whether this apparent release of dye on 
gel filtration was simply related to the gel pore size, a 
liposome preparation was fractionated through Sepharose 
6B gel. This has a larger pore size than Sepharose 4B. A 
very similar separation and calculated entrapment was 
found for both types of gel (9.2 and 9.0% for Sepharose 
6B compared to 9.6% and 8.9% respectively for Sepharose 
4B). 
Thiomersal (0.01%) was used as a gel preservative and 
washed out with buffer before use. Loss of incorporation 
could be due to thiomersal; a residual amount of which 
may have been retained on the columns. To test this, 
liposomes were purified by repeat dialyses (as above), 
mixed with 0.01% thiomersal for 30 minutes, then 
redialysed. The release of dye was very small; being 
calculated as 0.2% dialysed. Furthermore, the 
thiomersal-treated liposomes had entrapment of greater 
than 99% of the dye using fluorescence quenching 
measurements. 
No marked difference in calculated entrapment by gel 
filtration was observed whether or not either 1 g/1 
bovine albumin (9.1%) or 1% normal sheep serum (9.5%) was 
added to the pre-equillibration and elution buffers; nor 
if distilled water was used in place of phosphate buffer 
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to elute the liposomes (8.8%). (Figures in brackets refer 
to the means of calculated entrapments from duplicate 
experiments). 
2.8 Effect of Encapsulation on the Spectrophotometric 
Properties of Sulphorhodamine B 
The optical properties of the dye in solution have been 
described (section 2.3). On encapsulation there was an 
unexpected change to the spectrophotometric scan of the 
dye. Figure 2.7 shows the scan between 500 nm and 600 nm 
of liposomes containing dye. The liposomes were prepared 
as in section 2.5, purified by Sepharose 4B, then 
dialysed three times against x40 volumes of fresh buffer 
at 40C, each for 24 hours, to remove free dye as 
completely as possible. The free dye's absorbance peak of 
565 nm was greatly reduced when the dye was entrapped in 
liposomes. There was a large second absorbance peak at 
530 nm for the entrapped dye whereas there was only a 
slight shoulder on the free dye scan. 
The liposomes were subsequently lysed by adding ethanol 
in the ratio of one volume to five volumes of the 
liposomes. When the liposomes were lysed the dye's 
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Figure 2.7 
Absorption Scans of Liposome-Entrapped Dye, Liposome-Entrapped Dye 
after Lysis by Ethanol and Free Dye 
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after lysis using ethanol; (c) free dye. 
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absorbance pattern changed to that of free dye (figure 
2.7). There was an increase in absorbance of 
approximately 2.2 times at 565 nm when liposomes 
containing entrapped dye were lysed. 
The effect was shown not to be an artifact of adding 
ethanol, by the alternative use of a detergent. 
Addition of a small volume of Triton X-100 to the 
liposomes (volume ratio 1- 50) produced the same effect. 
Sonication of the liposomes for two minutes caused a 
similar reversion to a free dye type scan by physical 
rather than chemical disruption of the liposomes. 
When a very low volume of Triton X-100 was added to 
liposomes diluted in phosphate buffer (one volume of 
Triton X-100 to 500 volumes of liposomes) the rate of 
decrease in absorbance at 530nm and the increase at 565 
nm could be monitored spectrophotometrically (figure 
2.8). The rate of absorbance change at either wavelength 
appeared to be constant over several minutes but 
eventually plateaued. This was concluded to be due to 
complete release of dye from the liposomes, since 
further addition of detergent did not cause any further 
absorbance change. The rate of absorbance change was 
dependent on the volume of Triton X-100 added, becoming 
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Figure 2.8 
Absorbance Changes on Lysis of Sulphorhodamine B-Containing 
Liposomes by Triton X-100 
r .ýft': 565 nm 
' "- t absorbance 
nrn 
565 
' erm 0 -i ' ; - , scan sp cm s 
1 cm 
Absorbance changes with time are shown. Triton X-100 was added to 
liposomes which contained Sulphorhodamine B (left). With the same solution 
in place in the spectrophotometer, the wavelength was rapidly changed from 
565nm to 530nm, and later to 565nm again. This was to demonstrate the 
reverse direction of absorbance changes at the two wavelengths. 
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almost instantaneous at higher detergent concentrations 
(e. g. 1- 50 ratio of detergent to liposomes). 
The absolute absorbances of a sample of dilute liposomes 
at either wavelength was found to be a combination of 
both entrapped and free dye. This meant that the 
absorbance at one or other wavelengths could not easily 
be used to calculate the absolute percentage entrapment 
of dye. In an assay, however, the total entrapment would 
be of less importance than whether the rate or extent of 
absorbance change reflected the rate or extent of dye 
release from the liposomes. 
The relationship between absorbance at either 530 nm or 
565 nm and the relative amounts of entrapped and free dye 
was investigated by combining free dye and a liposome 
preparation purified by dialysis (as above) in which 
more than 99% of the dye was estimated to be entrapped. 
These were both diluted to give approximately equal 
absorbances at 530 nm (figure 2-9a), then in a separate 
experiment to give approximately equal absorbances at 
565nm (figure 2-9b). The absorbances when various 
proportions of free dye and liposome dilutions were 
combined are shown in figures 2-9c and 2-9d respectively. 
There was an approximately linear inverse relationship 
between percentage of liposomes in the mixture and 
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Figure 2.9 
Absorbance Changes on Combining Diluted Liposomes Containing 
Sulphorhodamine B with Diluted Free Dye 
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Sulphorhodamine B solution was mixed, in various proportions, with liposomes 
containing the same dye. The liposome preparation had first been extensively 
dialysed to remove free dye. In (a) solutions of liposomes and free dye of 
equal absorbances at 530 nm were mixed in various proportions. Figure (c) 
shows the resulting absorbances at 565 nm. In (b) dye and liposomes of equal 
absorbances at 565 nm were mixed. Figure (d) shows the resulting absorbance 
changes at 530 nm. The percentages shown in each figure are the percentages 
of liposomes in the liposome-free dye mixture (inferred to be the percentages 
of liposome-entrapped dye). 
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absorbance at 565 nm in the first case, and a near linear 
positive relationship at 530 nm in the second case. 
These results are consistent with the view that the 
change in absorbance at 530 nm or 565 nm could be used to 
monitor release of Sulphorhodamine B dye from liposomes. 
This can be summarised by the following relationships; 
, N% dye entrapped = - kl A Ab565nm (6) 
6% dye entrapped = k2 b Ab530nm (7) 
4% dye entrapped = k3 A(Ab530nm Ab565nm) (8) 
2.9 Optimization of Incorporation of Sulphorhodamine B 
2.9.1 Procedure to Assess and Compare Incorporation and 
Stability 
Liposome preparations were submitted to Sepharose 4B gel 
chromatography and the percentage of the total dye in the 
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liposome fraction calculated as described in section 
2.4). The liposomes were then subjected to dialysis, (as 
described in section 2.5) with mixing, against x40 
volume of phosphate buffer. This allowed the stability of 
the liposomes at room temperature to be assessed. 
Stability was also assessed at 4°C by dialysis. While for 
practical reasons this did not employ constant mixing, 
dialysis experiments were mixed by hand daily. 
2.9.2 Effect of Various Lipid compositions on Dye 
incorporation and Stability 
The liposomes prepared using the conditions described in 
section 2.5 had given disappointing incorporations of 
dye of approximately 9% in the liposomal fraction after 
gel filtration. They were very stable however with very 
little dye release on dialysis over several weeks. 
Several other combinations of lipids were used to prepare 
liposomes using the same reverse phase evaporation 
technique. The results are shown in Table 2.1. Although 
it appeared that in general a slightly higher 
incorporation was obtained using lipids which were 
neutral, these liposomes showed poorer long term 
stability. It did not seem possible to improve 
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incorporation greatly by changing the type of 
phospholipid used. 
Since the dye is negatively charged at near neutral pH, 
the use of stearylamine containing liposomes, which are 
positively charged, might have been expected to increase 
incorporation by electrostatic attraction. However it 
proved impossible to form these liposomes. The dye and 
stearylamine appeared to interact to prevent liposome 
synthesis. No gel-phase formed during the rotary 
evaporation stage. After prolonged rotary evaporation, 
the lipid/dye/sterylamine mixture, which was milky in 
appearance, stayed at the top of the gel filtration 
column. Under the microscope, aggregates were observed. 
In a control experiment when dye was omitted, 
stearylamine liposomes formed readily. 94% of the 
turbidity at 250 nm of the sample applied to gel 
filtration eluted in the liposomal fraction. 
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TABLE 2.1 
Effect of lipid composition used in the reverse 
evaporation procedure on the liposomal entrapment of 
Sulphorhodamine B dye and on the stability of 
liposomes purified by gel filtration 
Lipid composition. %Dye Encapsulated. Lipid Charge. Instab. 
* 
PC-PTA-Chol 9.3 negative <0.1% 
(10-1-2) 
PC-PTA 8.6 negative 0.75% 
(10-1) 
PC-Chol 4.2 neutral 0.75% 
(10-2) 
PC only 10.6 neutral 1.5% 
PC-Chol-PG-PE 12.4 neutral 0.9% 
(30-10-3-1) 
PG only 13.5 neutral 2.5% 
not not 
PC-Chol-Stearylamine formed positive applicable 
* Instability calculated as % dye loss / 24 hrs on 
dialysis at room temperature excluding first 24 hours. 
values are means of duplicate preparations 
2.9.3 Effect of Dye Concentration on Incorporation and 
Stability 
Liposomes incorporating Sulphorhodamine B at varying 
concentrations were prepared to assess the effect of the 
dye concentration on encapsulation and stability. The dye 
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was found to be soluble at 0.1 mol/1 but at higher 
concentrations became saturated. To avoid this 0.1 mol/1 
was the maximum concentration used. 
The effect of dye concentration is shown in Figure 2.10. 
A greater percentage entrapment was found at lower 
concentrations such that, for a 0.02 mol/l dye solution 
there was incorporation of approximately 25% which is 
close to that found for bleomycin (section 2.3). However 
the higher incorporation was achieved by the undesirable 
means of initially diluting the dye, the intensity of 
which might be a major advantage in immunological 
applications. 
A measure of the total amount of dye entrapped can be 
calculated from the initial dye concentration, the 
initial volume of dye and the percentage incorporation. 
It was found that, although the percentage incorporation 
was increased by diluting the dye, the total amount of 
dye incorporated in each preparation was lower. This 
removed any advantage of using a more dilute dye (figure 
2.10). 
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Figure 2.10 
Relationship Between Dye Concentration used in Liposome Synthesis, 
Entrapment of Dye and Rate of Leakage of Dye from Liposomes 
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The concentration of dye used in the liposome synthesis was varied as 
indicated. Dye was dissolved in phosphate buffer (0.05M). The symbols used 
were as follows: dye incorporated within liposomes, expressed as a percentage 
"; incorporated dye expressed as an amount (calculated from the percentage 
entrapment and the amount of dye used in the liposome synthesis) Q; and rate 
of dye release from liposomes (percent per 24 hours) 0. 
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2.9.4 Effect of Buffer Composition on Incorporation and 
Stability 
Another variable which was examined was the effect of the 
strength of the phosphate buffer used to make up the dye 
solution. The incorporation and stability effects of 
varying buffer concentration are shown in figure 2.11. 
There was an increase in incorporation from approximately 
9.5% to approximately 13% if distilled water was 
substituted for 0.05M phosphate buffer. 
If the poor incorporation were due to an electrostatic 
effect, varying the pH of the buffer might alter the net 
charge on the dye or on components of the lipids and 
increase the incorporation. To test this, dye was 
prepared in 0.05 mol/l phosphate buffers between pH 2 and 
pH 12. A dye concentration of 0.1 mol/1 was used 
initially, but the experiment was repeated using 0.02 
mol/1 dye. At the lower dye concentration, the higher 
percentage entrapment gave a clearer indication of any 
incorporation changes due to pH. The results are shown in 
figures 2.12 and 2.13. At the lower dye concentration the 
highest incorporation was obtained at near neutral pH but 
incorporation was not very sensitive to pH over a range 
of approximately 5 to 9. The effect of pH on entrapment 
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Figure 2.11 
Relationship Between Buffer Concentration of Dye Solution Used in 
Liposome Synthesis, Liposomal Dye-Entrapment and Leakage of Dye 
from Liposomes 
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The concentration of phosphate buffer used to make up the Suiphorhodamine 
B solution was varied, and following liposome preparation, the liposome- 
incorporated dye (%) " and rate of dye release from the liposomes (% in 24 
hours) 0 were measured. 
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Figure 2.12 
Effect of pH of Buffer Used to Prepare Dye Solution on Liposomal Dye 
Entrapment and Leakage of Dye from Liposomes 
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The, pH of the phosphate buffer (0.05 moll! ) used to prepare the solution of 
Sulphorhodamine B (0.1 mol/1) was varied and following liposome 
preparation, the liposome-incorporated dye (%) " and rate of dye release from 
the liposomes (; % in 24 hours) o were measured. 
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Figure 2.13 
Effect of pH of Buffer Used to Prepare Dilute Dye Solution on Liposomal 
Dye Entrapment and Leakage of Dye from Liposomes 
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The pH of the phosphate buffer (0.05 moU! ) used to prepare the solution of 
Sulphorhodamine B (0.02 moll) was varied and following liposome 
preparation, the liposome-incorporated dye (%) " and rate of dye release from 
the liposomes (% in 24 hours) o were measured. 
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using the higher dye concentration was too small to be 
clearly defined. 
2.9.5 Effect of Cholesterol Content on Incorporation and 
Stability 
Cholesterol has been reported to have effects on liposome 
formation and stability (51). Various amounts of 
cholesterol were added to liposomes, without altering the 
molar ratio of PTA and PC. Figure 2.14 illustrates that 
cholesterol increased the incorporation although the 
liposomes became less stable. A cholesterol content of 
40% seemed a reasonable compromise between improved 
incorporation and loss of stability. 
2.9.6 Modifications to Original Reverse Phase Evaporation 
Procedure to Improve Incorporation 
The indications were that incorporation of dye could be 
increased both by reducing the buffer concentration and 
by increasing the cholesterol content of the liposomes. 
Liposomes were prepared containing 40% cholesterol and 
encapsulating Sulphorhodamine B (0.1mol/1) in distilled 
water. This procedure gave incorporations which were 
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Figure 2.14 
Effect of Cholesterol Content of Lipid Used in Liposome-Synthesis on 
Liposomal Dye Entrapment and Leakage of Dye from Liposomes 
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The cholesterol content of the lipid used in liposome preparation was varied 
and following liposome preparation, the liposome-incorporated dye (%) " and 
rate of dye release from the liposomes (% in 24 hours) o were measured. All 
overlaid points represent duplicate measurements. 
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considered satisfactory and approached that obtained for 
bleomycin encapsulation (section 2.3). There was a 
moderately increased instability at room temperature, 
although this was still probably acceptable for most 
applications. Table 2.2 compares the encapsulation and 
stability of these liposomes with the "original 
procedure" described in section 2.5. 
TABLE 2.2 
Liposomes prepared by modified procedure using increased 
cholesterol and dye solution in distilled water, compared 
with liposomes of lower cholesterol and dye in phosphate 
buffer (original procedure) 
Preparation 
_ 
%Dye Encapsulated Instability 
original 8.9 <0.1% 
9.6 <0.1% 
modified 20.0 0.8% 
.... 22.5 1.0% 
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2.9.7 Effect of Phosphatidyl Ethanolamine on Liposome 
Incorporation and Stability 
Phosphatidyl ethanolamine (PE) is commonly incorporated 
into liposome membranes to introduce amino groups which 
can be subsequently used in coupling reactions. The 
effect of adding various amounts of PE to liposomes was 
examined. The remaining lipid was in the same molar ratio 
as described in section 2.9.6. 
Figure 2.15 shows that in low amounts PE has little 
effect on either the amount of dye incorporation or the 
stability of the liposomes. 
2.9.8 Effect of Cardiolipin on Liposome Incorporation and 
Stability 
The introduction of cardiolipin into liposomes can 
enable their use as reagents in the detection of 
anticardiolipin antibodies (108). Cardiolipin was 
supplied in ethanolic solution, which had to be removed 
to prevent possible disruption of the liposomes. An 
appropriate volume (usually approximately 6 ml) of 
cardiolipin solution was dried in a rotary evaporator, 
redissolved in 6m1 chloroform, again evaporated to 
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Figure 2.15 
Effect of Phosphatidyl Ethanolamine Content of Lipid Used in Liposome- 
Synthesis on Liposomal Dye Entrapment and Leakage of Dye from 
Liposomes 
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The phosphatidyl ethanolamine content of the lipid used in liposome 
preparation (66 umol) was varied. Following liposome preparation, the 
liposome-incorporated dye (%) " and rate of dye release from the liposomes 
(% in 24 hours) o were measured. All overlaid points represent duplicate 
measurements. 
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dryness and finally redissolved in 2ml of chloroform. To 
this solution the other lipids, 2ml of petroleum ether 
and lml of dye were added and the reverse evaporation 
procedure carried out as described in section 2.5. 
The effect of incorporating cardiolipin into liposomes in 
various proportions of the total lipid is shown in figure 
2.16. As PTA and cardiolipin are both negatively charged 
lipids, it was suspected that PTA might not have a 
significant effect on entrapment in the presence of 
larger amounts of cardiolipin. Furthermore; decreasing 
the percentage incorporation of PTA in proportion to the 
other lipids at high cardiolipin contents reduced the PTA 
content to a very small, and not very accurately 
weighable, amount. Figure 2.16 shows that the presence 
or absence of PTA at two cardiolipin concentrations had 
little apparent effect and PTA was omitted from the 
third. Apart from PTA; the other lipids, cholesterol and 
PC, were incorporated in the same molar ratio as in 
section 2.9.6. 
The incorporation of dye was not found to vary greatly at 
molar compositions of cardiolipin up to 40% of total 
lipid. Incorporation of cardiolipin seemed to improve 
liposome stability at room temperature. Stability at 4°C 
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Figure 2.16 
Effect of Cardiolipin Content of Lipid Used in Liposome-Synthesis on 
Liposomal Dye Entrapment and Leakage of Dye from Liposomes 
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The cardiolipin content of the lipid used in liposome preparation (66 umol) was 
varied. Following liposome preparation, the liposome-incorporated dye (%) 
(closed symbols) and rate of dye release from the liposomes (% in 24 hours) 
(open symbols) were measured. All overlaid points represent duplicate 
measurements. Cardiolipin was incorporated either in the presence (circles) or 
absence (squares) of PTA (otherwise using the modified procedure, as 
described in section 2.9.6). 
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was measured over several months and indicated negligible 
release of dye. 
To compare experimental findings with those of Tashiki et 
al (142) who used liposomes of a lower cardiolipin 
content, liposomes were also prepared according to their 
directions. These contained 2.5% cardiolipin, 48.75% 
cholesterol and 48.75% PC. The liposomes were found to 
give an entrapment of 19.8% which was similar to that 
obtained for other cardiolipin compositions. 
2.10 Comparison of Fluorescence and Spectrophotometric 
Properties of Liposome Preparations 
A large number of the liposome preparations described in 
Section 2.9 were found to exhibit similar 
spectrophotometric scans to those shown in figure 2.7. 
This indicated that the shift in absorbance wavelengths 
compared to free dye was not dependent on the lipid 
types used to form the liposomes. Neither was there 
detectable variation in fluorescence properties when 
liposome preparations of various lipid compositions were 
compared. 
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2.11 Comparison of Liposomal Encapsulations of Kodak and 
Sigma Sulphorhodamine B Dyes 
Despite the presence of non-chromogenic impurities (30% 
by weight), the Sigma dye was demonstrated to show 
similar optical characteristics to a purer source of dye 
(Kodak) (section 2.3). Sigma dye was used subsequently. 
However, the dependence of dye entrapment on sodium 
phosphate buffer strength was subsequenly demonstrated 
(section 2.9.4). To assess whether the impurities in the 
dye might have affected percentage dye entrapment; 
liposomes containing the Kodak dye were prepared, using 
two different liposomal lipid contents and dye 
concentrations. The results, compared to those obtained 
using the Sigma dye, are shown in table 2.3. 
As additional evidence that the impurities did not seem 
to affect entrapment, a 0.5ml aliquot of Sigma dye (0.1M 
in distilled water) was added to a Sepharose 4B gel 
filtration column, and eluted using phosphate buffer (pH 
7.4,0.05M). The eluted dye fractions close to the dye 
peak (2 x 0.5 ml) were collected. The eluted dye was 
adjusted to 0.02M by addition of phosphate buffer (pH 
7.4,0.05M), and its entrapment was compared to that of 
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TABLE 2.3 
Comparison of Liposomal Entrapments of Kodak and Sigma 
Dyes 
Preparation Dye Concentration % Entrapment 
Kodak Sigma 
original 0.05M 16.5 17.5 
(section 2.5) (in phosphate buffer) 
modified 0.1M 22.5 21.7 
(section 2.9.6)(in distilled water) 
results are means of duplicate preparations 
dye diluted to the same concentration. The mean 
entrapment of two prepararations of the eluted dye was 
23.0%, while compared to the mean entrapment of the 
diluted dye of 24.3%. This again suggested that the 
impurities did not reduce entrapment, as might be 
predicted from figure 2.11 if the impurities were simple 
salts. In this experiment, however, there remained a 
possibility that impurities eluted with the dye. 
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2.12 Entrapment of Rhodamine B 
Although the studies centred on the use of 
Sulphorhodamine B, attempts were made to prepare 
liposomes containing Rhodamine B. Rhodamine B is a dye 
in the same class as Sulphorhodamine B, although it lacks 
the sulphite group, rendering it more basic. 
The dye was dissolved in water at a concentration of 
0.02M, and an absorbance coefficient of 6.45 x 104 1 
mole-1 cm-1 was found (maximum absorbance at 554 nm) 
(compared to 1.13 x 105 1 mol-1 cm-1 for Sulphorhodamine 
B at 565 nm). The dye was found to be insoluble in water 
at concentrations above 0.02M, and precipitated out 
rapidly on standing at 0.1M (the concentration used for 
Sulphorhodamine B). Liposomes were prepared using 
Rhodamine B (0.02M in water) (under the conditions of the 
original procedure, section 2.5), but no separation 
between free and entrapped dye was evident on gel 
filtration. None of the eluted fractions showed 
detectable shifts in absorption maximum. The failure to 
demonstrate significant entrapment, together with the 
lower absorbance coefficient and solubility, suggested 
the dye was a less suitable candidate for a chromogenic 
marker than Sulphorhodamine B. 
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2.13 Discussion 
Sulphorhodamine B was 
because of its high 
solubility in aqueous 
its potential, as 
analytical approaches 
and dye release. 
investigated as a potential marker 
molar absorbtivity and its good 
solutions. Fluorescence added to 
well as increasing the range of 
available for assessing entrapment 
A variety of techniques were available to assess 
entrapment and stability; including gel filtration, 
dialysis, fluorescence quenching release and 
centrifugation. The choice of techniques depended on 
their convenience in individual experiments. Gel 
fitration is a well established, simple, rapid and 
convenient method. It can also be subject to less sources 
of imprecision than dialysis which involves careful 
estimation of small volumes of preparations. For these 
reasons; gel fitration was used to obtain comparative 
data on the entrapment of dye in different liposome 
preparations, even though it was found to underestimate 
the entrapment approximately 10% compared to dialysis and 
fluorescence data. Another concern with gel filtration 
was the presence of a small proportion of free dye in the 
liposome preparation. These observations suggest the 
disruption of a small proportion of the liposomes during 
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their passage through the column. It was not possible to 
influence this underestimation by altering the pore size 
of the gel or factors which might affect electrostatic 
binding (e. g. buffer concentration). 
Problems with the use of 
fractionation of liposomes 
previously, due to non-specific 
onto gels (34). It seems likely 
could have accounted for the ob 
contents in this report. 
gel filtration in 
have been reported 
adsorption of liposomes 
that similar mechanisms 
served loss of liposome 
While gel filtration was considered acceptable to obtain 
comparative data, the potential losses of entrapped dye 
involved suggest that dialysis might be a preferable 
means to purify liposomes as part of liposomal 
preparations. However, in some instances dialysis would 
not be an option; for example if macromolecules such as 
proteins are being entrapped. It was not thought 
necessary in these studies to employ another alternative, 
centrifugation, as a purification technique. 
Dialysis was found more easily applicable to calculations 
of liposome stability. 
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The calculation of entrapment using the fluorescence 
quenching release technique was a very rapid method to 
assess new preparations. By taking sequential readings, 
it could also be used to assess liposome stability. The 
entrapments calculated in this way were as a rule within 
a few percent of dialysis data while somewhat higher than 
the data from gel filtration. Nevertheless, potential 
errors in this approach have not been extensively 
studied. Data obtained by this technique were generally 
used only as a check on data obtained by either gel 
filtration and dialysis, and were not included in this 
report. 
The use of Sigma dye, which contains non-chromogenic 
impurites, rather than a more pure Kodak dye, was 
considered justified because of its very similar optical 
properties. The presence of non-chromogenic impurities 
was not found to reduce entrapment; as might be predicted 
from the effects of buffer concentration (section 2.9.4), 
if the impurities were simple salts. If they were salts, 
is possible that the entrapment was not dependent. on 
their concentration below that found in the Sigma dye. 
Alternatively the impurities may be another material such 
as sucrose, which might not affect entrapment to 
measurable degree. 
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The differences in spectrophotometric absorption spectra 
of the entrapped dye, compared to free dye, were 
unexpected and do not appear to have been previously 
reported in liposomes. They seemed to be independent of 
the lipid composition of the liposomes. 
It is possible to deduce a mechanism for these 
differences based on earlier studies (143,144). 
Sulphorhodamine B is a member of the group of rhodamine 
dyes. Using optical cuvettes with very short path 
lengths; a similar type of shift in absorption spectra 
has been observed for other members of this group of 
dyes, using absorbance measurements at concentrations not 
normally measurable by conventional spectrophotometry. 
The altered absorption spectra at high concentrations 
have been attributed to dimerization of zwitterionic 
forms of the dyes, caused by hydrophobic interactions of 
the alkyl substituents. The blue shift in absorption 
maximum is characteristic of these interactions for the 
other rhodamine dyes, including Rhodamine B (143). The 
failure to show this for Rhodamine B in the present study 
(section 2.12), probably indicates that the entrapment 
conditions were unsuitable for Rhodamine B, which is less 
negatively charged at neutral pH than Sulphorhodamine B. 
The blue shift in absorption maximum is presumably 
accounted for by increased electron delocalization. 
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In these studies, the dye is held at high concentration 
within the liposomes. On release of the dye from the 
liposomes; it is diluted into the surrounding aqueous 
medium, resulting in a shift in absorption spectrum. 
It appeared possible in principle that the change in 
absorbances at 565nm and at 530 nm, either alone or in 
combination, could be used as a novel means to monitor 
liposome lysis. This would enable colorimetric assays to 
be developed which might be simpler or more convenient 
than alternatives such as fluorescence or enzyme release 
(as described in section 1.6.2). 
Because of the marked absorption shift due to 
Sulphorhodamine B dimer formation, another possible 
reason for an absorption change on encapsulation of a 
chromophor was not examined. It might to predicted that, 
at high enough concentrations, entrapped chromogen would 
have a lower absorbance than the equivalent amount of 
chromogen in free solution. This is because it is hard to 
see how the very high concentration of liposome-entrapped 
chromophor could obey the Beer-Lambert law (equation 3.1, 
section 3.4.3). 
This proposition is illustrated by the following 
hypothetical example. Suppose the concentration of dye 
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were such that virtually all the light waves falling on a 
liposome were absorbed in passing half way through it. 
The remaining 50% of dye in the liposome would not 
contribute to the absorption. At the same time, some 
light may pass through the solution without encountering 
a liposome. The absorption due to this portion of the 
light would be zero (or low, dependent on any non- 
liposomal absorbance). The net effect should be a 
reduction in absorbance compared to the equivalent amount 
of free dye, which would have a much lower concentration. 
This situation would seem analogous to the quenching 
effect of fluorescence at very high concentrations 
(described in section 2.6). 
Ethanol and detergent at high concentrations caused rapid 
release of liposome contents, apparently by complete 
disruption of the liposomes. At low detergent (Triton X- 
100) concentrations a slower release of dye was observed. 
The mechanism for the effect of Triton X-100 on liposomes 
is believed to be the formation of mixed micellar 
structures, after incorporation of the detergent into the 
lipid bilayer (145). 
The poor incorporation of dye could have been due to the 
choice of lipids, which would have formed negatively 
charged liposomes because of the inclusion of PTA. A 
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degree of exclusion of the dye may have occurred, since 
the dye is also negatively charged at near neutral pH. 
Although, in general, neutral liposomes showed a slightly 
higher entrapment than negatively charged liposomes they 
were also less stable. Positively charged liposomes 
containing stearylamine failed to form, apparently 
because of an interaction between stearylamine and the 
dye. It could be speculated that stearylamine-dye 
complexes may have formed by electrostatic interaction. 
These complexes may have aggregated by adopting micellar 
structures (2). 
Diluting the dye resulted in greater percentage 
entrapment, but less dye was entrapped in absolute 
amounts. One mechanism to explain the lower percentage 
incorporation at higher dye concentrations would be 
exclusion of dye by electrostatic repulsion. However, 
over quite wide pH ranges (pH 5- 9), entrapment seemed 
insensitive to changes in pH. 
Although initial dye entrapment was poor, extensive 
optimization of preparation conditions led to entrapments 
of over 20%, which was considered acceptable for the use 
of the liposomes in subsequent studies. This was achieved 
in part by increasing the cholesterol content. This was 
not unexpected, since cholesterol has been reported to 
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reduce the fluidity of liposome membranes by 
perpendicular packing at a level below the phospholipid 
head groups (52). An unpredicted increase in dye leakage 
occurred at the highest cholesterol content, of 
approximately 2% per day compared to 1% per day for 40% 
cholesterol content. This was despite a higher 
percentage entrapment at the higher cholesterol content. 
(figure 2.14). 
If the stabilizing effect of cholesterol is due to a 
decrease in membrane-fluidity, a parallel increase in 
liposome entrapment and stability might have been 
expected. It could be speculated that another mechanism 
may have contributed to the higher amount of leakage at 
60% cholesterol content. While liposomes composed of 50% 
cholesterol have been found to be stable; small 
unilamellar liposomes with 66% cholesterol content have 
been shown to be metastable, forming larger structures on 
standing (146). One possibility is that the liposomes 
containing 60% cholesterol in this study showed a small 
degree of structural rearrangement by a similar 
mechanism, which was sufficient to release dye at a 
higher rate. However, no microscopic evidence of such an 
effect was found. 
120 
Decreasing the buffer molarity also increased entrapment, 
perhaps by reducing electrostatic effects. 
The finally adopted preparative conditions showed 
acceptable stability of less than 1% leakage per day at 
room temperature and very low leakage rates at 40C. Small 
amounts of phosphatidyl ethanolamine, necessary for 
coupling of proteins to liposomes, had only a small 
effect on entrapment and stability. The inclusion of 
cardiolipin, used as an antigen in subsequent studies, 
marginally improved entrapment and liposomes were more 
stable at room temperature. 
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Chapter 3 
Liposomal Immunoassays for Serum and Urinary Albumin 
3.1 Clinical Value of Serum and Urinary Albumin Assays 
Albumin is normally the most abundant protein in the 
human plasma and it is a commonly measured analyte in 
clinical biochemistry laboratories. Its estimation in 
serum or plasma may be useful in assessing liver disease, 
poor nutritional status or prognosis in myeloma, in 
patients undergoing long term albumin replacement (e. g. 
parenteral nutrition) and in elucidating the cause of 
oedema. Albumin concentrations are also useful in 
assessing the free levels of constituents which are 
partially albumin-bound in the plasma, such as calcium or 
unconjugated bilirubin (147). 
Serum albumin is usually measured by chemical dye-binding 
methods which have been shown to lack specificity (148). 
In particular, bromocresol green (BCG) has been shown to 
overestimate results, particularly at low serum albumin 
concentrations. This is largely due to reaction with 
globulins, which can cause falsely elevated results in 
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the presence of acute phase proteins. The bias can be 
reduced by using short reaction times. An alternative 
dye-binding method, using bromocresol purple, has much 
greater specificity. Despite this -bromocresol purple has 
been slow to be adopted, mainly because animal-based sera 
react differently to human serum and cannot be used as 
calibrators. Participation in animal sera -based quality 
assurance schemes is also difficult, particularly if most 
other participants use a BCG method. 
Immunological methods are considered to be more specific 
than BCG. However they are more cumbersome to automate 
and are less popular. Assay methods have included radial 
immunodiffusion, electroimmunoassay, and more recently 
immunoturbidimetry and immunonephelometry. Both 
homogeneous and heterogeneous "labelled" immunoassays 
have also been described, for example using fluorescent 
labels (149). In addition, it is also possible to measure 
albumin by scanning densitometry following electro- 
phoresis; though this is relatively imprecise and is 
rarely used as a routine method. 
Urinary protein above 200 ug/minute (or approximately 200 
mg/1) is found in frank proteinuria. Albumin may be a 
major component of this proteinuria, for example in renal 
glomerular damage. Alternatively, there may be an "over- 
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flow" proteinuria caused by increased plasma proteins; 
for example immunoglobulin light chains in myeloma, or 
myoglobin in muscle trauma. The clinical significance of 
proteinuria has recently been reviewed (150). 
Urinary protein is usually measured by a chemical method, 
either as a semi-quantitative strip test or by a 
quantitative laboratory method. Both approaches lack 
specificity and may have different sensitivity to various 
types of protein (151,152). For these reasons urinary 
albumin, measured by an immunological method, may be 
preferable to total protein as an index of glomerular 
disease. 
Urinary albumin in the range between normal 
concentrations and those detected by the chemical 
methods normally used in strip tests (approximately 20 - 
200 mg/1), can be associated with subsequent nephropathy 
and other vascular disease. These levels are a 
significant risk factor in Diabetes mellitus. They are 
usually termed "microalbuminuria"; implying low (but 
increased) concentrations of albumin, rather than 
suggesting the presence an abnormally small albumin 
molecules. The term "pauci-albuminuria" has been 
suggested as a more appropriate description of 
microalbuminuria but not widely adopted. 
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In both insulin-dependent and non-insulin dependent 
diabetics, microalbuminuria is associated with poorer 
glucose control, raised arterial blood pressure and lipid 
abnormalities. As well as nephropathy, increased levels 
are associated with cardiovascular mortality and 
retinopathy (153,154). Microalbuminuria has also been 
shown to be a predictor of vascular disease in non- 
diabetics (155), and of increased mortality in the 
elderly population in general (156). 
Microalbuminuria clearly reflects generalized vascular 
disease and not only renal disease. A mechanism to 
explain this was put forward by Deckert et al. (157), who 
postulated a genetic polymorphism of enzymes involved in 
the metabolism of heparin sulphate proteoglycan. 
According to the theory, some diabetics have iso-enzymes 
that are susceptible to poor diabetic control. This 
results in a reduction in heparin sulphate proteoglycan, 
a component of the glomerular basement membranes, aortic 
myomedial cells, mesangium and endothelial plasma 
membranes. The consequential loss of glomerular membrane 
anionic charge results in albuminuria. 
Loss of heparin sulphate has a number of other 
consequences; including disruption of the microstructure 
of the glomerular basement membrane and increased pore 
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size, leading to a more generalised proteinuria. Heparin 
sulphate proteoglycan also has anti-thrombogenic 
properties. Its loss could result in microthrombi and/or 
platelet plug formation, which might ultimately lead, for 
example, to retinopathy. Heparin sulphate proteoglycan 
also binds to lipoprotein lipase, stimulating its 
activity, and inhibits smooth muscle cell proliferation 
in arteries. Its loss could be a promotor of 
atherosclerosis. The proposed genetic polymorphism would 
explain why only certain diabetic individuals develop 
microalbuminuria. 
The value of measuring microalbuminuria rests on the 
belief that careful treatment can reverse both 
microalbuminuria and its associated clinical 
consequences. This has been bourne out in trials; for 
example, one large study showed that intensive treatment 
of diabetes could reduce the development of 
microalbuminuria and its progression to frank 
proteinuria. The progression of retinopathy and 
neuropathy were also slowed. (158). Treatment relies 
mainly on control of glycaemia, blood pressure and 
protein intake. 
Accurate measurement of the low albumin concentrations 
found in microalbuminuria requires a specific 
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immunoassay. Gel-based techniques, such as radio- 
immunodiffusion (159) have been used to measure 
microalbumin. Current methods, however, mainly employ 
radioimmunoassay (160), assays using alternative labels 
such as fluorescence (161), and immunonephelometry or 
immunoturbidimetry (99). 
There have also been near-patient tests developed, which 
allow an estimate of microalbuminuria to be obtained 
quickly, perhaps during a patient's consultation. Like 
the laboratory methods, these are based on immune 
reactions, including latex agglutination methods (162) 
and ELISA methods (163). These methods often lack 
sufficient sensitivity to completely replace laboratory 
methods, at least for the present. 
There has been considerable debate as to the type, timing 
and storage conditions of microalbumin specimens which 
are optimal. Microalbuminuria has been defined as an 
albumin excretion rate of 20-200 ug/minute, which is 
approximately 30-300 mg/24 hours. Because of the 
inconvenience and difficulties in accurate timing of 24 
hour or overnight collections, untamed collections are 
usually collected. The first morning sample is often 
favoured, as this has been found to correlate most 
closely to a timed collection. 
127 
Some centres advocate simple concentration measurements, 
with a positive result being above approximately 20 mg/1. 
Errors in rates of water excretion are reduced by taking 
at least three specimens over several months. Two out of 
three increased levels is often taken as indicating 
incipient diabetic nephropathy. Others measure the 
albumin: creatinine ratio (164). This reduces the effect 
of changes in water excretion, but creatinine 
measurements in diabetics can themselves be problematical 
(165) and analytical errors may be compounded. 
There is little consensus as to whether samples should be 
stored refrigerated or frozen. Silva et al. (166) showed 
no significant difference between results of samples 
stored at -20°C for one month, or 4°C for either 18 hours 
or one week. Centrifugation of samples after freezing, to 
remove precipitate, did not appear to significantly alter 
the results. 
While albumin and microalbumin are frequently measured as 
indicators of renal disease and incipient renal disease 
respectively, it is not yet clear whether specific 
measurements of other urinary proteins might have 
greater prognostic value. For example, transferrin 
excretion is more often raised than microalbumin, both in 
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diabetic nephropathy (167) and in diabetic retinopathy 
(168). 
3.2 Aims of Liposomal Studies for the Measurement of 
Albumin 
Complement-mediated liposomal immunoassays have been 
described using a number of markers, such as enzymes, 
fluorophors and chromophors, as describes in section 1.6. 
Complement is used to lyse liposomes which have undergone 
an immune reaction at their surfaces. After optimization 
of entrapment of the dye, Sulphorhodamine B (section 2.9) 
it was shown to have potential uses as either a 
fluorogenic marker or as a novel chromogenic marker in 
immunoassays. The possible use of these liposomes 
containing Sulphorhodamine B in a complement-mediated 
immunoassay was examined, using serum albumin as a model 
assay to demonstrate the assay principle. The aim was to 
extend this assay to urinary albumin, should the model 
assay be viable. There do not appear to have been any 
previous reports of a liposomal immunoassay of human 
albumin in serum or urine. 
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3.3 Preparation of Albumin-Coated Liposomes 
Liposomes coated with albumin were prepared using the 
heterobifunctional reagent, N-succinimidyl 3-(2- 
pyridyldithio) propionate (SPDP) (described in section 
1.5.2) (78). The coupling method is summarized in figure 
3.1. 
3.3.1 Formation of Dithiopyridyl-albumin (DTP-albumin) 
DTP-albumin was prepared by a standard method essentially 
as described by Truneh et al. (36). An aqueous solution 
of purified human albumin (4 ml of 10g/1) was mixed 
gently with SPDP reagent in 140 ul methanol to give a 
molar ratio of SPDP to albumin of 10: 1 . The mixture was 
incubated at approximately 230C for 30 minutes with 
occasional stirring. The pH was then reduced to 
approximately pH 4.5 by the addition of 250ul of acetic 
acid, pH 3.0. 
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Figure 3.1 
SPDP-Coupling of Albumin to Liposomes 
1. Introduction of 2-pyridyl disulphide structures onto albumin (A) 
giving DTP-albumin. 
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2. Introduction of 2-pyridyl disulphide structures onto phosphatidyl 
ethanolamine (B) to give DTP-PE. 
3. Formation of liposomes incorporating DTP-PE. 
4. Thiolation of DTP-albumin using dithiothreitol (DTT). 
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5. Conjugation of liposomes and thiolated albumin. 
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3.3.2 Synthesis of Dipyridyl Phosphatidyl Ethanolamine 
(DTP-PE) and Liposome Formation 
DTP-PE was prepared using a standard method (36) adapted 
to allow its synthesis and its incorporation in the 
formation of liposomes to be completed within a working 
day. PE (6.9 mg in 300 ul chloroform), SPDP (3.75 mg in 
300 ul methanol) and triethanolamine (2.7 ul) were mixed, 
solubilized by brief heating to 300C and then incubated 
at room temperature for two hours. The organic phase was 
then washed once in phosphate buffer and twice in 
distilled water, centrifuging at 2000 xg for five 
minutes and discarding the aqueous phase at each stage. 
Chloroform (1 ml) was added prior to the last 
centrifugation step to facilitate complete removal of the 
final aqueous phase without excessive loss of the organic 
phase. A white precipitate which formed at the solvent 
interface could be reduced but not eliminated by the 
addition of a small amount of methanol. This precipitate 
was discarded after the final centrifugation, leaving a 
clear organic phase containing DTP-PE. 
The concentration of DTP-PE formed was estimated by the 
release of dithiopyridine as described by Truneh et al. 
(36). An aliquot (25 ul) of the organic phase was gently 
evaporated to dryness then immediately redissolved in "L 
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Buffer" (1 ml) with vigorous vortexing. The absorbance 
before and after adding 50u1 dithiothreitol (100 mM) was 
measured and the molar concentration of DTP-PE calculated 
as; 
(change in absorbance at 343 nm x (dilution factor)) / 
molar absorbance coefficient of dithiopyridine at 343 nm 
(8.08 x 103 M 
1cm 1). 
The DTP-PE was immediately incorporated into liposomes by 
the reverse phase evaporation method, described in 
section 2.9.6, including 2 umol of DTP-PE (typically 
approximately 0.5 ml). Aliquots of two preparations of 
liposomes showed entrapments of Suiphorhodamine B 
of 19.0% and 18.9% respectively on gel filtration which 
is similar to that which had been achieved when PE was 
incorporated in place of DTP-PE (figure 2.15). 
The liposomes were immediately filtered by passage 
through a 200 nm polycarbonate filter to increase 
homogeneity, then dialysed overnight (as section 2.8) to 
remove unencapsulated dye. The DTP-liposomes were then 
coupled to DTP-albumin within two days. 
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3.3.3 Coupling of DTP-Albumin to Liposomes 
Immediately prior to coupling with the liposomes 50 ul of 
dithiothreitol (500 mM) was added to the DTP-albumin 
preparation which was then incubated for 20 minutes at 
room temperature. The DTP-albumin was separated from the 
other reagents by gel filtration using Sephadex G50 
equilibrated in phosphate buffer. The protein content of 
the protein fraction, eluting in the void volume, was 
measured using the Coomassie blue method. 
Equal volumes of the liposomes and DTP-albumin reagent 
were mixed and incubated overnight at room temperature. 
The mixture was then applied to a Sepharose 4B column, 
the antigen-coated liposomes eluting in the void volume 
while the residual free dye and uncoupled protein was 
retarded by the gel (the latter demonstrated by the 
Coomassie blue method). 
The protein content of the preparation was determined by 
the Bio-Rad Coomassie blue method, modified for this 
purpose by solubilizing the lipid by the addition of 50 
ul ethanol to 20 ul of liposome preparation. The standard 
colorimetric procedure was then followed by adding 1 ml 
saline and 200 ul of Coomassie blue reagent, incubating 
at room temperature for 15 minutes and then measuring the 
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absorbance at 580 nm. It was also necessary to subtract a 
blank for the absorbance of Sulphorhodamine B at the same 
wavelength. In this case 9 g/l ("normal") saline 
replaced the Coomassie blue reagent. Ethanol (50 ul) was 
also added to the standards to compensate for the small 
additional effect of ethanol on the reagent. 
As mentioned previously (section 2.4), measurement of the 
lipid content of the liposomes was complicated by the 
interfering intense absorbance of Sulphorhodamine B. This 
was avoided by overnight dialysis of the preparations in 
the presence of detergent (Triton X-100) against a 1000 
fold excess of distilled water. Detergent lysis of the 
liposomes allowed the dye to be dialysed while the lipid 
was retained. Cholesterol was assayed by the cholesterol 
oxidase procedure after dialysis (allowing for dilution 
during dialysis) and the total lipid calculated as (moles 
cholesterol x 2.5). 
The retention of lipid 
detergent was verified 
contain dye (prepared 
experiments, the mean 
dialysed liposomes 
agreed acceptably with 
on dialysis in 
using liposomes 
as in section 
Cholesterol conce; 
was 5.2 
the cholesterol 
the presence of 
which did not 
2.4). In two 
atration of the 
mmol/1. This 
content without 
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dialysis (but diluted slightly to allow for a small 
volume increase during dialysis) of 5.0 mmol/l. 
Using these calculations a binding of 54 ug albumin / 
umol lipid was calculated to have been obtained. The 
protein content of the final preparation was 0.8 g/l. The 
absorbance was inferred to be 120 A at 565 nm (by 
measurement, following dilution to an absorbance below 
2). The liposomes formed were stored at 40C in a glass 
tube until used, showing negligible loss of dye over 
several months. In an assessment of instability (as 
described in section 2.6), the liposomes showed a leakage 
of 0.2% per 24 hours at room temperature. 
3 .4 Effect of Complement and Anti-Albumin Antiserum On 
Liposomes 
The reaction of complement and antiserum when combined 
with albumin-coated liposomes was examined by 
fluorimetric monitoring, using a spectrophotometer 
(SP1800), and also using an automated Cobas Bio 
centrifugal analyser. 
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3.4.1 Spectrofluorimetric Measurement 
To assess whether the release of dye by the addition of 
complement and antiserum could be monitored 
fluorimetrically, fresh guinea-pig complement (20u1) and 
liposomes (5u1) (free dye having been removed by 
dialysis) were combined with "buffer All (2ml) in a 
fluorimeter cell and mixed. The cell contents were 
monitored (ex. 405nm, em. 580nm) for five minutes without 
detectable fluorescence change. Antialbumin antiserum 
(20u1) was then added and the contents rapidly mixed and 
monitored. There was a rapid increase in fluorescence 
indicating liposomal lysis with dye release (figure 3.2). 
The complement-mediated lysis was found to be initially 
rapid but slowed so that only a small rate of 
fluorescence change occurred later than four minutes 
after mixing. 
As the lysis slowed but did not cease completely after a 
few minutes, the effect of complement over longer 
incubation times was investigated. Test tubes were 
incubated using the same components as above (figure 3.2) 
and the amounts of lysis were measured fluorimetrically 
at 20 minutes, 15 hours and 24 hours. The specificity 
of the lysis for the immune reaction was also assessed. 
Control experiments in which normal sheep serum or 
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Figure 3.2 
Change in Fluorescence Resulting from Complement-Mediated 
Immunolysis of Albumin-Coated Liposomes 
anti-albumin antiserum= 
ti 
min =1' 
=' lcm - 
The change in fluorescence with time is indicated, on addition of antialbumin 
antiserum (right of chart) to a mixture of albumin-coated liposomes and 
complement. The reaction conditions are described in section 3.4.1. The 
vertical scale chart gradations are equivalent to 9 arbitrary units. Arbitrary units 
have been defined in the materials and equipment section. 
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buffer A replaced the antiserum 
addition, a control experiment in 
heat-inactivated (incubated at 45°C 
carried out. The results are shown 
entrapment was calculated using eqi 
section 2.6, i. e. 
were performed. In 
which complement was 
for 45 minutes) was 
in figure 3.3. The 
cation (5) given in 
fluorophor-release(%) = 
(final fluorescence - initial fluorescence) x100% 
(maximum fluorescence (ft) - initial fluorescence) 
The initial fluorescence was taken as the mean of the 
duplicate tubes prior to adding the final reagent. For 
clarity the individual points at zero time are not shown 
in figure 3.3. None of the points differed from zero by 
more than 1% entrapment. 
When the order of addition of complement and antiserum 
was reversed (i. e. antiserum added first) a similar if 
slightly lower fluorescence rise was observed. Antiserum, 
or its substitute, was added as the final reagent in each 
control experiment. 
The initial rapid dye release only occurred when 
complement and antiserum were both present. Over longer 
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Figure 3.3 
Release of Entrapped Dye Measured by Increase in Fluorescence 
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incubation period (hours) 
Effect of various reaction mixtures on the percentage release of entrapped dye 
from the albumin-coated liposomes measured by reduction in fluorescence 
quenching (as described in section 2.6). Symbols are as follows: o antialbumin 
antiserum added after complement, " complement added after antiserum, - 
buffer substituted for antiserum, A normal sheep serum substituted for 
antiserum, 0 complement-heat inactivated, f buffer and liposomes only. All 
overlaid points represent duplicate measurements. 
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incubation periods, however, the slower release of dye 
was observed in several of the control experiments. The 
latter appears to be mainly though not entirely non- 
specific since a similar though slightly lower rate of 
release occurred when antiserum was replaced by either 
buffer A or normal sheep serum. This secondary rise was 
shown to be dependent on the presence of complement and 
was almost absent when the complement was heat 
inactivated. These results suggest the initial rise was 
due to complement mediated immune-lysis while the 
secondary lysis was, at least in part, a non-specific 
reaction (perhaps of complement with the liposomal 
phospholipid surfaces). 
The effects of varying antiserum, complement and liposome 
amounts on the initial rapid lysis were examined by 
incubating the reactants for twenty minutes at room 
temperature. The total volume was kept constant by 
varying the amount of buffer. In each case a blank 
fluorescence was taken immediately prior to adding the 
final reagent and this was subtracted from the 
fluorescence increase in order to estimate the amount of 
lysis. 
The immune lysis was found to be dependent on both the 
amount of antiserum (figure 3.4) and the amount of 
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Figure 3.4 
Effect of Varying Antiserum Amount on the Complement-Mediated Lysis 
of Albumin-Coated Liposomes 
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The reaction conditions were as described in section 3.4. The entrapped dye 
released was measured by the reduction in fluorescence quenching, as 
described in section 2.6. Overlaid points represent duplicate measurements. 
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complement (figure 3.5) added. For simplicity of 
experimental design, complement was added after antiserum 
in figure 3.4 and visa-versa in figure 3.5. The dye 
release was calculated from the fluorescence increase 
after twenty minutes (using equation 2.5, section 2.6). 
In both cases there was an optimum concentration above 
which the lysis decreased. This "hook effect" is 
reminiscent of other types of immunoassay such as 
immunoturbidimetry. Figure 3.6 demonstrates that both the 
amount and percentage of dye released were dependent on 
the amount of liposomes present. (Antiserum was added 
last). 
3.4.2 Spectrophotometric Monitoring of Complement- 
Mediated Dye Release 
The monitoring of quenched fluorescence released when 
liposomes lyse, as demonstrated above, has been used in 
immunoassays (see sections 1.4 and 1.6.6) which used 
fluorophors other than Sulphorhodamine B. The phenomenon 
of the absorbance change when Sulphorhodamine B is 
released, described in section 2.8, has not been adopted 
in an immunoassay previously and would be a novel 
application. To assess whether the release of dye by 
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Figure 3.5 
Effect of Complement Amount on Liposome-Entrapped Dye Release 
Measured by Fluorimetry 
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The effects of varying the amount of complement added to the reaction mixture 
which also contained antialbumin antiserum and albumin-coated liposomes. The 
reaction conditions are described in section 3.4. The entrapped dye release was 
measured by reduction in fluorescence quenching as described in section 2.6. 
Overlaid points represent duplicate measurements. 
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Figure 3.6 
Effect of the Amount of Liposomes Added to the Reaction Mixture on the 
Release of Entrapped Dye Measured by Fluorimetry 
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The volume of albumin-coated liposome preparation added to the reaction 
mixture was varied as described in section 3.4.1. The reaction mixture also 
contained antialbumin antiserum and complement. The release in 
Sulphorhodamine B was detected by a reduction in fluorescence quenching, as 
described in section 2.6. The increase in fluorescence is indicated 0. This was 
used to calculate the percentage release of entrapped dye ". Overlaid points 
repesent duplicate measurements. 
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complement-mediated immunolysis could be monitored 
spectrophotometrically, reagents were combined as 
described above (section 3.4.1) and monitored at 565 nm 
in a spectrophotometer. Changes in absorption analogous 
to those in fluorescence were indeed detected (figure 
3.7). When the order of addition of antiserum and 
complement was varied similar lysis rates were observed. 
3.4.3 Monitoring Entrapped Dye Release Using a Cobas Bio 
Automated Centrifugal Spectrophotometric Analyser 
Although spectrophotometric measurements of dye-release 
were possible, the manual analysis of large numbers of 
tubes was found to be impractical. For example, accurate 
timing of batches of tubes was difficult. Therefore a 
Cobas Bio Centrifugal analyser was used to assess the 
potential of the spectrophotometric monitoring of 
complement-mediated dye release as a routine procedure. 
The reactant conditions were optimized using different 
criteria to those in the manual assays described above. 
The Cobas Bio uses smaller total volumes and is 
restricted to two reagent additions so it was necessary 
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Figure 3.7 
The Effects of Adding Antiserum and Complement to the Absorbance of 
the Albumin-Coated Liposome Preparation 
s. l ... ýýr 
. "; 1. I. 1. i. i .{.! " !, fý . "1 .Fi, 
yý"F: ,, t 
I. 1" 
" 1. "1'1: "1+ ...:.; 
ý11. 
ý. 
'}.., . ';. 
'. i. 
". 
i... 
iý .i-.:. Lýýyi. ý.... ý'. w1 ý. "w... 
!- 
ýs il "' 'ý! ' '{ý i its. s" iiir'. ý:: 
": 
ý"iF { ;i `'}!: 'll Ef '"rý i s' 
irt 
ý'i}ý 
a. ?I }s ssý s: 
: Fs..:: e...! "i 
F: ' 'L, 
` 
'' rý. iFj' -º - 
,.!. 
.... 
i: "I' . 
ý: ý i"'yl r: 1 :f lid 
li 't 'ýý 1ý"ý; i "i, ; ;! 1"ýü 
ý 
liý 
ý1! 
'i j :: ""; 
( r.; ', .. 
t, ' 
"tý"ý, ,, 
sri 
ý" G ii. 
". ý1 y. 1'. 
L: ýta.:. +ý ... -. 
{-". 
". 
L". s}. '', nr. ' 
i 
""y.. 
l .: ý! 
'ý. 
a 
IFlI 1G : {I1'il: ý{a"i i +F Ij, 'sä:: 
: 
rl1li; { 
#a i1 
fF1 
'' 
.: 1" 
i 
1.: 
" 
ýý1 
.I". 1V 1ý. :"t "1 1' 
ý: i }1:: 1[ 11" 111 'ý- 
"ý"i 
1" 
} /"1 1". 1". ý:, 
:i 
{t C f` 
''111{1 ý"Fr 
ý! 
"! 
ý' 
"i+l 
. l. 
ý 
'" 
ý'. 
.1I 
ý_ :. -'"ý.. 1 ` is 'i.: 
ili1. ý !. '' q 
ý'L" ý'! 
1ý}; ý:. 
ý ýü_"FI '" p"'_týlll , 
ý_1^ 
1. I .r 
ýy` 
. ý_ : {, ý 
a. 
ýi{ 
!ýF:. 1it,! 
ý 
I. 
" 
1 Isi "I 
.. 
ý, 
' ý, 'Ij' "Ij " "ý. i .:. +' 
s'' 's ýs la 
. {,. .. 
t''s: 
I. 
rsI 
ý. 
if. lýýýr"! 
ýý"ýi 
ýi 7t 
t 
.: t", 'i.. "+"1 
t,! i "`. is1ý: 
ýL! '; 1 
"-ý, 
I`.. 
_. . ", ,. ="ý'E;; 1! "" `.. 
ý 
a' {: "E". 1 1 
Iß... 
1 
... _. 
ý" { "_1ý t"11ý: i.! :i 1ý" ý! {. s: {t.. "1ý1. l7,.. 1 'il"' i .. 1 "a ý"; 
",: i 
'; "is" 
`/'" 
"! " 
. 1ý: 
7. s. x. y ; "ieýt}ý"4 
Lf. 
l't 
"ý 
1 1; { ý, 
'^t; 171. 
 s4znýc: J i min air 
It 
1cm 
The absorbance changes which occurred when albumin-coated liposomes, 
antialbumin antiserum and complement were mixed are shown. The 
experimental conditions have been described in section 3.4.2. Antiserum and 
liposomes were first mixed (right of chart), followed by complement. In a 
separate experiment (centre) liposomes and complement were first mixed, 
followed by antiserum (right). The diluted liposomes had an initial absorbance 
of 0.344A and horizontal lines (right of chart) indicate absorbance increments 
of 0.02A. 
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to modify the reagent volumes and combine some reagents. 
As the Cobas could monitor reactions accurately over 
small time intervals shorter incubation times were used 
since this would contribute to a more attractive routine 
procedure. Another difference was in the amount of 
liposomes added to each reagent cuvette. A reasonable 
absorbance change was desirable but the initial 
absorbance of the liposomes at the wavelength used was 
limited by the optical specifications of the analyser. 
The Cobas is claimed to measure accurately at 
absorbances up to 3.0. However in practice liposomes were 
never used at concentrations which would give an 
absorbance above 2.0 using a1 cm pathlength; to ensure 
any procedures would be transferable, in theory, to other 
spectrophotometric instruments. 
The Cobas Bio operates by measuring absorbances 
vertically through the reaction cuvette contents rather 
than by the conventional method of reading across the 
cuvette with a fixed path length (usually 1 cm). This is 
feasible because the absorbance measurements are made at 
high centrifugal acceleration which flattens menisci and 
minimizes the effects of light scatter. 
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By Beer's law (equation 3.1), the absorbances measured by 
the Cobas are dependent on the total volume of reactants. 
A= ecl (equation 3.1) 
A= absorbance 
e= molar absorbance coefficient 
c= concentration 
1= path length 
A volume of 250 ui in a Cobas Bio cuvette was found to be 
equivalent to a path length of 1 cm. Total reaction 
volumes of as little as 60 ul could be used on the Cobas. 
It would have been possible, therefore, to add 
considerably larger volumes of liposomes in proportion to 
other reactants without exceeding the optical 
capabilities of the Cobas, than would be the case if the 
reaction path length were fixed at 1 cm. However it was 
decided to restrict the liposome volumes added to those 
that would give absorbance readings of no more than 2.0 
if the reaction volume had a path length of 1 cm. This 
was to ensure transferability of results to other 
spectrophotometric instruments, many of which operate 
using a1 cm path length. 
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If reactant volumes other than 250 ul were used, 
absorbance readings were adjusted by multiplying by a 
factor of (250/volume). This was to ensure equivalent 
absorbances would be obtainable with the same reaction 
conditions if reagents were scaled up in proportion in 
other instruments which use 1 cm path lengths. 
In initial experiments reagents were combined as shown in 
table 3.1 and absorbances monitored over three minutes. 
The absorbances obtained at wavelengths of both 565 nm 
and 530 nm were plotted (figure 3.8). A rapid initial 
rate of absorbance rise at 565 nm which slowed to a low 
rate over a few minutes was observed, similar in general 
to that seen in fluorimetric (section 3.4.1) or 
spectrophotometric (section 3.4.2) manual experiments. 
The initial reaction was more rapid, perhaps reflecting 
either the greater concentration of some reagents or that 
the Cobas was operated at 37°C rather than room 
temperature. At a wavelength of 530 nm there was a 
decrease in absorbance which mirrored the increase at 
565nm. This was consistent with the effects of dye being 
released from the liposomes, as described in section 2.8. 
The increase in absorbance at 565 nm was found to be 
greater than the decrease at 530 nm. 
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TABLE 3.1 
Reaction parameters used initially on Cobas Bio Analyser 
Complement-Mediated Immune Lysis 
R1 (reagent 1): 5ml buffer A plus 40u1 liposomes 
100 ul/cuvette 
sample: antialbumin antiserum (neat) 4u1/cuvette 
diluent: (distilled water) 10 ul/cuvette 
R2 (reagent 2): complement diluted x2 in distilled water 
4u1/cuvette 
Temperature: 379C 
Printout type: 3 (absorbance measurements) 
Assay process: R1, sample and diluent dispensed into 
cuvettes and mixed. Five minute pre-incubation. R2 added 
and readings taken at 10 second intervals over 180 
seconds (first reading after 3 seconds). 
To assess the effect of varying antiserum 
the above parameters were modified by 
sample volume to 30 ul and monitoring the 
range of antiserum dilutions as samples 
The amount of antiserum was calculated as 
neat antiserum present in the reaction 
concentration, 
increasing the 
reaction with a 
(in buffer A). 
microlitres of 
cuvette. The 
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Figure 3.8 
Absorbance Changes Measured by the Cobas Bio Analyser Due to 
Complement-Mediated Immunolysis of Albumin-Coated Liposomes 
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Absorbance changes due to Sulphorhodamine B release from liposomes 
monitored using a Cobas Bio analyser. Dye release resulted from the reaction 
of albumin-coated liposomes, antialbumin antiserum and complement. The 
stated reaction time excludes an automatic initial mixing time of three seconds. 
The reaction conditions have been described in section 3.4.3. 
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results (figure 3.9) showed a "hook effect", similar to 
that seen for fluorescence measurements (figure 3.4). 
There was a negligible rate when normal sheep serum was 
used in place of antiserum. 
To assess the effect of complement concentration on the 
reaction rate, complement diluted in buffer A replaced 
antiserum as "sample" and the antiserum was added as 
"R2". Again a "hook effect" was observed (figure 3.10) 
similar to that for fluorescence measurements (figure 
3.5). Negligible rate was observed when complement was 
heat inactivated (see section 3.4.1). When rabbit 
complement was used instead of guinea-pig complement 
there was a similar "hook effect" but the absorbance 
changes were lower. Human complement, examined under the 
same conditions, (as figure 3.10), failed to show any 
detectable concentration-dependent lysis and the maximum 
absorbance change was 2mA. 
It was possible to vary the reaction temperature on the 
Cobas Bio. This indicated the early rates of lysis to be 
temperature dependent (figure 3.11). However if the total 
absorbance change over three minutes or more were 
monitored, rather than initial rate, the temperature had 
little effect. 
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Figure 3.9 
Spectrophotometric Measurement of Effect of Antiserum Amount on 
Complement-Mediated Immunolysis of Albumin-Coated Liposomes 
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Various volumes of neat antialbumin antiserum (") or neat normal sheep serum 
(o) were added to the reaction cuvette of the Cobas Bio analyser. The reaction 
also contained complement and albumin-coated liposomes. The reaction 
conditions have been described in section 3.4.3. Overlaid points represent 
duplicate measurements. 
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Figure 3.10 
Effect of Varying the Amount of Complement on the Immunolysis of Albumin- 
Coated Liposomes 
140 
120 
goo 
ev 
80 
tu 
a, 
60 as 
ea 
N 
42 40 
tu 
20 
complement (ul) 
The effect of adding various volumes of neat complement preparation to the 
reaction cuvette, as described in section 3.4.3. The Cobas Bio cuvettes also 
contained albumin-coated liposomes and antialbumin antiserum. Symbols used 
refer to: "= guinea-pig complement, Q= rabbit complement, o= guinea-pig 
complement which had been heat-inactivated at 450C for 45 minutes. Overlaid 
points represent duplicate measurements. 
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Figure 3.11 
Effect of Temperature on Complement-Mediated Immunolysis of 
Albumin-Coated Liposomes 
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Effects of the temperature of the release of entrapped dye measured using a 
Cobas Bio Centrifugal analyser. Dye release was due to the reaction of 
albumin-coated liposomes, antialbumin antiserum and complement. (Reaction 
conditions are described in section 3.4.3). Symbols are: o= 25°C, f= 300C, 
-= 37°C. 
156 
0 50 100 150 
3.4.4 Inhibition of Complement-Mediated Immune Lysis by 
Albumin 
Competitive complement-mediated immunoassays are based on 
the inhibition of antibody binding to antigen-coated 
liposomes by free antigen. To assess whether the immune- 
mediated lysis of these albumin-liposomes could be 
inhibited by addition of albumin, various concentrations 
of albumin were added to reactants and monitored using a 
Cobas Bio. The buffer used was buffer A containing 
teleostean gelatin (lg/1) to minimize adsorption onto 
plastic surfaces. 
The conditions shown on table 3.1 were modified so as to 
mix albumin and antiserum and preincubate before adding 
complement and albumin-coated liposomes. The volume of 
the sample (albumin) was also increased to improve 
sensitivity. Antiserum and complement concentrations were 
re-optimised to give near maximal lysis under this 
modified order of addition. However similar dilutions to 
those found previously to be optimal (figures 3.9 and 
3.10) gave maximal rates of lysis. The preincubation 
period was increased to 15 minutes and the absorbance 
change over five minutes reaction was monitored. Since 
temperature had been shown to have only a small effect 
over this measurement period (figure 3.11) a temperature 
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of 250 C was used. The revised conditions are shown in 
table 3.2. 
TABLE 3.2 
Reaction Parameters to Demonstrate Inhibition of Lysis by 
Albumin on Cobas Bio Analyser 
R1 (reagent 1): Antiserum diluted x4 in Buffer A+1 
g/l gelatin; 20 ul/ cuvette 
sample: Purified human albumin diluted in Buffer A+1 
g/1 gelatin by doubling dilutions to concentrations 
between 8 mg/l and 4 g/1; 20 ul/ cuvette 
diluent: distilled water; 10 ul/ cuvette 
R2 (reagent 2): Buffer A+1 g/1 gelatin containing 
liposomes diluted 1/20 and complement (dilution x8); 10 
ul/ cuvette. 
Temperature 25°C 
Printout mode 2 (absorbance change) 
Assay process; R1 and sample (+ diluent) dispensed and 
mixed. 15 minute preincubation. R2 added and readings 
taken at 30 second intervals over 5 minutes. 
Under these conditions inhibition of lysis could be 
demonstrated using samples with albumin concentrations of 
between approximately 125 mg/l and 4 g/l, as shown in 
figure 3.12a. 
158 
A similar degree of inhibition was obtained when the 
pre-incubation period was reduced to only 10 seconds 
(figure 3.12b). 
Figure 3.12 demonstrates that in principle inhibition of 
lysis could be used to measure albumin concentrations. 
The range of concentrations found in human serum (usually 
20 to 50 g/1) might be measurable with appropriate 
dilution. To test this in practice, human serum was pre- 
diluted in buffer A (1/40) and assayed against a pure 
albumin standard curve. The samples were compared to a 
routine bromocresol green method (obtained by a Bayer 
Axon analyser). The comparison is shown in figure 3.13. A 
significant correlation was found (r = 0.96 p<0.01)). The 
regression equation was; 
y(liposomal albumin) = 1.02x(BCG albumin) - 1.93 
Despite the reasonable regression equation and 
correlation for serum albumin, the assay could not 
measure below approximately 125 mg/l (figure 3.12) under 
these experimental conditions. This was too high to 
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Figure 3.12 
Effects of Pre-incubation Period on Inhibition of Liposomal Lysis by 
Albumin 
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The effects of pre-incubation time on the inhibition of lysis by albumin, of 
albumin-coated liposomes in the presence of antialbumin and complement. The 
reaction conditions are described in section 3.4.4. 
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Figure 3.13 
Comparison Between Serum Albumin Concentrations Obtained Using 
Liposomal Immunoassay and BCG Chemical Method 
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Thirty two human serum samples were measured by both the liposomal 
immunoassay and by a chemical bromocresol green (BCG) method (as 
described in section 3.4.4). The measured concentrations are compared. 
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accurately measure urinary microalbuminuria, for which a 
limit of detection of approximately 5 mg/l would be 
desirable. 
The effects of decreasing the amount of bound albumin 
were examined as a means to potentially improve 
sensitivity. Liposomes were prepared as described in 
section 3.3.2; except that the amount of PE coupled to 
SPDP and incorporated into the liposomes was reduced 
from 2 umol per preparation (66 umol) to 0.4 umol per 
preparation. This resulted in a reduced protein: lipid 
ratio of 66 ug albumin: umol lipid (compared to 216 
ug/umol using 2 umol PE (section 3.3.3)). 
The lysis of these liposomes was monitored using the 
Cobas Bio procedure described in section 3.4.3. The 
optimal antiserum dilution was approximately 10 ul per 
cuvette and the optimal complement dilution was 
approximately 2 ul per cuvette. These were similar to 
those for the liposomes prepared using 2 umol PE. 
However the absorbance change under these reaction 
conditions was 40 mA, compared to 140 mA found using the 
previous liposomes (figures 3.9 and 3.10). 
Because the small absorbance change it was not 
feasible to set up a precise inhibition assay. 
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3.5 Preparation of Antialbumin Liposomes and Effects of 
Complement 
In a further attempt to develop an assay of greater 
sensitivity; antialbumin-coated liposomes were prepared 
to assess their response to complement-mediated 
immunolysis. The liposome synthesis was as described for 
albumin-coated liposomes (section 3.3.1); except that 
sheep anti-albumin antiserum (purified IgG fraction, 7.0 
g/1) was substituted for albumin and DTP-antialbumin, 
rather than DTP-albumin, formed. 
The protein and cholesterol contents of the final 
liposome preparation were measured as described in 
section 3.3.3. The binding was estimated to be 72 ug 
immunoglobulin / umol lipid. 
The stability of the liposomes was assessed by dialysis 
(as described in section 2.6) and the preparation gave a 
leakage of 0.3% per day at room temperature and 
negligible (<0.1%) at 4°C. 
The responses of the liposomes to various combinations of 
complement, antigen, antibody, and also a donkey anti- 
sheep second antibody, were assessed. Change in 
fluorescence over a given time was used as an indicator 
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of dye release (see section 2.7). Typical results are 
shown in table 3.3, based on the following experimental 
protocol. 
Liposome preparation (10 ul) was mixed with 100 ul of 
various solutions (see table 3.3) and 
with buffer A. After 20 minutes incubat 
of guinea-pig complement (in buffer A) 
for the control) and the fluorescence 
further 20 minutes, also at 37°C. 
made up to 2 ml 
ion at 37°C, 20 ul 
was added (except 
measured after a 
Dye release was 
calculated using the formula derived from section 2.6; 
i. e dye release = 
(final fluorescence - initial fluorescence) 
(maximum fluorescence - initial fluorescence) 
The initial fluorescence was 14 arbitrary units and the 
maximum possible fluorescence was 405 arbitrary units, 
established by adding 5 ul Triton X-100 to liposomes 
diluted to the final volume. 
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TABLE 3.3 
Effects of Various Sera and Serum Constituents on 
Liposomal Dye Release 
Solution IFl. Increase I Dye Released (%) 
(a) I (b)(mean) 
donkey anti-sheep serum 18 17 4.5 
(1/5 dilution) 
human serum albumin 12 12 3.1 
(800 mg/1) 
human serum albumin 14 12 3.3 
(800 mg/1) plus 
sheep anti-albumin 
(1/5 dilution) 
normal sheep serum 14 14 3.6 
(1/5 dilution) 
normal sheep serum 10 10 2.6 
(1/5) in buffer 
replacing complement 
Although a slight dye release was obtained using donkey 
anti-sheep antibody compared to the normal sheep serum 
control, no increase in lysis was observed by the 
addition of serum albumin, with or without free sheep 
anti-albumin. These results suggested that liposomes 
coated with anti-albumin could not be used in a 
complement-mediated immunoassay for albumin. 
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3.6 Complement-Mediated Immunolysis of Liposomes Coated 
with Antialbumin Fab' Fragments 
3.6.1 Preparation of Fab' Antialbumin Liposomes and 
Complement-Mediated Immunolysis 
Liposomes were prepared coated in Fab' fragments to 
assess their suitability for complement-mediated 
immunolysis. The procedure for preparation of antialbumin 
liposomes was followed (section 3.3), except anti-albumin 
Fab' fragments (9.6 g/1) replaced albumin in the 
formation of DTP-Fab' (section 3.3.1). The DTP-Fab' was 
coupled immediately to liposomes, to reduce any 
potential cross-linkage with Fab' thiol groups. The 
binding of Fab' fragments was calculated to be 237 ug 
protein/umol lipid. The liposomes, like intact 
antialbumin liposomes, (section 3.5), showed good 
stability with leakage of less than 0.1% per day at room 
temperature and at 4°C. 
Unlike intact antialbumin liposomes; preliminary 
spectrophotometric and fluorimetric assays, similar to 
those in section 3.4.1 and 3.4.2, demonstrated 
complement-mediated immunolysis when the Fab'-coated 
liposomes were mixed with human albumin and sheep 
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antihuman albumin (intact). This was examined using a 
Cobas Bio (as described for albumin-liposomes in section 
3.4.3). The reaction conditions shown in table 3.4 were 
used to assess the effects of variation in complement 
concentration on the reaction. These effects are shown in 
figure 3.14. The lysis was positively related to the 
complement concentration. No maximum lysis or "hook 
effect" was observed, in contrast to that seen for lysis 
of albumin liposomes (figure 3.5). 
Table 3.5 indicates the assay conditions used to optimize 
antiserum concentration. The resulting absorbance changes 
are shown in figure 3.15. 
Using optimized conditions for anti-albumin, at the 
complement concentration giving near-maximum lysis, the 
absorbance changes for the reaction was monitored over 
approximately 30 minutes (assay parameters as table 3.6). 
Liposomes were, for comparison, combined with complement 
in reagent 1 (R1) immediately before assay. However, 
delays between combination of liposomes and complement of 
up to at least 45 minutes had no observed effect on the 
reaction rate. 
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TABLE 3.4 
Reaction Parameters used on Cobas Bio Analyser to Assess 
Effects of Complement Concentration on Liposome 
Lysis 
R1 (reagent 1): buffer A plus liposomes (1/20), 20 
ul/cuvette 
sample: guinea-pig complement dilutions in buffer A plus 
200 mg/1 human albumin (pure); 20u1/cuvette 
diluent: (distilled water); 10 ul/cuvette 
R2 (reagent 2): antialbumin (1/4); 10ul/cuvette 
Temperature: 250C 
Printout type: 3 (absorbance measurements) 
Assay process: R1, sample and diluent dispensed into 
cuvettes and mixed. 5 minute pre-incubation. R2 added and 
readings taken at 30 second intervals over 5 minutes 
(first reading after 3 seconds). 
Reaction Parameters used on Cobas Bio Analyser to Assess 
Effects of Antiserum Concentration on Liposome Lysis 
R1 (reagent 1): buffer A plus liposomes (1/20) plus 
albumin (pure) 200 mg/1; 20 ul/cuvette 
sample: antialbumin antiserum dilutions in buffer A; 
20ul/cuvette 
diluent: (distilled water); 10 ul/cuvette 
R2 (reagent 2): complement (neat); lOul/cuvette 
Temperature: 250C 
Printout type: 3 (absorbance measurements) 
Assay process: R1, sample and diluent dispensed into 
cuvettes and mixed. 5 minute pre-incubation. R2 added and 
readings taken at 30 second intervals over 5 minutes 
(first reading after 3 seconds). 
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Figure 3.14 
Effect of Varying the Amount of Complement on the Immunolysis of 
Fab'-Coated Liposomes 
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The effect of varying the volume of neat complement preparation added to the 
Cobas Bio reaction cuvette. The reaction mixture also contained liposomes 
coated with antialbumin Fab' fraction, human albumin and free antialbumin 
antiserum. The reaction conditions are described in Table 3.4. 
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Figure 3.15 
Effect of Varying the Amount of Antiserum on the Complement- 
Mediated Immunolysis of Fab'-Coated Liposomes 
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The effect of varying the volume of neat antialbumin antiserum added to the 
Cobas Bio reaction cuvette. The reaction mixture also contained Fab' 
(antialbumin)-coated liposomes, human albumin and complement. The reaction 
conditions are described in Table 3.5. 
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TABLE 3.6 
Final Reaction Parameters used on Cobas Bio Analyser 
for Complement-Mediated Immune Lysis of Fab' Liposomes 
Ri (reagent 1): buffer A plus liposomes (1/20) and 
complement (guinea pig) (1/4); 20 ul/cuvette 
sample: albumin (e. g. urine or standard); 20u1/cuvette 
diluent: (distilled water); 10 ul/cuvette 
R2 (reagent 2): anti-albumin (1/3); lOul/cuvette 
Temperature: 25°C 
Printout type: 3 (absorbance measurements) 
Assay process: Rl, sample and diluent dispensed into 
cuvettes and mixed. 5 minute pre-incubation. R2 added and 
readings taken at 1 minute intervals over 30 minutes 
(first reading after 3 seconds). 
A more gently plateauing in reaction was observed under 
these conditions (figure 3.16), compared to earlier 
reaction curves using albumin-liposomes (cf. figure 3.8). 
A small decrease in absorbance in the absence of albumin 
was observed. This was initially attributed to an 
artifact caused by instrument drift over the 30 minute 
reaction period. To increase sensitivity, although at 
some sacrifice in assay speed, a reaction time of 30 
minutes was adopted subsequently. 
Human teleostean gelatin (lg/1) was added to the Buffer A 
in order to minimize any absorption of albumin onto 
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Figure 3.16 
Absorbance Changes Over Prolonged Reaction Period 
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The absorbance changes monitored using a Cobas Bio analyser, due to the 
reaction of Fab'(antialbumin)-coated liposomes, albumin, free antialbumin 
antiserum and complement. The reaction conditions have been described in 
Table 3.6. 
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the plastic surfaces. The effects of varying albumin 
concentrations were examined (figure 3.17). This showed a 
satisfactory overall absorbance changes between 0 and 200 
mg/1. Varying the pre-incubation had a small effect on 
the slope of the curve, but it was considered that 
insufficient advantage would be gained in increasing the 
five minute pre-incubation period. 
The slope of the standard curve was shallow at low 
concentrations. For a microalbumin assay a limit of 
detection below 20 mg/l is required. The poor dose- 
response at low concentrations was circumvented by 
including a low concentration of pure human albumin (50 
mg/1) in the first reagent (R1). This gave a reasonable 
slope at low concentrations, while avoiding any 
plateauing at the higher assay concentrations (figure 
3.18). The effect of adding the same concentration of 
bovine albumin is also shown. Unlike human albumin, this 
failed to improve the dose-response at low 
concentrations. 
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Figure 3.17 
Effect of Albumin Concentration on Complement-Mediated Immunolysis 
of Fab'-Coated Liposomes Measured for a Prolonged Period 
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Absorbance changes due to dye-release over a thirty minute period measured 
by a Cobas Bio analyser, caused by reaction of various concentrations (in 
sample) of albumin, Fab' antialbumin-coated liposomes, antialbumin antiserum 
and complement. The reaction conditions were as described in Table 3.6; 
except that the preincubation period was varied as follows: "= 10 seconds, 
Q=5 minutes, o= 30 minutes. Overlaid points represent duplicate 
measurements. 
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Figure 3.18 
Effect of Human Albumin Concentration on Complement-Mediated 
Immunolysis of Fab'-Coated Liposomes with Albumin added to First 
Reagent 
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Absorbance changes due to dye-release over a thirty minute period measured 
by a Cobas Bio analyser, caused by reaction of various concentrations (in 
sample) of human albumin, Fab' antialbumin-coated liposomes, antialbumin 
antiserum and complement. The reaction conditions were as described in Table 
3.6. The first reagent (RI), which contained liposomes, complement and buffer, 
also included either human albumin (50 mg/1)" , or 
bovine albumin (50 mg/1)o. 
Overlaid points represent duplicate measurements. 
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3.6.2 Assessment of Potential Interferences in 
Microalbumin Estimation 
The effects of variation in the amounts of several 
urinary components were assessed, including pH; 
magnesium, calcium,, sodium and potassium ions, and 
globulin concentrations. 
The reference ranges for twenty four hour urine 
excretions are well established. Microalbumin, however, 
is often measured in untimed early morning samples. To 
gain an idea of the likely range of interferent 
concentrations, these were measured in untimed early 
morning specimens collected for microalbumin estimation. 
These specimens were obtained from diabetes mellitus 
patients attending out-patient clinics. The specimens 
were frozen immediately on receipt, thawed prior to 
assay, mixed and briefly centrifuged to remove any 
precipitated material. Aliquots of these specimens were 
assayed for the concentrations of potential interferents, 
and for pH, within two days of thawing. 
To assess the likely effects of sample pH on the lysis 
reaction; various proportions of sodium dihydrogen 
phosphate (0.05M) and disodium hydrogen phosphate (0.05M) 
were combined to produce solutions of pH between 4.6 and 
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8.7. Teleostean gelatin was added (1%). These solutions 
were sampled in the assay procedure, with and without the 
addition of 75 mg/l human albumin. 
The pH which each of these solutions produced in 
combination with the other reagents in the reaction 
cuvette was estimated as follows. Each phosphate 
solution was mixed with distilled water and assay buffer 
in the proportions of the assay and the resultant pH was 
measured using a pH meter. Normal sheep serum was added 
in proportion to replace the antiserum. The sheep serum 
made a maximum change of 0.1 pH unit. Complement was 
replaced in proportion by assay buffer. Figure 3.19 
indicates the effect of sampling these phosphate 
solutions on the liposomal assay. The reaction was only 
slightly pH dependent between estimated reaction pHs of 
6.0 and 7.7 (sample pHs of 4.6 and 8.7 respectively). 
The pHs of twenty urine samples were measured, both 
alone and in proportionate mixtures to mimic assay 
conditions, as described in the previous paragraph. Their 
urine pHs ranged from 5.5 to 7.0 (mean 6.35, s. d. 0.28), 
and from 6.2 to 7.2 (mean 6.9, s. d. 0.24) after mixing to 
mimic assay conditions. 
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Figure 3.19 
Effect of Reaction pH on Dye Release due to Complement-Mediated 
Immunolysis of Fab'-Coated Liposomes 
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Absorbance changes due to dye-release over a thirty minute period measured by a 
Cobas Bio analyser, caused by reaction of human albumin, Fab' antialbumin-coated 
liposomes, antialbumin antiserum and complement. The reaction conditions were as 
described in Table 3.6, except that human albumin(50 mg/1) was also added to the first 
reagent. The sample buffer pH was varied as described in section 3.6.2. The reaction 
pHs were estimated using, as samples, phosphate solutions. (0.05M) of the following 
pHs; (estimated reaction pHs in brackets); 4.6 (6.0); 5.7 (6.65); 6.5 (6.9); 7.6 (7.5); 
8.2 (7.6); 8.7 (7.7). The samples either did not contain albumin ", or contained human 
albumin (75 mg/1)1. Overlaid points represent duplicate measurements. 
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To minimize the effect of pH on the response of the 
albumin standards, human albumin was diluted in pH 6.5 
phosphate buffer (0.05M) rather than buffer A (pH 7.5). 
This buffer resulted in an estimated reaction pH of 6.9. 
Using these standards a similar dose-response curve was 
obtained (figure 3.20) to that previously found using 
buffer A. However, the small negative absorbance change 
at low albumin concentrations observed using buffer A was 
not found at this pH. 
The potential inaccuracy caused by incomplete buffering 
of the samples was estimated. Extrapolating the variation 
in figure 3.19 to the standard curve (figure 3.20), the 
maximum error due to the observed urine pHs was 
approximately 2 mg/l at zero concentration and 4 mg/l at 
75 mg/1 albumin. 
The effects of varying phosphate concentration was 
examined by preparing solutions of various strengths of 
sodium phosphate buffer, pH 6.5; each containing gelatin 
(1%), with and without human albumin. Figure 3.21 shows 
that the reaction was insensitive to changes in these 
solutions up to approximately 200 mmol/1 phosphate 
concentrations. However at higher concentrations negative 
absorbance changes were observed. At the highest 
concentration (500 mmol/1), some precipitation of the 
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Figure 3.20 
Standard Curve for Complement-Mediated Immunoassay Using Fab'- 
Coated Liposomes and Albumin Standards in pH 6.5 Buffer 
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Standard curve used to estimate urinary microalbumin. The reaction conditions 
are described in Table 3.6, with the inclusion of human albumin (50 mg/1) in the 
first reagent (RI). Standards were prepared in pH 6.5 phosphate buffer 
(0.05M). Overlaid points represent duplicate measurements. 
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Figure 3.21 
Effect of Phosphate Concentration on Dye Release due to Complement- 
Mediated Immunolysis of Fab'-Coated Liposomes 
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Absorbance changes due to dye-release over a thirty minute period measured by a 
Cobas Bio analyser, caused by reaction of human albumin, Fab' antialbumin-coated 
liposomes, antialbumin antiserum and complement. The reaction conditions were as 
described in Table 3.6, except that human albumin(50 mg/I) was also added to the first 
reagent. Samples were prepared using sodium phosphate buffer (pH 6.5). The sample 
phosphate concentration was varied as described in section 3.6.2. The samples either 
did not contain albumin ", or contained human albumin (75 mg/1) Q. Overlaid points 
represent duplicate measurements. 
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liposomes was evident in the reaction cuvette after the 
assay. 
The observed effects using phosphate buffer could be 
due to either a specific effect of phosphate or of 
sodium; or a non-specific effect of high ionic strength. 
These alternatives were assessed by adding either sodium 
chloride or potassium chloride in various concentrations 
to phosphate buffer, pH 6.5 (0.05M) with gelatin 
(1%). (Phosphate buffer was used to maintain pH. ) To 
these sodium concentrations was added the sodium content 
of the phosphate buffer, which was calculated to be 69 
mmol/l using the Henderson-Hasselbalch equation. 
The effect of complete absence of sodium ions from the 
sample was also assessed using potassium phosphate buffer 
(0.05M, pH 6.5). This gave very similar absorbance 
changes to sodium phosphate buffer of the same pH and 
concentration (98 mA and 95mA in the presence of 75mg/1 
albumin, and 0 mA and 4 mA in the absence of albumin). 
Sodium showed minimal effects below approximately 450 
mmol/l (figure 3.22). Potassium showed only a slight 
inhibition up to 400 mmol/l. Both cations showed similar 
loss of lysis to phosphate at higher concentrations 
although to a less marked degree at equivalent 
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Figure 3.22 
Effect of Sodium Chloride Concentration on Dye Release due to 
Complement-Mediated Immunolysis of Fab'-Coated Liposomes 
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Absorbance changes due to dye-release over a thirty minute period measured by a 
Cobas Bio analyser, caused by reaction of human albumin, Fab' antialbumin-coated 
liposomes, antialbumin antiserum and complement. The reaction conditions were as 
described in Table 3.6, except that human albumin(50 mg/1) was also added to the first 
reagent. Samples were prepared using sodium phosphate buffer (pH 6.5), to which 
various concentrations of sodium chloride were added as described in section 3.6.2. 
The samples either did not contain albumin, or contained human albumin (75 mg/l)13 
Overlaid points represent duplicate measurements. 
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concentrations. Unlike at high phosphate concentrations, 
no precipitation was evident using sodium or potassium 
chloride. 
Twenty urine samples were assayed for sodium, potassium 
and phosphate to assess whether an error was likely at 
the concentrations of these ions. The observed 
concentrations of sodium ranged between 44 and 166 mmol/l 
(mean 87.0, s. d. 32.8). This is well below the level 
likely to significantly interfere; (interference over 
approximately 400 mmol/1). 
The range for phosphate of 10 to 37 mmol/l (mean 19.7, 
s. d. 9.8) would seem also not high enough to interfere; 
(interference not seen below 200 mmol/1). 
For potassium, the observed range was 3 to 99 mmol/l 
(mean 32.1, s. d. 23.7). Potassium was found not to 
interfere up to 100 mmol/l (figure 3.23). Slightly 
higher concentrations might give a small negative bias. 
However even if much higher concentrations could occur, 
the error in albumin concentrations would still be small; 
e. g. at a potassium concentration of 400 mmol/l, less 
than 2 mg/l at zero albumin concentration and 4 mg/l at 
75mg/l albumin concentration (deduced by extrapolating 
the absorbance error to the standard curve, figure 3.20). 
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Figure 3.23 
Effect of Potassium Chloride Concentration on Dye Release due to 
Complement-Mediated Immunolysis of Fab'-Coated Liposomes 
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Absorbance changes due to dye-release over a thirty minute period measured by a 
Cobas Bio analyser, caused by reaction of human albumin, Fab' antialbumin-coated 
liposomes, antialbumin antiserum and complement. The reaction conditions were as 
described in Table 3.6, except that human albumin(50 mg/1) was also added to the first 
reagent. Samples were prepared using sodium phosphate buffer (pH 6.5), to which 
various concentrations of potassium chloride were added as described in section 3.6.2. 
The samples either did not contain albumin, or contained human albumin (75 mg/1)[3 
Overlaid points represent duplicate measurements. 
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To assess the effects of calcium and magnesium, various 
amounts of the respective chloride salts were added to 
phosphate buffer, pH 6.5 (0.05M) and sampled. The results 
are shown in figures 3.24 and 3.25. Calcium showed a 
small augmenting effect between 0 and 10 mmol/l 
(equivalent to approximately 1 mg/1 albumin at zero 
albumin concentration and 4 mg/l at 75 mg/l albumin 
concentration). The observed range for calcium was 0.4 - 
4.1 mmol/1 (mean 2.2, s. d. 1.1). This is equivalent to a 
negligible potential error at zero concentration and an 
error of less than 2 mg/l at 75 mg/l albumin 
concentration. 
The observed range in concentration for magnesium was 0.9 
to 4.8 mmol/l (mean 2.3, s. d. 1.1). Magnesium 
concentrations had little effect over a wide range of 
concentration (figure 3.25). 
The effect of pure human gamma globulin concentration is 
shown in figure 3.26. Human gamma globulin seemed to have 
little effect on the absorbance changes up to a sample 
concentration of 1 g/l. 
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Figure 3.24 
Effect of Calcium Choride Concentration on Dye Release due to 
Complement-Mediated Immunolysis of Fab'-Coated Liposomes 
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Absorbance changes due to dye-release over a thirty minute period measured by a 
Cobas Bio analyser, caused by reaction of human albumin, Fab' antialbumin-coated 
liposomes, antialbumin antiserum and complement. The reaction conditions were as 
described in Table 3.6, except that human albumin(50 mg/l) was also added to the first 
reagent. Samples were prepared using sodium phosphate buffer (pH 6.5), to which 
various concentrations of calcium chloride were added as described in section 3.6.2. 
The samples either did not contain albumin, or contained human albumin (75 mg/1)D 
Overlaid points represent duplicate measurements. 
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Figure 3.25 
Effect of Magnesium Choride Concentration on Dye Release due to 
Complement-Mediated Immunolysis of Fab'-Coated Liposomes 
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Absorbance changes due to dye-release over a thirty minute period measured by a 
Cobas Bio analyser, caused by reaction of human albumin, Fab' antialbumin-coated 
liposomes, antialbumin antiserum and complement. The reaction conditions were as 
described in Table 3.6, except that human albumin(50 mg/1) was also added to the first 
reagent. Samples were prepared using sodium phosphate buffer (pH 6.5), to which 
various concentrations of magnesium chloride were added as described in section 
3.6.2. The samples either did not contain albumin, or contained human albumin (75 
mg/1). O. Overlaid points represent duplicate measurements. 
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Figure 3.26 
Effect of Human Gamma Globulin Concentration on Dye Release due to 
Complement-Mediated Immunolysis of Fab'-Coated Liposomes 
100 
80 
E 
so 
10 
E 
C 40 
to 
V 
c 
to 20 
0 
-20 
gamma globulin (mg/1) 
Absorbance changes due to dye-release over a thirty minute period measured by a 
Cobas Bio analyser, caused by reaction of human albumin, Fab' antialbumin-coated 
liposomes, antialbumin antiserum and complement. The reaction conditions were as 
described in Table 3.6, except that human albumin(50 mg/1) was also added to the first 
reagent. Samples were prepared using sodium phosphate buffer (pH 6.5), to which 
various concentrations of purified human gamma globulin were added as described in 
section 3.6.2. The samples either did not contain albumin, or contained human 
albumin (75 mg/1)0. Overlaid points represent duplicate measurements. 
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3.6.3 Urinary Microalbumin Assay Performance 
Using the standard curve based on standards in pH 6.5 
buffer (figure 3.20), early morning urine albumin samples 
were assayed. The measured concentrations were compared 
to a conventional radioimmunoassay (RIA) method which 
used an overnight incubation and PEG precipitation 
(NETRIA). The radioimmunoassay tests were assayed in 
duplicate and compared to a standard curve in the same 
batch. Samples were assayed in the liposomal assay in the 
same way. The results are shown in figure 3.27. The 
correlation (r) was 0.94 and the regression equation 
was; 
y (liposomal assay) = 1.09 x (radioimmunoassay) - 1.54 
The within-batch imprecision was assessed in single assay 
rotors and compared to the within-batch imprecision of 
the radioimmunoassay. Since the radioimmunoassay used 
duplicate means, comparison with imprecision of duplicate 
means in the liposomal assay was appropriate. This 
indicated less imprecision in the liposomal assay (figure 
3.28). 
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Figure 3.27 
Comparison of Urinary Microalbumin Concentrations Measured by 
Complement-Mediated Immunolysis Using Fab'-Coated Liposomes and 
by Conventional Radioimmunoassay 
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The microalbumin concentrations of early morning urine samples (n=34) were 
measured, following the procedures described in section 3.6.3, by the liposomal 
assay using Fab' (antialbumin)-coated liposomes and by a conventional 
radioimmunoassay (NETRIA). 
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Figure 3.28 
Comparison of Imprecisions in Measurement of Microalbumin by 
Complement-Mediated Immunolysis Using Fab'-Coated Liposomes and 
by Conventional Radioimmunoassay 
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Comparison of within-batch imprecisions of the liposomal immunoassay and 
conventional radioimmunoassay (NETRIA) for the measurement of urinary 
microalbumin. The procedures followed are described in section 3.6.3. The 
imprecision of the liposomal assay was assessed either using singletons (n=24) 
 , or using duplicates (n=12) o. The imprecision of the radioimmunoassay was 
assessed using duplicate measurements (n=20) A. The microalbumin 
concentration indicated is the mean of the measurements used to calculate 
imprecision. 
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The limit of detection can be assessed from this data in 
two ways. If it is defined as the concentration giving a 
C. V. % of 10%, this can be obtained by extrapolation of 
the curve in figure 3.28. If, on the other hand, it is 
defined as 3 standard deviations of the results of a 
value close to zero, this can be approximated from the 
data for the lowest pool (10.3 mg/1). The limits of 
detection calculated in these ways are indicated in table 
3.7. The limits derived using singleton tubes is shown 
for comparison. The data indicate that, at least using 
duplicates, the liposomal assay had similar or lower 
limits of detection to the radioimmunoassay. The 
reliability of the limits of detections estimates is 
questionable because the pool is relatively a little high 
(10 mg/1) compared to the derived limits of detections. 
Nevertheless it is clear that the true limit of detection 
for the liposomal assay, using duplicate means, lies 
below 10 mg/l. This is acceptable, since the clinically 
important cut-off is usually taken as approximately 20 
mg/l. 
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TABLE 3.7 
Limits of Detections of Microalbumin Assays (mg/1) 
method 1 10% C. V. 13sds 
RIA (duplic. ) ý <10 (8)** I3 
(n=20) 
Liposomal (duplic. ) <10 (4)** 2 
(n=10) 
Liposomal (sing. ) C 12 I4 
(n=20) 
*3sds 
refers to 3 standard deviations of the results for 
a low sample. 
** The concentrations given in brackets are an 
approximation by extrapolating the respective curves in 
figure 3.28 to a C. V. of 10% 
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3 .7 Immuno-Precipitation by Antialbumin-Coated Liposomes 
Antialbumin-coated liposomes had been prepared but were 
found, unlike Fab'-coated liposomes, not to be useful in 
complement-mediated immunoassays (section 3.5). However 
it was noticed that when the liposomes were mixed with 
albumin and left to stand overnight a small amount of 
red, dye-containing precipitate formed. When these 
liposomes were subsequently centrifuged gently (i. e. 
2000g for ten minutes), the liposomes and their entrapped 
dye sedimented leaving a clear supernatant. The 
possibility of using antibody-coated liposomes as a solid 
phase in an immunoassay was examined since liposomes are 
potentially more easy to pipette than other particulate 
precipitation reagents (e. g. cellulose), particularly in 
automatic pipettors. A radioimmunoassay of microalbumin 
was used as a model assay. 
3.7.1 Evidence of Competitive Label Binding 
In order for the liposomes to function as a solid phase, 
there should be competitive binding of the albumin and 
radiolabelled albumin with the liposomes. Gel filtration 
was used to establish that this occurred, independently 
of the immunoprecipitation effect. 
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Various concentrations of albumin (6 ul) were added to 30 
ul of liposome preparation, 6 ul 
125I 
radiolabelled 
albumin and 100ul of phosphate buffer which contained 1% 
normal sheep serum. After four hours incubation at room 
temperature, the mixtures were each separated using 
Sepharose 4B. The eluted fractions (0.5 ml) were analysed 
for radioactivity by a gamma counter. The results are 
shown in figure 3.29. The amount of radioactive albumin 
in the void volume (which contained the liposome 
fraction, as shown in section 2.4) was found to be 
inversely related to the amount of unlabelled albumin 
added. 
As a control experiment, liposomes were prepared as in 
section 3.5 but not coupled to antialbumin. These 
liposomes were incubated with labelled albumin as before. 
On gel filtration, very little radioactivity was found in 
the liposomal fraction (figure 3.30). As additional 
controls, solutions of free albumin alone and also free 
antialbumin alone both eluted with similar retention 
times to the free radioactive albumin (as assessed by the 
Coomassie Blue method). Furthermore, no significant 
elution of albumin label in the liposomal fraction was 
observed when free antialbumin was added to labelled 
albumin prior to incubation and chromatography. 
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Figure 3.29 
Evidence of Competitive Label Binding by Liposomes 
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Various amounts of albumin (0 ng x, 10 ng ", 50 ng", 200 ng +, 2 ug *) were 
incubated with anti-albumin liposomes and 1251-labelled albumin (as described 
in section 3.7.1). Mixtures were separated by Sepharose 4B gel 
chromatography. Fractions (0.5 ml) were collected and measured for 
radioactivity. The liposomes and bound label eluted in the void volume. 
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Figure 3.30 
Elutions of Liposomes Not Coated With Antibody in Presence of Radio- 
Labelled Albumin 
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Control experiment showing elution positions of components following gel 
filtration on Sepharose 4B; after incubation of liposomes, not coupled to 
antialbumin antibody, with 1251 albumin. Peaks are: (a) = liposome entrapped 
dye, (b) = free dye, (c) = free 1251 albumin. The Sulphorhodamine B content 
by absorbance at 565 nm (peaks (a) and (b), +) and radioactivity (peak (c), x) 
of 0.5 ml fractions are shown. 
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3.7.2 Use of Liposomes as a Solid Phase 
Early morning urine specimens were collected from 
diabetes mellitus patients and frozen on receipt. Prior 
to assay they were thawed, mixed and briefly centrifuged 
to remove any precipitated material. 
A standard immunoassay protocol was adopted as follows, 
but was modified experimentally as subsequently 
described. Phosphate buffer (100 ul) containing 1% normal 
sheep serum and 6 ul radiolabelled albumin were mixed in 
a4 ml plastic tube with antialbumin liposomes (30 ul) 
and 6 ul of urine sample or human albumin standard (0 - 
200 mg/1). The tubes were incubated at 370C overnight (16 
hours), centrifuged for ten minutes at 2000 g, washed in 
buffer containing 1% normal sheep serum (2 ml), then 
centrifuged as before. After aspiration of the 
supernatant, the precipitated liposomes were counted for 
300 seconds per tube using a gamma counter. 
Using this assay protocol, no visible sediment formed in 
control tubes containing either 0 mg/1 of 200 mg/l 
albumin, and using liposomes to which anti-albumin had 
not been coupled. 
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The effect of temperature on 
assessed. A temperature of 37°C 
better sensitivity, in terms of do; 
or 45°C (figure 3.31). At 370C, 
slope of dose-response curve) 
incubation time up to 16 hours, but 
improve further if the incubation 
hours (figure 3.32). 
the immunoassay was 
was found to give 
; e-response, than 25°C 
the sensitivity (i. e 
increased with an 
did not significantly 
were extended to 40 
The maximum binding of label was found to be dependent on 
the volume of liposomes added to each tube (figure 3.33). 
For this experiment the standard protocol was adjusted by 
reducing the added buffer volume so that the total 
reaction volume was constant. Using the standard 
protocol, a maximum binding (zero standard/total counts) 
of 10-20% was obtained. 
A typical standard curve is shown in figure 3.34. Table 
3.8 indicates the within-batch imprecision of the 
liposomal assay, obtained by analysing twenty replicates 
of two levels of urine pools. The imprecision of a 
commercial radioimmunoassay which used an overnight 
incubation and PEG precipitation (NETRIA) (referred to in 
section 3.6), also obtained using twenty replicates of 
the urine pools, was compared and found to be similar. 
200 
Figure 3.31 
Effects of Temperature on the Dose Response Curve of the 
Radioimmunoassay Using Antialbumin-Coated Liposomes 
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The effect of varying the temperature was examined. The radioimmunoassay 
which used liposomes as a solid phase is described in section 3.7.2. A 16 hour 
incubation was adopted in these experiments. In the procedure, 200 mg/1 added 
standard was equivalent to 1.2 ug albumin standard per tube. Temperatures 
were as follows: 250C (+), 370C (x), 440C (0). 
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Figure 3.32 
Effects of Incubation Period on Dose-Response Curve of Radio- 
Immunoassay Using Antialbumin-Coated Liposomes as a Solid Phase 
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Incubations were performed at 370C. Total counts per minute were 6400 per 
tube. In the assay protocol, described in section 3.7.2,200 mg/l added albumin 
standard was equivalent to 1.2 ug albumin standard per tube. Incubation times 
were 1 hour (*), 4 hours (+), 16 hours (") and 40 hours (x). 
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Figure 3.33 
Effects of Varying Amounts of Liposomes on Maximum Binding of Label 
In Radioimmunoassay Using Antialbumin-Coated Liposomes 
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Effects of varying amounts of liposomes on the observed maximum binding of 
radiolabelled albumin in the radioimmunoassay using antialbumin-coated 
liposomes as a solid phase, The assay protocol has been described in section 
3.7.2). Total counts per minute were 6500 per tube. 
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Figure 3.34 
Standard Curve for Radioimmunoassay of Urinary Microalbumin Using 
Liposomes Coated with Antialbumin Antibodies as a Solid Phase 
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The immunoassay procedure is described in section 3.7.2. Total counts per 
minute was 6540 per tube. The binding of the zero standard was 15% of the 
total counts. In the protocol, 200 mg/l added albumin standard was equivalent 
to 1.2 ug albumin standard per tube. 
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TABLE 3.8 
Within-Batch Imprecision of Liposomal Immunoassay and 
Conventional Radioimmunoassay 
Sampled Liposomal Conventional (NETRIA) 
Pooll 20.1 ±1.6 7.8 23.5 ±1.9 8.2 
Poo12 46.0 ±2.3 5.1 49.2 ±2.6 5.3 
When the albumin concentrations measured by the liposomal 
method and the NETRIA radioimmunoassay were compared 
(figure 3.35), a good correlation was obtained (r=0.97). 
The regression equation was (y(liposomal) = 0.83 
x(NETRIA) + 1.65 ). 
3.8 Discussion 
This chapter first described the synthesis of albumin- 
coated liposomes and their use in a complement-mediated 
immunoassay for the measurement of albumin in human sera. 
The assay was of the type usually referred to as 
competitive. Antialbumin antiserum was first preincubated 
with free albumin in the sample or standard. Albumin- 
coated liposomes and complement were then added. The 
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Figure 3.35 
Comparison of Urinary Microalbumin Concentrations Measured by 
Liposomal Radiommunoassay and Conventional Radioimmunoassay 
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Thirty nine urine samples were measured by the radioimmunoassay using 
liposomes coated with antialbumin antibodies, and by a conventional 
radioimmunoassay (NETRIA). Their measurements of urinary microalbumin 
concentrations were compared. 
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complement-mediated lysis was dependent on the amount of 
antibody bound to the liposomes and inversely related to 
the amount of albumin in the sample or standard. 
The assay using albumin-coated liposomes was not found to 
be sufficiently sensitive to measure urinary 
microalbumin. A sandwich type assay was therefore 
developed as an alternative. In this type of assay, 
liposomes coated with antibody are incubated with antigen 
(in this case albumin), free antiserum and complement. A 
"sandwich" of liposome-bound antibody, antigen and free 
antibody occurs, which initiates complement-mediated 
immunolysis. As opposed to a competitive assay; in this 
type of assay the lysis is directly related to the 
concentration of antigen in the sample or standard. 
The sandwich type assay is theoretically more sensitive 
than the competitive assay and will tend to have a lower 
detection limit. This is because in a competitive assay, 
the amount of antigen must be in excess of available 
antibody binding sites. (If this were not the case in the 
complement-mediated liposomal assay there would always be 
sufficient antibody to lyse all the immunoreactive 
liposomes. ) Conversely, in the sandwich type liposomal 
assay, the antigen is required not to be in excess of 
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either the liposomal-bound antibody or the free antibody 
binding sites. This can enable higher antibody 
concentrations to be incorporated into reagents. 
A sandwich-type assay was developed using liposomes 
coated with Fab' fragments of antialbumin antiserum. As 
predicted this had a lower limit of detection compared 
to the competitive assay, enabling its use in a 
complement-mediated immunoassay to measure urinary 
microalbumin. 
Liposomes coated in intact antialbumin antibodies were 
also prepared. These were found not to initiate 
significant complement-mediated immunolysis and were not 
used in an homogeneous assay. The possible reasons for 
the lack of immunolysis will be discussed later. 
However; an observation was made that after immune 
reaction, incubation and gentle centrifugation, these 
liposomes precipitated. This led to their use as a 
solid-phase in an heterogeneous immunoassay; as 
demonstrated by a model radioimmunoassay, also for 
urinary microalbumin. 
The development of complement-mediated immunoassays 
using release of encapsulated Sulphorhodamine B as a 
colorimetric signal satisfied a major objective of these 
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these studies. This was in establishing the general 
applicability of the use of the dye as a marker in 
liposomal immunoassays, which most frequently have used 
complement-mediated lysis. 
Complement-mediated immunolysis is based on antigen- 
antibody reaction at the membrane surface, which leads to 
complex-formation with complement. This in turn is 
believed to initiate the complement cascade leading to 
puncturing of the liposome membrane and loss of its 
contents. 
The initially high rate of release of dye by complement, 
slowing to a near-plateau after a few minutes (e. g. 
as shown in figure 3.2) has been found previously; 
including in early studies using glucose release (103). 
The complement-mediated immunolysis was significantly 
slower in reaching a near-plateau in the sandwich-type 
assay, possibly because the immune-complex, which'had 
more components, took longer to form. 
Early studies reported the "hook effect" observed at 
high antiserum concentrations (103). In the present 
study, the effect was seen in both the competitive and 
sandwich assays. A hook was also demonstrated for 
complement in the competitive assay, but not in the 
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sandwich assay. Unlike the antiserum hook, the hook for 
complement does not appear to have been previously 
reported. 
In earlier reports which assessed varying complement 
amounts, a maximum activity of below 20 CH50 units/ml was 
used (47,97,111,115,118). The stock complement used in 
the present study had a high activity (manufacturer's 
stated activity 2694 CH50 units/ml) enabling greater 
activities to be assessed. The hook effect was observed 
in the Cobas experiments at concentrations above a 
dilution of 1/12; equivalent to a concentration of 225 
units/ml. While it is difficult to compare reaction 
conditions directly, it is likely that the effect was not 
shown previously because of lower complement activity. 
The nature of either antiserum or complement hook effect 
is unclear but a number of mechanisms could be 
postulated; such as electrostatic repulsion at high 
protein concentrations, steric hindrance, or 
configurational changes at the liposomes' surfaces. 
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No evidence was found that human complement might 
interfere with the reaction. In one previous report, 
human complement has been shown to react in a liposomal 
immunoassay (64). In general, however, marked species to 
species variability occurs in complement reactivity which 
seems also to depend on the animal species used to raise 
the antiserum. A relative lack of reactivity of human 
complement with animal antisera, compared to guinea-pig 
complement, has also been found previously (169). 
As the sandwich assay used the same intact antibody as 
the competitive assay, it would seem unlikely that human 
complement would interfere with one assay and not the 
other. Furthermore, substantial complement activity would 
seem unlikely to occur in urine, even in the presence of 
gross proteinuria (e. g. haematuria), since this would 
require all the components of the cascade to be active. 
In any case, the presence of frank proteinuria could be 
screened for prior to assay, as will be discussed later 
in this section. 
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Confimatory evidence for the lack of substantial 
interferences with the complement-mediated reaction was 
also provided by the good correlation of results on 
testing patients' samples with those obtained by the 
comparison method. 
Prior to this study, the use of liposomes coated in Fab' 
fragments in a complement-mediated sandwich assay had 
been suggested (170) but no performance data had 
apparently been published. Since commencing the study, a 
report of such an assay has been published, claiming a 
good correlation with radioimmunoassay for estimation of 
serum ferritin (171). However, a minority of serum 
samples showed non-specific lysis which was attributed to 
complement activity. It was considered that this effect 
was due to excess unreacted DTP-PE in the liposomes 
following coupling to Fab' thiol groups using SPDP. DTP- 
PE seemed to increase lipid fluidity and susceptibility 
to complement attack. Use of an alternative coupling 
method involving bromoacetyl-PE reduced but did not 
eliminate the effect. 
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A sensitivity of liposomes containing DTP-PE to human 
complement was shown previously (169). One factor which 
may affect the amount of this non-specific lysis is the 
density of packing of the antigen (or antibody) on the 
liposome surfaces. At high density, non-specific lysis 
might be sterically hindered. 
Unfortunately it was not possible to compare the 
conditions used by Ishimori (171) or Okado (169) with the 
current report, since liposome size distribution and 
amounts of proteins incorporated were not stated. The 
liposome preparations were also substantially different 
to the current study. Neutral MLVs were used, and 
carboxyfluorescein incorporated. Furthermore, a rabbit 
antiserum was used by Ishimori (rather than sheep in this 
report). 
If there is a general non-specific complement-mediated 
effect due to the use of SPDP reagent; it might 
presumably affect to some degree all liposomal 
immunoassays which use this coupling method, and not only 
those involving Fab' fragments. As discussed, 
interference by human complement was not observed in the 
current study. A considerable number of other liposomal 
immunoassays have also been published (see section 1.6) 
which have not reported this effect. Nevertheless, 
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possible interference by human complement needs to be 
carefully assessed before applications of the technique 
are put into routine use. 
The liposomes in this report were coated with protein 
using the heterobifunctional reagent, SPDP (N- 
succinimidyl 3-(2-pyridyldithio) propionate). The 
coupling method is described in section 1.5.2 and 
summarized in figure 3.1. The method has advantages in 
that the reagents are commercially available, the method 
is straightforward and it is not generally susceptible to 
non-specific cross-linking. 
A difference in the coupling reaction of Ishimori who 
used SPDP (171) was that DTP-PE was coupled directly to 
the Fab' thiol groups. This has been reported previously 
(77,79). In the present study, the Fab' fragments were 
coupled to liposomes by modification of their amino 
groups, in the same way as albumin and intact antiserum. 
The use of derivatized Fab' amino groups instead of 
Fab'-thiol groups was considered more convenient. Use of 
thiol groups would seem to require coupling immediately 
after Fab' synthesis, presumably because of the 
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susceptibility of the thiol groups to oxidation. To 
reduce the possibility of some thiol groups cross 
linking with DTP-Fab', the latter was reduced and coupled 
to DTP-PE liposomes immediately after synthesis of DTP- 
Fab'. 
A possible reason 
with antialbumi 
immunolysis might 
liposome membrane 
liposome surface, 
molecules. 
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There has, nevertheless, been one report of the 
successful use of intact antibody in a sandwich assay of 
this type to measure C-reactive protein (115). There were 
several differences in their approach; for example 
multilamellar large vesicles were used. The workers also 
reported species to species variation in antiserum and 
complement effects. Some combinations failed to initiate 
complement, while others caused non-specific lysis. These 
effects may also at least partially explain the lack of 
lysis in the present study. 
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A further factor which may account for differences 
between liposomes bearing intact antibody and those 
coated in Fab' fragments arises from an estimation of 
the number of molecules bound per liposome. This can be 
calculated from protein/lipid ratios. 
The coupling of albumin and antialbumin was 54 ug 
albumin/ umol lipid and 72 ug antialbumin/ umol lipid 
respectively. The coupling of Fab' fragments was higher 
(237 ug / umol lipid). Hutchinson et al. (45) pointed 
out the difficulty in accurately calculating the number 
of protein molecules per liposome unless the size 
distribution is known and is narrow. Nevertheless; as the 
liposomes in this study were all filtered through a 200 
nm filter during preparation, it is possible to calculate 
the number of protein molecules per liposome based on the 
approximation of homogeneous 200 nm liposome populations. 
Although no accurate size measurements were performed, 
electron microscope photographs suggested 200 nm to be a 
reasonable approximate estimate of the average liposome 
size (as discussed in appendix 1). Furthermore, electron 
micrographs were previously produced of liposomes 
prepared by Szoka and Papahadopoulos (18) using a similar 
reverse evaporation procedure, although a different lipid 
composition was used (phosphatidyl glycerol: phosphatidyl 
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choline: cholesterol, molar ratio 1: 4: 5). After passage 
through a 200 nm polycarbonate filter, the vesicle size 
was estimated to be 120 nm to 300 nm by electron 
microscopy. Other estimates of size include an average 
size of 260 nm for MLVs extruded through a series of 
filters culminating in a 200 nm filter (33). 
The lack of size homogeneity could be due to several 
factors. Some liposomes may be less than 200 nm prior to 
filtration. Some reduction in liposome size may also 
occur during filtration by electrostatic effects as the 
liposomes pass through the filter. Countering this; some 
deformation of the liposomes may also occur allowing some 
liposomes larger than 200nm to be sqeezed through the 
filter without their disruption. 
Based on the approximation of a homogeneous population of 
200 nm diameter, the following formulae were applied to 
calculate the number of protein molecules per liposome 
(45); 
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N= 4'RR2 + 411 (R - h)2 (equation 3.2) 
aa 
where N= number of lipid molecules per liposome 
a= area of lipid molecule in a bilayer (taken as 
0.5 nm2) 
R= radius of liposome (assuming spherical single 
walled liposomes) 
h= bilayer thickness (taken as 7.5 nm) 
Pi = (P/L) N (equation 3.3) 
where Pi = number of protein molecules per liposome 
P/L = molar ratio of protein to lipid 
The following molecular weights were used in calculating 
the molar ratio of protein to lipid; 
albumin = 69000 D 
anti-albumin = 150000 D 
Fab" fragment = 52000 D 
Applying these formulae, there were calculated to be 
366 molecules of albumin per liposome, 233 molecules of 
antialbumin antibodies per liposome and 2130 molecules of 
Fab' molecules per liposome. 
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The larger number of Fab' molecules bound to each 
liposome, compared to intact antibody, might therefore be 
another possible explanation for their greater ability to 
initiate complement-mediated immunolysis. 
Hutchinson et al. (45) reviewed several of the reports 
that have estimated the number of molecules bound to each 
liposome. The few relating to similar sized liposomes 
show general agreement to the present study. Intact IgG 
was bound to 200 nm liposomes at 200 molecules per 
liposome (74). Two reports describe directly attaching 
Fab' fragments to similar sized liposomes via their thiol 
groups (using different reagents). The reports claimed 
binding of "more than 3000" molecules per liposome and 
"up to 600011 molecules per liposome respectively (79,77). 
In the competitive assay using albumin-coated liposomes; 
the large number of molecules bound to each liposome is 
unlike the situation in conventional competitive 
immunoassays. in a competitive immunoassay such as a 
radioimmunoassay only one molecule of antigen is usually 
coupled to each molecule of label. Provided the labelled 
antigen is immunologically similar to the free antigen, 
approximately half the labelled antigen tends to be 
displaced from the antibody when the the free and 
labelled antigen have equal concentrations. 
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In a competitive liposomal immunoassay; if each antigen- 
antibody complex caused an equal amount of complement- 
mediated lysis, the amount of signal produced would be 
related to the ratio in each liposome of dye to bound 
antigen (i. e. the number of marker molecules per 
antigen). This would be a measure of the amount of 
amplification of signal produced by the use of liposome- 
entrapped marker. 
The ratio of bound protein to entrapped dye can be 
calculated in a similar way to the calculation of the 
bound protein per liposome. The number of lipid molecules 
per liposome (N) was calculated from equation 3.2. 
Assuming all the dye in the preparation is entrapped, the 
number of dye molecules per liposome (Di) is given by; 
Di = (D/L) N (equation 3.4) 
where D/L is the molar ratio of dye to lipid. 
The molarity of dye was deduced from the absorbance of 
the dye in the preparation (after lysis with ethanol as 
described in section 2.6, using the absorbance 
coefficient given in section 2.3). 
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The number of dye molecules per liposome (assuming 200 nm 
diameters) was calculated to be 79000. This is equivalent 
to the following; 
216 molecules of dye per molecule of bound albumin 
339 .... .... anti-albumin 
37 .... .... .. Fab" fragment 
In a complement-mediated immunoassay the situation is 
more complex than a conventional immunoassay. It is not 
easy to predict, for example, the ratio of free and bound 
albumin which would reduce liposome-antibody binding to a 
sufficient degree as to reduce lysis by 50%. This can be 
estimated experimentally, however, by comparing the free 
and liposomal-bound albumin concentrations. 
The concentration of albumin bound to liposomes in the 
reaction mixture was calculated to be approximately 6 
mg/l (1/120 dilution of final preparation, section 
3.3.3). Albumin at a sample concentration of 
approximately 1.5 g/l (i. e. a reaction concentration of 
500 mg/1) was required to inhibit lysis by 50%. It 
therefore required free albumin molecules at 
approximately 83 times the number of bound albumin 
molecules to halve the lysis rate. 
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There are several possible explanations for this lack of 
equivalence. Assuming the free and bound albumin were 
in true competition for the antibody; liposomal lysis 
may have occurred when only a small proportion of the 
liposomal antigen sites were occupied. This would not be 
surprising since the complement complex formation at only 
a few sites might initiate the complement cascade 
leading to lysis. In this model, it would require 
displacement of the majority of bound antibody molecules 
to significantly reduce the amount of lysis. 
Another possibility is that, up to a certain 
concentration of free albumin, the liposomal and free 
albumin might not be in true competition for the 
antibody. In other words, free albumin may not always 
displace antibody-albumin complexes at the liposome 
surface. Instead a proportion might bind to antibody at 
the liposome surface, creating larger complement- 
activating aggregates on the liposome membrane. This 
would be analogous to immune-complex formation in 
immunoturbidimetry. 
Whatever the mechanism, it appears that competitive 
complement-mediated assays using liposomes may be 
particularly insensitive compared to other competitive 
immunoassays (e. g. radioimmunoassays). 
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There was yet another consideration which was found to 
hinder an increase in sensitivity of the competitive 
liposomal assay. In a conventional competitive 
immunoassay (e. g. radioimmunoassay), provided the signal 
of the label is intense enough, the sensitivity can be 
improved by lowering the concentration of labelled 
antigen. This means that equivalence occurs at a lower 
concentration. In the liposomal immunoassay there are two 
ways to attempt this. The first would be to reduce the 
amount of liposomes. However, this would reduce the 
absorbance in this colourimetric assay, and hence 
probably also the amount of measurable absorbance change. 
In these studies the amount of liposomes was maintained 
to give an initial absorbance of approximately 1 A. 
Reducing the amount of liposomes would appear to be less 
of a problem if a more sensitive label were used (e. g. a 
fluorescent label). 
The second approach would be to reduce the amount of 
antigen bound to each liposome; so that, at an absorbance 
of 1A, there would be less labelled albumin in the 
reaction mixture. It proved possible to reduce the 
protein coupling by incorporating less DTP-PE into the 
liposomal membranes (section 3.4.4). The protein content 
was reduced to a protein: lipid ratio of 17 ug 
albumin: umol lipid (compared to 54 ug albumin: umol lipid 
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found previously). This was calculated to be equivalent 
to approximately 112 albumin molecules per liposome 
(compared to 366 in the liposomes incorporating more 
DTP-PE). The liposome-bound albumin content in the 
reaction mixture was also calculated to be reduced from 
17 mg/l to approximately 3 mg/1. 
Unfortunately, although the amount of bound antigen was 
lower, so was the amount of complement-mediated lysis. 
The low complement-mediated absorbance change appeared to 
preclude a sensitive inhibition assay using these 
liposomes. 
Although the competitive complement-mediated liposomal 
assay would seem to have particular difficulties in 
achieving sensitivity, the same is not necessarily true 
of sandwich type complement-mediated assays. In sandwich 
type assays, one would predict that increasing 
sensitivity would be achievable by increasing the amount 
of bound antibody on the liposome. This might have a 
combined effect of increasing both the sensitivity to 
small amounts of antigen and increasing the amount of 
complement-mediated lysis. In other words, the two 
effects would be predicted to work in tandem, rather than 
in opposition as in the competitive complement-based 
assay. 
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Adequate sensitivity was found using large unilamellar 
vesicles in the sandwich type assay for the 
measurement of urinary microalbumin. Nevertheless, it 
might be predicted from the previous considerations that 
small unilamellar liposomes, with their increased surface 
area to volume ratio, might enable a greater sensitivity 
in a sandwich type complement-mediated immunoassay. This 
would be because, for a given amount of entrapped dye, 
there would be more liposome-bound antibody in the 
reaction mixture. 
The inclusion of albumin (50mg/1) in the first reagent 
(R1) of the sandwich type assay increased the sensitivity 
at low concentrations (i. e. dose: response) and lowered 
the limit of detection. The standard curve was sigmoidal 
in shape and inclusion of this albumin meant that low 
concentrations were measured in a steeper region of the 
standard curve. The reason for the curve flatness at low 
concentrations may be a requirement for a certain amount 
225 
of albumin to effectively initiate complement-mediated 
lysis. 
An alternative explanation could be that, despite the 
inclusion of gelatin, some non-specific adsorption of 
albumin onto the plastic sample cups or cuvettes was 
occuring. The lack of a similar improvement in 
sensitivity by the inclusion of bovine, rather than 
human, albumin suggests this was not the case. 
A limit of detection of below 20 mg/1 is equivalent to 
400 ng per reaction cuvette. This is still a relatively 
insensitive assay compared to many recent immunoassay 
techniques (10). However; the use of colorimetric dye was 
examined because of its other advantages, e. g. speed, 
convenience and ease of automation. The liposomal assay 
could, for example, be performed in approximately forty 
minutes; compared to radioimmunoassay which required an 
overnight incubation. 
These studies do not preclude high sensitivity in a 
sandwich-type complement-mediated immunoassay, but this 
would probably require the combination with an 
alternative marker, for example using fluorescence or 
chemiluminescence. The possibility of greater 
sensitivity by the use of fluorimetric measurement of 
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Sulphorhodamine B release was not examined in these 
studies. The relative strengths of colorimetric and 
fluorimetric properties of the dye are discussed in 
chapter 2 and appendix 2. The possible use of SUVs rather 
than LUVS as another means of improving assay sensitivity 
has also been discussed. 
The study of interfering substances in the microalbumin 
assay highlighted the careful assessment required of any 
immunoassay designed to measure urinary analytes. The 
good correlation with radioimmunoassay suggests that, in 
the microalbumin assay, potential interferences were 
largely avoided. Variation in urinary pH caused a small 
interference which was partially overcome by lowering the 
buffer pH of the standards. It was elected not to modify 
the assay buffer (buffer A) in this assay, since this is 
a buffer commonly used and well characterized in 
complement reactions. Nevertheless, greater confidence 
might be achievable by increasing the buffering capacity 
of the assay buffer. 
All urines were frozen on receipt and measured soon after 
thawing. This probably helped minimize any gradual 
increase in urinary pH due to bacterial action. The pH 
range of the urines tested was 5.5-7.0, which is less 
than a commonly quoted range of 4.5-8.0 (172). Fresh 
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urine samples should not vary beyond the range 4.5-7 
unless there is a urinary tract infection, in which case 
the pH can become alkaline (pH 7-8). By deduction from 
the pHs resulting from phosphate solutions, the quoted 
range would appear likely to cause a significant but 
probably acceptable interference of up to approximately 
2 mg/l at zero concentration and 4 mg/l at 75 mg/1. There 
would be an option, in any case, of checking the sample 
pH using a dip-stick test. The dip-sticks used to check 
for protein (referred to in the next paragraph) usually 
also measure pH; typically between pH5 and pH9 in pHi 
increments (e. g BM-Test 3, as described in the materials 
section). It would be feasible to check the pHs of the 
samples routinely and adjust extreme values with acid or 
base as required. 
The presence of a hook effect at high antigen 
concentrations is a potential limitation of the sandwich 
type assay, since it can lead to underestimation of high 
antigen concentrations. The hook effect fortunately is 
not a practical problem in this microalbumin assay, 
since samples with concentrations above the measurable 
range can easily be detected. All urines can be tested 
using the dip-stick test, based on a chemical reaction, 
for the presence of frank proteinuria (i. e. protein 
concentration greater than approximately 200 mg/1) 
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(section 3.1). This is a useful preliminary check; since, 
if proteinuria is detected, there is little point in 
further testing for microalbuminuria. As mentioned above, 
pH could be checked simultaneously. 
The hook effect at high antigen concentrations is also 
found in other immunoassay techniques, such as enzyme- 
linked immunosorbent assays (ELISAs) and 
immunoturbidimetry. It is often circumvented by assaying 
several dilutions of the antigen. The liposomal sandwich 
assay is effectively a "one step" assay in that all the 
reagents are combined in the assay mixture. The hook 
effect is probably mainly due to saturation of antibody- 
binding sites by free antigen. Reduction of the hook 
effect is possible in solid phase assays (e. g. ELISAs) by 
a washing stage ("two step assays"). However hook effects 
can still occur, probably due to conformational changes 
leading to desorption of bound antibody (173). 
The use of intact anti-albumin liposomes as a solid- 
phase arose from incidental observations. Despite the 
growing popularity of homogeneous and coated-surface 
assays (e. g. ELISAs), techniques involving separation of 
the bound and free label by precipitation (e. g. 
radioimmunoassays and often immunoradiometric assays 
(IRMAs)) are still widely used. 
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Other particulate solid-phases such as cellulose are not 
easily dispensed and settle out rapidly on standing. 
This has tended to limit their use in automated 
dispensing systems. 
The SPDP method for the coupling of proteins to liposome 
membranes was at least as simple as most methods used to 
generate antibody-coated solid phases, using cellulose, 
Sephadex or latex particles (174,175). 
The antialbumin-coated liposomes could be dispensed as 
easily as a liquid, and showed minimal sedimentation on 
standing for several days. Considerably greater 
sedimentation was observed after immunoreaction and 
gentle centrifugation. 
Microscopically, prior to immunoreaction, the liposomes 
appeared as homogeneous pink spheres (see appendix 1). 
After immunoreaction and incubation for several hours, 
the liposomes had clumped into heterogeneous clusters. 
One possible mechanism for this phenomenon would be 
immune complex formation by antigen-antibody cross- 
linkages between liposomes. This would be similar to the 
reported augmentation of latex agglutination by liposomes 
(131). 
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It might be predicted that such complexes would only form 
with large antigens such as proteins, which have multiple 
antibody binding sites. Sandwich type assays (e. g. 
ELISAs, IRMAs etc. ) have a similar restricted range of 
analytes. It is also possible, however, that the net 
negative charge of the lipids in the liposomes might be 
modified by immunoreaction at their surface to a 
sufficient degree to cause sedimentation by electrostatic 
effects rather than by large immune complex formation. 
No noticeable sedimentation was observed during the 
complement-mediated immunoassay reactions using either 
albumin-coated liposomes or Fab'-coated liposomes, with 
the exception of Fab' coated liposomes in the presence of 
high phosphate concentrations (figure 3.21). This was 
despite the Cobas Bio centrifugal analyser exerting a 
centrifugal force during the reaction periods. There 
were several differences in assay conditions which might 
have caused this discrepancy; in particular the 
incubation periods were shorter. 
Earlier in this discussion, the molar ratio of dye to 
bound protein was calculated for the liposomes used in 
complement-mediated lysis, assuming a homogeneous 
liposome pool of diameter of 200 nm. Taking albumin- 
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coated liposomes as an example, the number of bound 
protein molecules was calculated to be 366 and the number 
of entrapped dye molecules was 79,000. This is equivalent 
to a ratio of dye molecules to bound protein of 216. 
Further similar theoretical calculations can be used to 
infer optimum liposome sizes for a range of analytical 
applications of liposomes. 
It is possible to recalculate the ratio of entrapped 
dye molecules to bound protein for various sizes of 
liposomes, making the assumption that the only factor 
affecting incorporation is size. For example, it is 
assumed that there are no steric or electrostatic factors 
hindering incorporation. The calculations for small 
unilamellar vesicles of 50nm and 20nm diameters are shown 
in table 3.9. Numbers are average molecules incorporated 
per liposome. 
The dramatic reduction in dye 
bound protein is due to two 
liposome volume decreases as the 
the area decreases as the square 
the lipid bilayer thickness (est. 
a significant factor in reducing 
small liposomes. 
entrapment relative to 
factors. Firstly, the 
cube of the radius while 
of the radius. Secondly, 
imated as 7.5 nm) becomes 
the entrapped volume of 
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At a certain diameter (in this case approximately 26 nm) 
the ratio of entrapped dye to bound protein is unity. 
Below this size there is no advantage in signal 
amplification compared to direct coupling of a dye 
molecule to a protein molecule. There could still be some 
advantage, however, in the close proximity of antigen or 
antibody molecules in augmenting an immune-reaction. 
Furthermore, in small liposomes the total surface area 
for a given amount of lipid in the preparation will be 
much higher, so the total amount of bound protein will be 
significantly greater. 
Table 3.9 
Effects of liposome size on theoretical incorporation of 
dye and protein 
diameter bound albumin entrapped dye ratio 
(molecules per (molecules per 
liposome) liposome) 
200nm 366 79000 216 
50nm 24 535 22 
20nm 3.7 1.5 0.4 
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It is therefore incorrect to assume that, in an 
immunoassay, there will inevitably be an advantage in the 
use of large liposomes (i. e. LUVs) because of the 
potential increase in signal per liposome (e. g. on 
lysis). The optimum size is dependent on the specific 
application of the liposomes. 
Various types of liposomal assays have been described in 
section 1.6. in some cases, the lysis will be relatively 
independent of the amount of protein bound and liposomes 
with a high relative entrapment will be preferable. This 
type of assay may include solid phase assays, where the 
amount of antibody or antigen binding to a solid phase 
will be limited to a small portion of the liposome. 
Cytolysin assays (section 1.6.6) are not dependent on 
protein-binding and larger liposomes would also probably 
be advantageous in these assays. 
As discussed earlier in this section, complement-mediated 
immunoassays benefit from a high amount of surface 
protein since this increases the amount of complement- 
mediated lysis. In competitive complement-mediated 
assays, on the other hand, the limit of detection tends 
to be increased if the amount of bound protein increases. 
These conflicting trends pose a problem in optimizing 
this type of assay. Sandwich type complement-mediated 
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assays seem to benefit by an increased amount of surface 
protein, both in terms of limit of detection and amount 
of complement activity. Small liposomes would seem to 
have advantages in sandwich-type assays because of their 
higher surface area. 
Small liposomes might also be advantageous in particle 
enhanced light scatter techniques which depend on surface 
immune-reactions. Small particles will also move more 
quickly under the influence of Brownian motion, possibly 
speeding up complex formation. They also, in general, 
have an advantage of more uniform size distribution. 
Assays using destabilization of liposomes (section 1.6.7) 
have usually utilized SUVs. Phosphatidyl ethanolamine has 
a relatively small head group. It may be that the phase 
change caused by close proximity of unsaturated 
phosphatidyl ethanolamine is more marked if the surface 
curvature of the liposomes is greater, since the bilayer 
structure might be less easily sustained in these 
circumstances. 
Since the number of molecules of dye in 200 nm diameter 
liposomes has been calculated, another interesting 
exercise is to estimate the dye concentration within the 
liposomes. This was calculated to be approximately 0.04 
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M, despite 0.1 M dye being used in the preparations. 
There are two possible explanations for this discrepancy. 
It is possible that the average size of the liposomes is 
actually less than 200 nm. Alternatively, dye may have 
been excluded from the liposomes during preparation. The 
latter explanation seems possible, since a number of 
factors such as dye concentration and buffer 
concentration affected entrapment (section 2.9). 
Furthermore, the maximum entrapment obtained was less 
than 30%, while entrapments of over 60% have been found 
in liposomes prepared by reverse evaporation previously 
(18). 
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Chapter 4 
Liposomal Assays for Anticardiolipin Antibodies 
4.1 Introduction 
4.1.1 Clinical Applications of Anticardiolipin Antibodies 
Cardiolipin is one of a range of phospholipids which are 
immunogenic. Anticardiolipin antibodies (ACAs) are often 
grouped with lupus anti-coagulant (LA) as 
antiphospholipid antibodies (APAs). ACAs and LA can 
occur together in a range of conditions but they are not 
identical and sometimes one or other type of antibodies 
can occur in isolation. In patients with suspected APAs, 
they are both often measured and can provide 
complimentary clinical information. APAs, including ACAs, 
have been reviewed extensively (176-178). ACAs and LAs 
are measured by different techniques, usually ELISA and 
haematological anti-clotting tests respectively. 
While IgG and IgM classes of ACAs are the APAs most often 
measured, antibodies can also be present which bind to 
other lipids such as phosphatidyl serine, phosphatidyl 
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inositol, phosphatidic acid and phosphatidyl glycerol 
(179), and also phosphatidyl choline and phosphatidyl 
ethanolamine (180). In some cases where other antibodies 
are found, ACAs and LAs can both be undetectable (181). 
The poor correlation of immunological activity between 
LA, ACAs and antibodies to other lipids suggests that 
there are separate specific populations of antibodies, 
but also populations which cross-react to a variable 
degree with a range of lipid antigens. 
IgG ACAs are found in a subgroup of patients at risk of 
thrombosis, recurrent foetal loss and thrombocytopaenia. 
Patients, with or without the autoimmune disease, 
systemic lupus erythematosus (SLE), who have APAs and 
associated clinical conditions are included under the 
term "Antiphospholipid Antibody Syndrome" (APS). When 
thrombotic features are found together with APAs but 
without the other clinical features of SLE the condition 
is referred to as the Primary Antiphospholipid Antibody 
Syndrome (PAPS). IgM ACAS tend to be associated with a 
different range of clinical features than IgG ACAs, 
including livedo reticularis, chorea and haemolytic 
anaemia. 
The antiphospholipid antibody syndrome has been reported 
to be commonly associated with a range of clinical 
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conditions including venous thrombosis, arterial 
thrombosis, recurrent foetal loss, haemocytopaenia, 
livedo reticularis, cardiac conditions (such as valve 
lesions) and neurological associations. APAs are also 
but less commonly found in ischaemic necrosis of bone, 
pulmonary hypertension, splinter haemorrhages of fingers 
and toes, and Addison's disease (182). Other recently 
reported associations include dialysis patients (183), 
HIV infected patients (184), in polymyalgia rheumatica 
(with or without giant cell arteritis) (185) and in acute 
myeloid leukaemia and non-Hodgkin's lymphoma (186). 
A number of proposed mechanisms of action of APAs have 
been suggested, including decreasing prostacyclin levels, 
fibrinolysis, protein C and thrombomodulin levels, 
protein s levels, antithrombin levels or an increase in 
platelet activation and aggregation (182). Recently, B2 
glycoprotein I has been implicated as a co-factor in the 
binding of ACA (187). B2 glycoprotein I is an inhibitor 
of coagulation and platelet aggregation and interference 
with its action could also be a mechanism for the 
antibodies' actions. 
The establishment of APS has importance for treatment, 
since low dose aspirin, and possibly anticoagulation if 
thrombosis is involved, have been claimed to be 
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effective. Immunosuppressive therapy is generally only 
required for an underlying condition such as SLE (182). 
ACAs occur in SLE, but they are not the commonest type of 
autoantibody seen. In a follow-up study over five years 
(188) anti-nuclear antibodies were found in nearly all 
SLE patients (98%), anti-double stranded DNA in about 
half (56%), anti-Ro antibodies in 39% and anti- 
phospholipid antibodies in 38%. A diverse range of other 
antibodies are found in lower proportions of patients 
(189). However the association of IgG ACAs with 
thrombotic episodes, thrombocytopaenia and neurological 
episodes (190,191) largely explains the interest in ACAS 
in SLE. Screening for antibodies to phospholipids other 
than ACAS seems to add little additional clinical 
information, at least in SLE (179). A large prospective 
study of 500 patients summarised in detail the clinical 
features associated with APS in SLE (192). 
Neurological associations of APAs include multiple 
cerebral infarctions, transient ischaemic attacks, 
migraine-like headaches, visual abnormalities and 
encephalopathy (193,194). Anticardiolipin antibodies have 
been shown to be an independent risk factor for first 
ischaemic stroke (195). 
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In neurological disease associated with SLE, ACAS have 
been reported to be absent from CSF (196). Thus the 
neurological symptoms may be associated with cerebral 
infarcts, and the diffuse encephalopathy of acute central 
nervous system lupus appears not to be due to APAs acting 
against neurons directly. 
In contrast, ACAS were found in the CSF of a proportion 
of neurological patients with neurosyphilis and multiple 
sclerosis and occasionally in Guillain-Barre syndrome, 
suggesting localised immune reaction can occur within the 
brain (197). 
Serum antiphospholipid antibodies have also been found 
in a few Guillain-Barre patients (197,198) but this may, 
at least in some cases, be caused by underlying SLE 
(199). 
Although there appear to be clear associations of the 
antiphospholipid antibody syndrome with thrombosis (200), 
the clinical usefulness of ACA measurements in predicting 
thrombotic events has been questioned, both in SLE (201- 
203) and in the PAPS (204). While anticardiolipin 
antibodies seem an important tool in the management of 
women susceptible to recurrent miscarriages (205,206); 
the appropriate extent of APA measurements and the most 
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effective therapeutic intervention are still unresolved 
(207). 
Rote (208) suggested antibodies to phosphatidyl serine 
should be measured in pregnancy rather than to 
cardiolipin, since this correlated better with LA. 
Furthermore, it is easier to postulate a mechanism of 
action of antibodies during physiological cell fusion and 
exposure to phosphatidyl serine, than it is to implicate 
cardiolipin, a lipid which is generally restricted to 
the inner mitochondrial membrane. (209). 
An interesting cardiological application was suggested by 
Hamsten et al. (210), who found that raised ACAS were 
associated with a high risk of recurrent cardiovascular 
events in post-myocardial infarction patients. ACAs were 
Also shown in post-myocardial infarction patients in 
another small study which also demonstrated the increased 
presence of anti-cephalin antibodies (211). However, no 
influence of raised ACAS soon after myocardial infarct on 
immediate patient outcome was found (212). Further 
studies are required to reconcile these conflicting 
findings, which may be due to different selected 
populations and different lengths of study. 
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4.1.2 Existing Non-Liposomal Assays for Antiphospholipid 
Antibodies and Anticardiolipin Antibodies 
LA interferes with the conversion of prothrombin to 
thrombin and the activation of the clotting process, by 
binding to the phospholipid surface of the prothrombin 
activator complex (213). The presence of LA is normally 
established by haematological tests such as the prolonged 
activated-partial thromboplastin time or by the Russell 
viper venom test. Serological tests for syphilis may also 
demonstrate APAs but are not as sensitive as the 
haematological tests. There are problems in standardizing 
assays for LA, which makes interpretation and comparison 
of clinical studies difficult, although there have been 
attempts to improve this (214). 
Radioimmunoassay was introduced in 1983 to measure ACAs 
(215). Since then ELISA (enzyme-linked immunosorbent 
assay) has become popular. ELISA, which is based on 
cardiolipin-coated microtiter plates (216), has enabled 
analysis of large numbers of sera and elucidation of many 
clinical associations such as the association of ACAs 
with recurrent foetal loss. 
Considerable international efforts have been undertaken 
to compare the performance of centres carrying out ELISAs 
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and try to improve inter-laboratory agreement. Harris 
(217,218) proposed a means of quantitating ACAs by 
comparison to reference materials. Units were defined as 
the GPL unit (for IgG ACAS) and the MPL unit (for IgM 
ACAs). The GPL (or MPL) is the unit of activity of a 
standardized affinity-purified serum from a patient with 
high IgG ACAS alone (or IgM ACAS alone). One unit is 
equivalent to the binding activity of 1 mg/l of purified 
ACA antibody. 
Following the distribution of reference standards and 
controls, a degree of agreement was demonstrated, 
although results were expressed only semi-quantitatively 
(i. e. negative, low-positive, medium-positive or high- 
positive) and not directly in terms of concentration 
units (217,218). For convenience, high positive was 
defined as greater than 80 GPL or 50 MPL, medium-positive 
as 15-80 GPL or 6-50 MPL and low positive as below 15 GPL 
or below 6 MPL. There is confusion over the definition of 
negative results since there is no consensus over the 
cut-off values. Most studies refer to negative as meaning 
not increased, but this can be taken as above 2,3, or 
even 5 standard deviations from the mean of normal 
samples. This lack of consensus means publications have 
to be compared carefully and probably contributes to 
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marked variations in reported incidence of ACAS in 
various conditions. 
ELISA is currently the most popular technique for 
measuring ACAs; but there are problems affecting the 
performance of the test which affect agreement of assays 
and their comparability in clinical studies. Non-specific 
binding to the microtiter plates can cause problems. This 
is dependent on the blocking agent used in the buffer 
(218-220). Cheng et al (221) showed that heat-treating 
samples for 30 minutes at 56°C caused increased binding 
in the ELISA assay. This resulted in some samples 
previously negative for ACAS becoming positive, which was 
postulated to be due to deactivation of heat-labile 
inhibitors. 
There has been considerable debate about the role of the 
co-factor, B2 Glycoprotein I (B2-GPI) (also known as 
Apolipoprotein H), since its role in binding ACAS was 
first suggested by Galli et al (222). Galli's claim that 
B2-GPI was the agent to which ACAs bind, rather than 
cardiolipin, sparked controversy. Their findings were 
apparently supported by the detection of APAs using an 
ELISA with B2-GPI as antigen (223), but may have been 
due to trace amounts of phospholipid contaminants in B2- 
GPI preparations (224-227). It now appears that B2-GPI is 
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indeed required for ACA binding to cardiolipin, but that 
the antigen is a complex of cardiolipin and B2-GPI 
(187). 
Since ELISAs often employ large pre-dilutions of serum, 
low B2-GPI concentrations in the reaction mixture could 
cause variability and underestimation of ACA 
concentrations. The addition of high concentrations of 
bovine serum (10%), in which the co-factor is also 
found, (228), has been employed to reduce the effect of 
low B2-GPI on ACA detection in ELISAs. However, 
significant non-specific binding of normal IgG can occur 
which can lead to inappropriate high results unless the 
non-specific binding is removed by using control wells 
(229). 
As well as the problems associated with co-factors and 
non-specific binding, there are a few other practical 
disadvantages with ACA measurement by ELISA. Large 
numbers of samples can be easily processed only if sample 
and reagent dispensing, well-washing and measurements are 
automated. Each batch is usually restricted to the use of 
96 well plates, which either requires batching of samples 
or is wasteful on plates and possibly reagents. The 
introduction of eight-well strips has recently allowed 
smaller and more variable batch sizes. 
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The practical problems in automating ELISAs, together 
with a typical assay time of several hours, mean that 
ELISA measurement of ACAs is difficult to justify in a 
"district-general" hospital, which may only require a few 
tests a week. These few samples will usually be referred 
to a specialist centre, delaying reporting times often to 
a week or more. At the other extreme, large population 
studies to elucidate the clinical value of the tests are 
only feasible in very large centres using automated 
ELISAs. For these reasons, ACA measurements by ELISA are 
unlikely to move from specialist centres to other 
hospitals, let alone to "near-patient" testing in the 
out-patient or in the general-practice clinic. 
4.1.3 Liposomal Immunoassays for Anticardiolipin 
Antibodies 
Flow-cytometry, in which cardiolipin liposomes show an 
altered light scatter on binding ACAS, has recently been 
described (130). However, this requires equipment which 
is not universally available. There are two other 
reports of the use of liposomes which might form the 
basis of an alternative immunoassay technique to ELISA. 
Takashi et al., (142) demonstrated liposomal lysis of 
cardiolipin-containing liposomes by complement and anti- 
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cardiolipin antibodies, using glucose release as a 
marker. However their studies did not extend to potential 
analytical uses of this phenomenon. 
Janoff et al. (108), however, did report a liposome-based 
test for Systemic Lupus Erythematosus (SLE) antibodies. 
(ACAs are often a major component of SLE antibodies. 
The relationships of ACAS and other lupus antibodies, 
e. g. anti-nuclear antibodies and anti double-strand DNA, 
were still being clarified at the time of publication. ) 
The assay was based on destabilization of cardiolipin- 
containing liposome membranes by divalent cations. This 
phenomenon was reported by Rand and Sengupta' in 1972 
(58). Divalent cations cause a phase change of the 
cardiolipin from bilayer to a hexagonal (II) structure 
which tends to release the liposomes' contents and may 
cause precipitation. 
Large unilamellar liposomes containing the dye, Arsenazo 
III, were prepared by the ether-infusion method of Deamer 
and Bangham (27). Liposomes (200 ul) and serum (20 ul) 
were placed in the wells of a microtitre plate. After 
mixing and incubating for an hour, MgCl 2 (10 ul) was 
added and the mixture left for five to ten minutes. In 
the presence of non-SLE serum the mixture changed colour. 
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This was due to the breakdown of the liposomes and 
release of the dye, which changed from red to blue on 
complexing with Mg2+ ions. Using SLE serum no colour 
change was observed, presumably because binding of serum 
antibodies to the liposomes protected them against lysis. 
The assay required careful optimization of the liposome 
concentration and magnesium ion concentration to give the 
optimal colour change between SLE and non-SLE serum. It 
was claimed to produce quantitative results by 
spectrophotometric measurement of the absorbances of the 
wells at 610 nm. However, the value of this was limited 
since there was a lack of characterization or 
quantitation of the antibody present in the SLE serum 
used as a standard. 
4.1.4 Objectives of Anticardiolipin Studies 
The aims of these studies were to examine the 
possibilities for measuring anticardiolipin antibodies 
using Sulphorhodamine B-containing liposomes; firstly by 
the use of complement-mediated lysis and alternatively 
using Mg2+ ion-dependent lysis. 
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4.2 Complement-Mediated Immunolysis of Cardiolipin- 
Containing Liposomes 
Dye-containing liposomes were prepared as described in 
section 2.9.8, with an incorporation of 30% cardiolipin. 
They were used to demonstrate complement-mediated 
immunolysis on incubation with anticardiolipin antibodies 
and complement. 
A Cobas Bio was employed in a manner similar to that for 
albumin (chapter 3), except patients' sera samples, 
including a sample known to contain increased 
concentrations of anticardiolipin antibodies, were added 
in place of antialbumin antiserum (table 4.1). 
When buffer A alone was added as sample instead of serum, 
a rapid rate of lysis was observed, even though anti- 
cardiolipin antibody was not present (figure 4.1). When 
complement was replaced by buffer, however, this reaction 
was not found. This indicated that a non-immunospecific 
reaction was occurring between complement and the 
cardiolipin-containing liposomes. 
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TABLE 4.1 
Reaction parameters used on Cobas Bio Analyser to 
Monitor Complement-Mediated Immune Lysis 
R1 (reagent 1): Liposomes diluted to initial absorbance 
of lA (approx. 5ml buffer A plus 40u1 liposomes (100 
ul/cuvette)) 
sample: serum (4u1/cuvette) 
diluent: (distilled water) (10 ul/cuvette) 
R2 (reagent 2): complement diluted X2 in distilled water 
(4 ul/cuvette) 
Temperature: 37°C 
Printout type: 3 (absorbance measurements) 
Assay process: Ri, sample and diluent dispensed into 
cuvettes and mixed. 5 minute pre-incubation. R2 added and 
readings taken at 10 second intervals over 180 seconds 
(first reading after 3 seconds). 
A similar non-specific lysis occurred whether guinea-pig 
complement or rabbit complement was used, except the rate 
was much lower for guinea-pig complement (approximately 
20%). The lysis was absent when either complement was 
heat-inactivated (as section 3.4.1). The non-specific 
lysis was found whether or not the liposome preparation 
included PTA. This non-specific lysis, which was 
confirmed using a spectrophotometer (as described in 
section 3.4.2), was found to give an approximately linear 
increase in absorption at 565 nm over at least twenty 
minutes and to plateau after about an hour. The 
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Figure 4.1 
Effect of Complement on Dye-Release from Cardiolipin-Containing 
Liposomes in Absence of Anticardiolipin Antibodies 
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Non-specific complement-mediated release of dye from cardiolipin-containing 
liposomes. The reaction conditions are stated in Table 4.1. Symbols indicate: o rabbit 
complement, " guinea-pig complement. 
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relatively linear absorbance change differed from the 
rapid but slowing initial absorbance change typical of 
the specific immunolysis for albumin (for example, 
figure 3.11). 
In an attempt to reduce the non-specific lysis, small 
unilamellar liposomes were prepared as described by 
Schreier et al. (230). 100 umol of PC were sonicated in 5 
ml of distilled water for twenty minutes in an iced water 
bath. Equal volumes of this preparation and complement 
(guinea-pig or rabbit) were incubated for 30 minutes at 
37 0 C. The complement was then used in the reaction as 
before. Unfortunately no reduction in non-specific lysis 
could be demonstrated by this technique. 
The addition of either 
goat serum (1%) to the 
specific lysis, but 
presence of human sera 
human sera samples on 
was examined. 
normal 
buffer 
also ri 
Using 
rabbit 
sheep serum (1%) or normal 
markedly reduced the non- 
aduced the lysis in the 
sheep serum, the effect of 
complement-mediated lysis 
Two human sera samples were analysed, a pool of samples 
taken from patients with no evidence of increased ACA 
concentrations or immunological disease (normal pool) and 
a sample of known high ACA concentration. The lysis was 
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found to be related to the sample dilution. Even though 
the absorbance changes for both samples were low in the 
presence of normal sheep serum, consistent differences in 
lysis rates between the samples were apparent. A dilution 
of human serum samples of 1: 50 seemed to give the largest 
difference in absorbance between the two samples (figure 
4.2). 
Using this dilution of serum, the effect of varying the 
amount of complement was examined. The buffer content of 
reagent 1 was adjusted to accommodate larger complement 
volumes. As in the case of complement-mediated lysis of 
albumin or Fab' anti-albumin coated liposomes, (figure 
3.5), a "hook" effect occurred. Figure 4.3 shows that at 
complement concentrations up to and including the optimal 
concentration, the high ACA serum gave a higher rate of 
absorbance change, while at higher complement 
concentrations the high ACA serum gave a lower lysis 
rate. 
Under these conditions guinea-pig complement also gave a 
peak lysis at 2 ul/cuvette, although the lysis rate was 
much lower compared to rabbit complement (approximately 6 
mA). No reproducible difference between the ACA positive 
sample and the pool could be detected at this complement 
dilution. 
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Figure 4.2 
Effect of Serum-Dilution on Complement-Mediated Lysis of Cardiolipin- 
Containing Liposomes 
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Human serum was diluted in buffer A and measured in the sample position of 
the Cobas Bio analyser, using the conditions specified in Table 4.1. Serum was 
either a normal serum pool(o) or an anticardiolipin antibody positive serum(*), 
concentration 1100 GPL units. Overlaid points represent duplicate 
measurements. 
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Figure 4.3 
The Effect of Varying the Amount of Complement on the Immunolysis of 
Cardiolipin-Containing Liposomes 
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The reaction conditions are as indicated in section 4.2; the amount of complement 
added to each cuvette of the Cobas Bio being varied. The resultant dye release was 
measured, in the presence of cardiolipin-containing liposomes, and either 
anticardiolipin antibody-containing serum (o), or a normal serum pool ("). Overlaid 
points represent duplicate measurements. 
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The effect of mixing the ACA positive serum (1100 
GPL units) with the normal pool at the optimal for 
sample dilution (1/50) and rabbit complement (2u1/ 
cuvette) is shown in figure 4.4. A dependence of lysis 
on the amount of ACA was demonstrated, although the 
absorbance change was insufficient for a practical 
assay. The concentrations of ACAS in figure 4.4 were 
calculated from the assayed value of the ACA serum (see 
materials), and assumed an absence of ACAs in the normal 
pool. (This was therefore probably an underestimate since 
a low concentration of antibodies in the pool was 
likely). 
When liposomes which contained 2.5% cardiolipin, (similar 
to the cardiolipin content used by Takashi et al 
(142)) were used, no detectable absorbance change was 
found, irrespective of whether guinea-pig or rabbit 
complement was added. 
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Figure 4.4 
Effect of Anticardiolipin Antibody Concentration on Complement- 
Mediated Lysis of Cardiolipin-Containing Liposomes 
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The reaction conditions are as indicated in Table 4.1. The pre-diluted 
anticardiolipin antibody concentrations of the samples is indicated; obtained by 
mixing anticardiolpin reference serum (1100 GPL units) with a normal serum 
pool. The mixed samples were pre-diluted x50 in Buffer A prior to assay. 
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4.3 MgClz Dependent Lysis of Cardiolipin-Containing 
Liposomes 
The MgC12-dependent lysis of liposomes was examined as an 
alternative potential assay to the use of complement. 
4.3.1 MgC12-Induced Lysis Using Manual Spectrophotometer 
and Fluorimeter 
When a solution of liposomes containing 20% cardiolipin 
at a dilution giving an absorbance of 1.0 A at 565 nm was 
mixed with an aqueous solution of MgCl 2 at a final 
concentration of 0.4 mol/l, very rapid lysis occurred 
with an increase in absorbance or fluorescence of about 
15% within five minutes. 
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4.3.2 Application of MgC12-Dependent Lysis to the Cobas 
Bio Analyser 
The destabilization of the liposomes (as described in 
section 4.3.1) was investigated using a Cobas Bio 
analyser . The assay parameters used on the Cobas Bio are 
shown in table 4.2, modified as appropriate to assess and 
optimize variables. 
TABLE 4.2 
Reaction parameters used on Cobas Bio Analyser To Assess 
MgCl2 Destabilization 
R1 (reagent 1): 5m1 phosphate buffer plus 40 ul liposomes 
100 ul/cuvette 
sample: serum 5u1/cuvette 
diluent (distilled water): lOul/cuvette 
R2 (reagent 2): 5 mol/l MgCl 2 lOul/cuvette 
Temperature: 25°C 
Printout Type: 3 (absorbance measurements) 
Wavelength: 565 nm 
Assay Process: Ri and sample (+ diluent) dispensed and 
mixed. 3 minute preincubation. R2 added and readings 
taken at 20 second intervals over 120 seconds (first 
reading after 3 seconds) 
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The ACA positive sample, diluted in normal pool to 80 
GPL, gave a higher rate of dye release than the normal 
pool. When the absorbance was monitored over 
approximately ten minutes, the difference in rate of dye 
release between the two samples was found to be greater 
over the first few minutes (figure 4.5). 
Consistent with earlier results 
from liposome lysis (sections 2.8 
absorbance change at 530 nm was ob: 
change was, as before, greater 
wavelength was used subsequently. 
corresponded to those found when 
ratios were monitored using 
spectrophotometer or fluorimeter. 
involving dye release 
and 3,4.3), a negative 
served. The absorbance 
at 565 nm and this 
The absorbance changes 
reagents in the same 
either a manual 
As mentioned in section 4.2, although the normal pool had 
been prepared from patients without known immunological 
disorders, a certain amount of antibody might still have 
been present. This could cause errors if the pool were 
used as a diluent in preparation of an analytical 
standard curve. To ensure that the pool had as low 
antibody concentration as possible, 100 samples from 
patients without evidence of immunological disorders were 
collected. The 20 with the lowest lysis by MgC12, 
assessed on the Cobas Bio, were pooled and used 
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Figure 4.5 
Magnesium Chloride-Induced Release of Dye From Cardiolipin- 
Containing Liposomes 
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The assay conditions were as described in Table 4.2. Absorbance changes were 
monitored using a Cobas Bio analyser. The sample was either a normal serum 
pool (") or an anticardiolipin antibody positive serum (o), concentration 80 
GPL units. The reaction time excludes an automatic initial mixing time of three 
seconds. 
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subsequently as a "negative pool" and as a diluent for 
the ACA positive serum. 
Using dilutions of the reference serum in this new normal 
pool, the amount of dye release was found to be directly 
related to the concentration of anticardiolipin 
antibodies present, as shown in figure 4.6. 
This also demonstrates the effect of varying the amount 
of liposomes, which is indicated by the initial 
absorbance of the cuvette. The rate of absorbance change 
increased as the amount of liposomes increased. Although 
the Cobas Bio can measure higher absorbances than most 
other analysers because of its ability to use a short 
path length a maximum initial absorbance of approximately 
1A was used subsequently (for reasons discussed in 
section 3.4.3). 
The effect of ACA concentrations on lysis are also shown 
in figure 4.7. This shows results of figure 4.6 for an 
initial absorbance of 0.8, which are replotted using a 
logarithmic scale and include much higher ACA 
concentrations. The figure indicates the effects of 
reaction temperatures. Higher absorbance changes were 
observed at higher temperatures, but there was also 
greater lysis by the normal pool. As there seemed little 
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Figure 4.6 
Effect of Amount of Cardiolipin-Containing Liposomes on Magnesium 
Chloride and Anticardiolpin Antibody-Induced Release of Dye 
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The reaction conditions were as described in Table 4.2, except that the amount 
of liposomes in the first reagent (RI) was varied; giving the following initial 
absorbances: o=0.4A, "=0.8A, Q=1.6A. Overlaid points represent 
duplicate measurements. 
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Figure 4.7 
Effect of Reaction Temperature on Lysis of Cardiolipin-Containing 
Liposomes by Magnesium Chloride and Anticardiolipin Antibodies 
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The reaction conditions are described in Table 4.2; except that the reaction 
temperature was varied as follows: "= 25oC, El = 30°C, o= 370C. The 
points labelled as (x) indicate the absorbance changes in the absence of 
anticardiolipin antibodies; (absorbance changes increasing with temperature). 
Overlaid points represent duplicates, with the exception of points labelled 
which are singleton measurements. 
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advantage in using higher temperatures, 25°C was used in 
subsequent experiments. Figure 4.7 also shows a hook 
effect at very high ACA concentrations. 
The rate of liposomal lysis was shown to be dependent on 
the amount of cardiolipin within the liposomes (figure 
4.8). Although human sera rarely contain IgG 
anticardiolipin concentrations above 100 GPL units, 
occasionally concentrations up to 1000 GPL units can be 
found. Liposomes containing lower amounts of cardiolipin 
exhibited a "hook effect" at higher anticardiolipin 
concentrations, but this was absent at up to 1000 GPL 
units when liposomes containing 40% cardiolipin were 
used. When liposomes which did not contain cardiolipin 
were used (PC-Chol 10-2 or PC-Chol-PTA 10-2-1) the lysis 
rates were very low and not dependent on the amount of 
anticardiolipin antibody present. 
Because of the absence of a "hook" and the fact that much 
greater absorbance changes were observed, liposomes 
containing 40% cardiolipin were utilized in further 
experiments. 
No detectable release of dye was observed when liposomes 
containing 40% cardiolipin were mixed with varying 
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Figure 4.8 
Effect of Liposomal Lipid Composition on their Lysis Due to Magnesium 
Chloride and Anticardiolipin Antibodies 
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The reaction conditions were as described in Table 4.2. In separate experiments, various 
liposome preparations were used. The symbols refer to the following lipid contents: o= 40% 
cardiolipin, "= 30% cardiolipin, -= 20% cardiolipin, 0=2.5% cardiolipin, Q- 
PC/PTA/Chol (molar ratio 10-2-1),  = PC/Chol (molar ratio 10-2). In the absence of added 
anticardiolipin antibodies; the absorbance changes were below 0.010A in all cases except 
40% cardiolipin, which had a mean absorbance change of 0.018A. Overlaid points represent 
duplicate measurements, except for points labelled *, which are singletons. 
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concentrations of anticardiolipin antibody (as figure 
4.8) if distilled water was used as the second reagent in 
place of MgC12. In the absence of serum, increasing 
reaction concentrations of MgCl2 up to 0.4 mol/l 
increased the rate of lysis (figure 4.9). No insolubility 
was observed at this concentration which was adopted 
subsequently in favour of even higher concentrations, to 
avoid potential insolubility problems in the latter. 
The effect of varying the volume of sera added to the 
reaction cuvette is shown in figure 4.10. Serum volumes 
were obtained by setting the sample volume to 20 ul and 
assaying serial dilutions of sera in buffer. In the 
absence of normal serum, liposomes were lysed very 
rapidly by MgC12. Normal serum, at sufficiently high 
concentrations, protected the liposomes almost completely 
from this lysis. Anticardiolipin antibodies effectively 
reduced the protective effect of serum, over a limited 
range of serum concentrations. Undiluted serum, added at 
5u1 per cuvette, was found be close to the optimum for 
differentiating ACA containing serum from ACA free serum. 
The effects of adding, in place of serum, purified human 
albumin and human gamma globulin were also examined 
(figure 4.11). A protective effect similar to serum, 
though not as complete, was seen at high albumin 
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Figure 4.9 
Effect of Varying Magnesium Chloride Concentration on the Lysis of 
Cardiolipin-Containing Liposomes in the Absence of Serum 
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The reaction conditions were as described in Table 4.2, except that the 
concentration of magnesium chloride in the second reagent (R2) was varied to 
produce the indicated final reaction concentrations. 
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Figure 4.10 
Effect of Amount of Serum on Lysis of Cardiolipin-Containing Liposomes 
in Presence of Magnesium Chloride 
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The reaction conditions are stated in Table 4.2, except that the serum volume added to 
each cuvette was varied (as described in section 4.3.2). The serum either contained 
anticardiolipin antibodies (80 GPL units) (o), or was a normal serum pool (S). 
Overlaid points represent duplicate measurements. 
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Figure 4.11 
Effect of Amount of Purified Human Protein on Lysis of Cardiolipin- 
Containing Liposomes in the Presence of Magnesium Chloride 
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The reaction conditions are stated in Table 4.2, except that human albumin (o) or 
human gamma globulin (0) , each diluted 
in buffer, was used as sample. The protein 
content indicated is the concentration in the sample. (The sample volume was 5u1 and 
the total cuvette volume was 125 ul). 
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concentrations while lysis was less dependent on gamma 
globulin concentrations. 
To assess the effect of Ca2+ ions at near physiological 
concentrations, CaCl 2 at concentrations equivalent to a 
sample concentration of 1.0 to 3.0 mmol/l were added in 
place of MgCl2. No detectable lysis occurred. A reaction 
concentration of CaCl 2 of 0.4 mol/l, (equivalent to the 
concentration of MgC12 used above) caused a rapid 
precipitation of liposomes. A certain amount of dye 
release was associated with this precipitation. This was 
found to be variable. In experiments analogous to that of 
figure 4.10, no anticardiolipin antibody dependence of 
this lysis was detectable. 
4.4 Estimation of Anticardiolipin Antibodies by Enzyme- 
Linked Immunosorbent Assays (ELISAs) 
Both normal sera and anticardiolipin antibody positive 
sera were estimated using both the Cobas method (section 
4.3.2 and table 4.2) and by commercial ELISAs (Cambridge 
Life Sciences "SELISA" for IgG and for IgM 
anticardiolipin antibodies). The latter were performed 
according to the manufacturer's instructions. 
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These ELISA kits were conventional in format. Prediluted 
standards and samples (100u1,1 in 100) were added to 
cardiolipin-coated wells in plastic microtitre plates. 
After incubation for 30 minutes the plates' contents were 
decanted, and the plates washed and blotted. Antibody 
conjugated to enzyme (horse radish peroxidase - 100 ul) 
was then added to the plates, followed by incubation for 
30 minutes, decanting, washing and blotting. Enzyme 
substrate (100 ul) was added and a colour developed for 
10 minutes which was read, after stopping the reaction 
with sulphuric acid (4M, 50ul), in a microtitre plate 
reader. 
Typical standard curves obtained using the kits are shown 
in figure 4.12. 
4.5 Comparison of Patients' Ant icardiolipin Antibody 
Conc entrations by ELISA and by MgC1 2 -Dependent Lysis 
Thirty five samples, on which analysis of anticardiolipin 
antibodies had been requested, were collected from 
several hospitals . They were analysed using the Cobas 
MgC12 procedure and by ELISAs for both IgG and IgM anti- 
cardiolipin antibodies. 
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Figure 4.12 
Standard Curves for Measurement of Anticardiolipin Antibodies by 
ELISA Technique 
2 
1.8 
1.6 
1.4 
d 1.2 
c 
Co 
d1 
c 
to 
ß 
Co 
0.6 
0.4 
0.2 
0 
The reaction conditions have been described in section 4.4. Symbols refer to: " 
= IgG ACAs (GPL units); 0= IgM ACAS (MPL units). Overlaid points 
represent duplicate measurements. 
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The relationship between results using the liposomal and 
the ELISA procedures for IgG ACAs is shown in figure 
4.13. The regression equation obtained was; 
y (Liposomal ACAs) = -1.78 + 1.02 x (ELISA IgG ACAs) 
The correlation coefficient (r) was 0.90 . 
The examination of any relationship between the Cobas 
results and the ELISA IgM results was complicated by the 
lack of ready availability of an IgM reference serum. 
Furthermore only four of the thirty five samples analysed 
by ELISA gave IgM ACA concentrations above the 
manufacturer's quoted normal range (0.4 to 5 MPL units). 
There was no significant correlation between the Cobas 
responses (i. e. changes in absorbance) and the ELISA IgM 
ACA concentrations. 
The correlation coefficient (r) was 0.20 (probability of 
null hypothesis (p) = 0.27) . 
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Figure 4.13 
Comparison of the Measurements of IgG Anticardiolipin Antibodies by 
Liposomal Immunoassay and ELISA Technique 
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Human sera from 35 patients were measured by the liposomal assay, involving 
magnesium chloride lysis of cardiolipin-containing liposomes, and by enzyme- 
linked immunosorbent assay (ELISA). 
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4.6 Establishment of Normal Ranges for IgG ACAS 
The manufacturer of the ELISA kits recommended that each 
user should establish their own normal (reference) range. 
They quoted a range of 1 to 9 GPL units based on normal 
blood donors although the mathematical method used to 
calculate the manufacturer's range was not stated. A 
local reference range was established using 20 samples of 
citrated plasma from normal blood donors and also 20 sera 
samples from ante-natal clinic attenders without evidence 
of immunological illness. The samples were analyzed using 
both IgG ACA ELISA and by the Cobas method. Both 
techniques gave similar arithmetic mean values (table 
4.3) and were positively scewed (figure 4.14). A possible 
bimodal distribution of values was observed which would 
have contributed to the scew, although the number of 
samples was not large enough to confirm this. 
Logarithmic and square root transformations of the data 
were compared and the square root transformation proved a 
better means to normalize the results. The normalized 
means and standard deviations using this transformation 
are shown in table 4.4. There was some variation between 
the normalized mean values for the two types of samples 
and between these and the combined value. These were not 
significant using 2 sample t-tests (table 4.5); except 
277 
Figure 4.14 
Distribution of IgG Anticardiolipin Antibody Results for Normal Samples 
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Samples from normal blood donors and from ante-natal clinic attenders were 
analysed for IgG anticardiolipin antibodies by both the liposomal immunoassay 
and by ELISA. The distribution of results is shown. The black bars refer to 
results by the liposomal assay and the white bars refer to results by ELISA. 
Results are expressed in GPL units, to the nearest whole number. 
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TABLE 4.3 
Arithmetic Means and Standard Deviations for Normal Samples 
Blood Donors 
mean 
standard 
deviation (sd) 
Ante-Natal 
mean 
sd 
Overall 
mean 
sd 
(GPL units) 
10.9 
5.9 
7.8 
4.0 
9.4 
5.2 
(GPL units) 
9.5 
5.7 
7.0 
3.7 
8.5 
4.9 
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for the difference between the ELISA results for ante- 
natal clinic samples and blood donor samples which was 
weakly significant (p < 0.05). 
The reference ranges calculated after square root 
normalization and also by calculating the 95 percentiles 
are shown in table 4.6. The arithmetic "normal range", 
although statistically invalid due to the scewed results, 
is shown for comparison. 
The normal ranges derived from both the ELISA and 
Liposomal methods were found to be divergent from the 
ELISA manufacturer's quoted normal range. The 
latter, therefore, seemed inappropriate to the normal 
samples assayed. The liposomal and ELISA reference 
ranges were similar and an upper limit of normal for the 
liposomal method of 20 GPL units was established based 
on the normalized results from both groups of samples 
combined. 
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TABLE 4.4 
Normalized Values for Mean and Standard Deviation 
(GPL units) (GPL units) 
Blood Donors 
mean* 10.2 8.4 
sd of roots** 0.82 0.94 
Ante-Natal 
mean* 7.3 6.6 
sd of roots** 0.68 0.72 
Overall 
mean* 8.8 7.5 
sd of roots** 0.78 0.85 
* mean is defined as the square of the mean of the square 
roots 
** "sd of roots" is the sd of the square roots 
TABLE 4.5 
Analysis of Significance of Differences in Means (from 
table 4.4) 
ELISA v. Cobas (overall) 
ELISA donors v. Cobas donors 
ELISA ante-natal v. Cobas ante-natals 
ELISA donors v. ELISA ante-natals 
Cobas donors v. Cobas ante-natals 
0.26 
0.62 
0.51 
0.047 
0.14 
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TABLE 4.6 
Normal Ranges 
Square root* 
transformed 
5th - 95th 
percentiles 
Arithmetic** 
Manufacturer's 
Stated Range 
(GPL units) 
1.9 - 20.5 
4.2 - 18.5 
-1.1 - 19.8 
1.0 - 9.0 
(GPL units) 
1.1 - 19.9 
2.8 - 16.5 
-1.4 - 18.0 
* Rangg calculated as ((mean +/- 2 sds) of the square 
roots) 
** Mean +/- 2 sds. Statistically invalid due to scewed 
data but shown for comparison 
4.7 Comparison of Imprecisions of the Liposomal and ELISA 
Methods 
Pools of patient samples were prepared at various ACA 
concentrations to compare imprecisions. Since the ELISA 
normally analyses tests in duplicate the samples were 
assayed on the Cobas in the same way. The Cobas performs 
tests using rotors with a maximum capacity of 24 tests 
per sample tray. The ELISA imprecision was calculated 
from results obtained from a single microtitre plate. 
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Samples could be analysed on the Cobas either in a 
similar way to the ELISA method, i. e. with standards in 
the same rotor, or using a standard curve in an earlier 
rotor provided there was little drift in results from 
rotor to rotor. To assess both these options, 
imprecisions were calculated within a single rotor and 
also over three rotors. The results are shown in figure 
4.15. The imprecisions were similar, except that over 
three rotors the Cobas performed considerably worse at 
low antibody concentrations. 
4.8 Calculation of Limits of Detections of IaG 
Anticardiolihin Antibodies 
An estimate of the limits of detections of the methods 
can be obtained from these data in two ways. The limits 
of detections could be taken as the concentrations at 
which coefficients of variations (C. V. s) of 10% were 
found. These values were obtained from the curves shown 
in figure 4.15. Alternatively, if the limits of 
detections were defined as equal to three standard 
deviations of a value close to zero, these could be 
calculated from the imprecisions of the lowest pool 
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Figure 4.15 
Comparison of the Imprecisions in Measurement of Anticardiolipin 
Antibodies by the Liposomal Immunoassay and by the ELISA Technique 
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Imprecision in IgG anticardiolipin antibody measurement was assessed as 
described in section 4.7. Symbols refer to: o= ELISA results, duplicates within 
run (n=16); Q= liposomal immunoassay results, duplicates within run (n=12); 
0= liposomal immunoassay, duplicates over three rotors (n=36). 
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(approximately 5 GPL U/1). The limits of detections 
using both approaches (rounded up) are shown in table 
4.7. 
TABLE 4.7 
Limits of Detection of Anticardiolipin Assays (GPL U/1) 
* 
ELISA 72 
Liposomal within rotor 92 
Liposomal over 3 rotors 10 4 
3sds refers to 3 standard deviations of a low sample 
4.9 Confidence Limits of Anticardiolipin Assays 
The confidence limits of the results obtained using the 
various procedures were calculated, at various 
concentrations of antibodies, as (+/- 2 sds) using the 
imprecision curves of figure 4.15. These confidence 
limits (rounded up) are shown in table 4.8. 
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TABLE 4.8 
Confidence Limits of Anticardiolipin Assay Results 
(GPL units) 
5 +/- 2 +/- 2 +/- 3 
10 +/- 2 +/- 2 +/- 2 
20 +/- 3 +/- 3 +/- 3 
25 +/- 4 +/- 3 +/- 4 
4.10 Discussion 
A complement-mediates 
assay for ACAs were 
immunospecific lysis 
was obtained in the 
developed to show 
conventional ELISA 
imprecision. 
3 assay and a Mg 
2+ ion-dependent 
examined. Both showed a degree of 
although much greater dose-response 
Mg 2+ ion-dependent assay. This was 
an acceptable correlation with a 
assay for IgG ACAs and similar 
There was only a small amount of lysis of the PTA- 
containing liposomes in the absence of anticardiolipin 
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antibody, and no antibody-dependent change in lysis-rate 
was found. Like cardiolipin, PTA is a negatively charged 
lipid. The lack of lysis of PTA-containing liposomes 
accords with the view that the MgC12-dependent lysis is 
specific for cardiolipin, effected by a phase change from 
lamellar to hexagonal (II) phase (58). 
Although dependence on serum protein, mainly albumin, was 
observed (figure 4.11); albumin concentrations below 
about 20 g/l in serum are uncommon. Variations in albumin 
in patients sera were not found to be a likely major 
source of analytical interference. 
The concentration of Mg2+ ions in the reaction was far 
higher than physiological concentrations (normal range 
approximately 0.7 to 1.0 mmol/1) and it can be deduced 
from figure 4.9 that variations in Mg2+ ions in patients' 
sera would not affect the degree of lysis significantly. 
The liposomal ACA assay was configured as a two step 
assay (table 4.2). This provided a check of any liposomal 
lysis by human complement, which would have resulted in a 
high absorbance after the pre-incubation relative to the 
other cuvettes. No such anomalous absorbance changes were 
noted. 
287 
The liposomal assay has many potential advantages over 
ELISA (as have been described in section 4.1.2). One 
potential disadvantage compared to ELISA, however, is 
that the sample dilution is much lower. This means that 
more standard material is likely to be consumed. However 
this is mitigated by the small sample volume used on the 
Cobas Bio. 
On the other hand; the use of a greater amount of serum 
in the assay might have a beneficial effect compared to 
ELISA, since the concentration of B2-glycoprotein I is 
also much greater. It seems probable that adequate B2-GPI 
was present in the liposomal immunoassay. The addition of 
animal serum is necessary in ELISAs which involve large 
pre-dilutions of serum (as discussed in section 4.1.2). 
The presence of adequate B2-GPI is suggested by the 
reasonable correlation with the commercial ELISA method, 
which used 10% bovine serum as diluent. 
The variation in B2-GPI concentrations in normal serum 
has been found to be between 74 and 285 mg/1 (mean 179.8 
± 48.7 (s. d. )), and no significant difference was found 
between ACA positive and ACA negative sera (227). The 
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range of B2-GPI is therefore quite narrow in normal 
samples. Although possible pathological causes of 
variation in B2-GPI concentrations may remain to be 
elucidated, there is little evidence that the liposomal 
assay would be likely to suffer from the occasional 
sample which had a gross deficiency or excess in B2-GPI. 
There are several potential interferences, other than 
B2-GPI concentrations, which can affect ELISA assays for 
ACAS (as discussed in section 4.1). In addition, aspects 
of the liposomal technique differ markedly from ELISA. 
For example, the presentation of cardiolipin in the 
lipid membrane might have a different configuration and 
orientation to that of cardiolipin coated directly onto a 
micro-titre plate. Despite these differences, a 
satisfactory agreement between IgG ELISA and the 
liposomal assay (r = 0.90) was obtained. A similar 
correlation (r = 0.91) was quoted by the manufacturer of 
the ELISA used in the comparison; when two IgG ACA ELISA 
methods were compared (Manufacturer's Technical Leaflet). 
On the face of it, the augmentation of liposomal lysis by 
ACAs is contradictory to the report of Janoff et al. 
(108). Their assay, described in section 4.1.3, gave 
inhibition of liposomal lysis by SLE serum. However, 
both the preparation of liposomes and the reaction 
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conditions used by Janoff differed. Some of these 
differences are compared in table 4.9. As the 
procedures varied so markedly, it is perhaps not 
surprising that different effects were observed. 
TABLE 4.9 
Comparison of Mg2+ Ion-Dependent Assay Conditions 
Janoff et al. This Report 
preparation 
ether infusion 
approx size 
not stated 
serum dilution 
1: 9 
reverse evaporation 
200 nm (filtered) 
1: 25 (table 4.2) 
Mg2+ conc. 
reaction period 
140 mmol/1(approx) 
5 -10 minutes 
400 mmol/1 
2 minutes 
Unfortunately it is not possible to estimate the relative 
amounts of liposomes used in the techniques, since the 
liposome dilution of Janoff was not indicated. 
Nevertheless, a tentative explanation for the apparently 
different effects of antibody can be put forward based on 
the relative amounts of reaction components; in 
particular the amounts of serum and liposomes. If the 
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amount of serum used by Janoff was much higher relative 
to the amount of liposomes, the antibody found in normal 
sera (section 4.6) might be sufficient to augment lysis. 
The SLE serum, under the conditions used by Janoff, might 
on the other hand contain sufficient antiserum to inhibit 
lysis by the "hook-effect" found in this study (figure 
4.8). 
At sufficient concentration, normal serum inhibited ion- 
dependent lysis (figure 4.10), an effect that was more 
dependent on albumin concentration than globulin 
concentration. This is likely to be due to a non-specific 
adsorption of protein onto the liposome surface, probably 
due to electrostatic interaction. The serum protein 
probably has this effect by covering the liposome 
surface, impeding the access of Mg (II) ions. At lower 
serum concentrations the non-specific effect of serum 
proteins of inhibiting lysis is largely lost and it is at 
these serum concentrations that ACAs increase lysis. 
The effects of divalent cations were elucidated by Rand 
and Sengupta (58). The cations neutralize the negative 
charges on the cardiolipin and enable the head-groups to 
come together, causing a phase change from bilayer to 
hexagonal (II) phase. The differential effects of Ca (II) 
ions and Mg (II) ions, observed experimentally (section 
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4.3) are compatible with Rand and Sengutpa's findings. 
Ca (II) ions are more able to form hexagonal structures 
which tend to precipitate. Mg (II) ions tend to form more 
hydrated structures enclosing larger water volumes and 
with a larger area per polar head group at the water 
interface. Cardiolipin is present with other 
phospholipids in these preparations, and a mixture of 
lamellar and hexagonal (II) phases probably will have 
resulted. While no precipitation was observed in these 
studies, the integrity of the liposomes was compromised 
sufficiently to allow dye release. 
The mechanism of the enhancement of lysis by ACAs is 
harder to explain. As no significant release of dye was 
observed in the presence of ACAS but without the addition 
of Mg (II) ions, (section 4.3.2) the antibody must 
augment Mg (II) ion-dependent lysis, rather than acting 
independently. 
There are several possible mechanisms for augmentation of 
ion-dependent lysis. ACAS could perhaps bind 
specifically to cardiolipin molecules and draw several 
molecules together, acting as a focus for Mg (II) 
ion-dependent phase change. This would, however, seem 
unlikely since IgG antibodies are divalent, each molecule 
having only two Fab' binding sites. Therefore each 
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antibody could only bind to, at most, two cardiolipin 
molecules. 
Alternatively ACAs could act by drawing liposomes 
together. This could perhaps occur by a certain amount of 
antibody binding non-specifically to a liposomes surface 
and binding specifically to cardiolipin on an adjacent 
liposome. Under the influence of Mg (II) ions a hexagonal 
(II) phase could form, possibly entrapping the antibody. 
The hexagonal (II) structures can be large enough to 
include protein molecules. Cardiolipin may contribute to 
pore formation in this way enabling protein movements 
across mitochondrial membranes (58). 
The latter mechanism could explain an absence of IgM ACA 
activity, since the IgM molecules could be too large to 
draw the liposomes together closely enough, or too large 
for hexagonal (II) structures to form around them. 
Another possibility is that the antibody, which at near 
neutral pH probably will have a net negative charge, 
attracts Mg (II) ions. On immune-reaction, ions could in 
effect be trapped in the vicinity of the liposome, 
creating a localized increase in ion concentration. 
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Each of these mechanisms could be reconciled with the 
observed "hook effect" at high ACA concentrations. Either 
ions could be sterically inhibited from approaching the 
liposomes, or cardiolipin could have restricted movement, 
preventing formation of cardiolipin-rich regions able to 
form hexagonal (II) phases. 
The liposomal immunoassay correlates with IgG ACAs 
measured by ELISA, but there is an apparent lack of 
correlation with IgM ELISA measurements. It is fortuitous 
that the main clinical applications of ACAS are related 
to their thrombotic effects; in particular in recurrent 
miscarriages, neurological and cardiological 
associations. These effects are reflected by IgG ACAS 
more than by IgM ACAS. ELISA is likely to remain the main 
technique for APA measurement for some time, not least 
because of the extensive efforts invested to standardize 
the technique. Nevertheless, because of its simplicity, a 
liposomal technique could be valuable in rapid screening 
of appropriate clinical populations. 
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Chapter 5 
Final Discussion 
5.1 Summary of Investigations 
These studies have examined several aspects of the role 
of liposomes in immunoassays. A principal aim was to 
develop a means of performing homogeneous liposomal 
immunoassays using a colorimetric marker. It was first 
necessary to find and evaluate a suitable chromogen and a 
means to generate an absorbance change on its release 
from liposomes. 
Sulphorhodamine B was chosen as likely to fulfil the 
criteria of a suitable chromogen. It has a large 
absorbance coefficient, which is at a high wavelength 
(565nm for the free dye). This will tend to reduce 
interferences due to light scatter in biological fluids. 
It also has a high aqueous solubility. The only previous 
application of Sulphorhodamine B in liposomes appears to 
be as a marker in an heterogeneous coated-tube assay 
(48). 
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The alteration in absorption spectrum which resulted from 
entrapment of the dye within liposomes was 
unexpected; although it could be explained by dimer 
formation at high concentrations, as described in section 
2.11. The absorbance change when the dye was released 
provided the mechanism to develop homogeneous, 
colorimetric immunoassays. 
Another aim of these studies was to examine the use of 
liposomes in a range of immunoassay techniques and for a 
variety of analytes. This included proteins, for which 
there have been relatively few published reports (as 
described in section 1.6). 
Using Sulphorhodamine B as a calorimetric marker, 
complement-mediated liposomal immunoassays were devised 
which could measure proteins in serum and urine. Albumin 
was chosen as a model analyte. Complement-mediated 
assays are the commonest approach to liposomal 
immunoassays, which suggests the use of Sulphorhodamine B 
as a marker could be generally applicable to a wide 
range of other analytes. 
Using this technique, a competitive assay for the 
measurement of serum albumin was developed. This was 
followed by a sandwich-type liposomal immunoassay for 
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urinary microalbumin which made use of liposome-coated 
Fab' fragments of antialbumin antiserum. The urinary 
microalbumin assay demonstrated adequate analytical 
performance compared to an established method (RIA), as 
described in chapter 3. 
Entrapped Sulphorhodamine B was also used as a novel 
marker to measure anticardiolipin antibodies. The assay 
was based on the specific effect of divalent cations to 
destabilize cardiolipin-containing liposomes, which was 
found to be augmented by ACAs under certain conditions 
(chapter 4). Comparable performance to an alternative 
technique (ELISA) was again demonstrated. 
The final application in this study employed antibody- 
coated liposomes as a solid-phase; as shown by another 
model assay for urinary microalbumin. This was an 
exception to the other assays in that it was based on 
immunoprecipitation of liposomes. This application was 
demonstrated in a radioimmunoassay using liposomes as a 
solid-phase, and did not rely on dye-release (section 
3.7). 
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5.2 Advantages and Disadvantages of the Use of Liposomes 
Containing Sulphorhodamine B 
The possible advantages of the use of liposomes in 
immunoassays were described in the introduction (section 
1.6). These may include speed of use, sensitivity and 
ease of automation. 
The development of homogeneous colorimetric liposomal 
immunoassays might enable both chemical assays and 
immunoassays to be performed on a single 
spectrophotometric analyser. This would be likely to 
confer considerable organizational benefits, for example 
to a high throughput clinical biochemistry department. 
It is possible to draw some specific conclusions 
regarding the advantages and disadvantages of 
Sulphorhodamine B as a marker in liposomal immunoassays, 
in comparison to other liposomal chromogen markers. 
There have been a few alternative 
liposomal markers in immunoassays 
described in section 1.6. These 
absorbance due to released chromogen 
ions. The reliance on a separation 
to the liposomes from the chromogens 
chromogens used as 
which have been 
employ a shift in 
binding with various 
of the ions external 
inside the liposomes 
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(or possibly visa-versa) complicates the preparation and 
optimization of the reagents. It may be necessary either 
to add the ions to the buffer at the time of assay, or 
risk reagent instability by the ions diffusing across the 
liposomal membranes on storage. 
The use of Sulphorhodamine B, on the other hand, could be 
claimed to be inherently simpler, stabler and require 
less optimization than other known chromogenic markers. 
This is because the colour change is developed simply by 
dilution, rather than relying on colour development by a 
second reagent. 
The reagents used in the liposomal immunoassays based on 
Sulphorhodamine B release were simple to prepare and 
assays were performed in minutes; while comparative 
immunoassays (RIAs and ELISAs) required at least several 
hours. The dye-containing liposomes were very stable when 
stored at 40C, loosing at most a few percent of 
entrapped dye per day at room temperature. No detectable 
alteration in immunoreactivity was found on storage of 
liposome preparations for at least six months. 
Sulphorhodamine B showed good solubility and a high 
absorbance coefficient. The shift in absorption between 
530nm and 565nm on dye release from the liposomes was 
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satisfactory for the Cobas Bio which uses a diffraction 
grating monochromator with a narrow transmitted 
wavelength range. 
Some analysers use a bichromatic approach. Measurements 
are taken at one wavelength and a blank reading at a 
secondary wavelength to reduce interferences (e. g. light 
scatter due to sample turbidity). In these analysers it 
might be possible to almost double sensitivity, by 
taking measurements at 565nm (with increasing absorbance) 
against a blank at 530nm (with decreasing absorbance). 
There are also several potential disadvantages of the use 
of Sulphorhodamine B-containing liposomes, compared to 
some other immunoassay techniques. 
Several instruments still use optical filters which allow 
a much wider range of wavelengths to be transmitted than 
diffraction grating monochromators (e. g. 30 nm). These 
may not be able to adequately differentiate the 
absorbances at 530 nm and 565nm. Furthermore, the release 
of entrapped dye showed only a slight visual colour 
change. Qualitative tests, perhaps for near-patient 
testing, would also benefit from a more marked colour 
change. 
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Another aspect which needs careful thought is the 
susceptibility of liposome preparations in general to 
disruption by detergents (chapter 2). This is not an 
insurmountable difficulty as some automated analysers, 
such as the Cobas Bio, do not use them. Other equipment, 
particularly those that clean reaction chambers and 
cuvettes rather than using disposables, may rely on 
detergents. Thorough rinsing would be required to 
eliminate the possibility of interference with the 
liposomal reagents. 
A further difficulty lies in the complexity of liposomes 
and their varied compositions. These can hinder a 
systematic prediction of their properties. Even with 
growing knowledge of liposome properties (e. g. 2-4), 
liposome preparation and assay optimization still seem to 
require a degree of trial and error. 
This unpredictability is illustrated by apparent 
contradictions in the present study to earlier reports. 
For example, anticardiolipin antibodies were found to 
augment destabilization of cardiolipin-liposomes by 
4 
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divalent cations. This contrasts with an earlier finding 
(108) which showed inhibition of lysis by anticardiolipin 
antibodies, although the difference may be largely due to 
different assay conditions (as discussed in section 
4.10). 
Another unpredictable factor lies in the use of 
complement. As discussed in chapter 3, this is a multi- 
component mixture whose activity depends on its species 
of origin and probably also on its preparation and extent 
of purification. 
The liposomes in this report were very stable at 4°C but 
showed a rate of dye loss of up to several percent per 
day at room temperature. This is probably acceptable for 
laboratory applications. For a wider use of liposomal 
immunoassays, e. g. in "near-patient testing", it would be 
preferable to have reagents stable for long periods at 
room temperature. 
A further potential problem which was not addressed was 
the possibility of batch to batch variation. For 
consistency, the reported results are based on a single 
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batch of each type of liposome. At least two batches of 
each type of liposomes were prepared and showed similar 
immunoreactivity. Extensive studies of the comparability 
of several batches of liposomes, however, were beyond the 
scope of this study. 
5.3 Areas for Further Study and Future Developments of 
Liposomal Assays 
Further studies could address some of the potential 
problems described in the previous section. For example, 
a systematic survey of the optical properties of other 
members of the rhodamine class of dyes, and indeed other 
dyes, would seem worthwhile. This might uncover other 
chromogens with a wider shift in absorption wavelengths 
on their release from liposomes. In this study, only one 
other member of the rhodamine family of dyes, Rhodamine 
B, was examined. This showed a less favourable absorbance 
coefficient and lower aqueous solubility to 
Sulphorhodamine B and also, in preliminary experiments, 
poor entrapment (section 2.12). 
It would also be worth examining alternative chromogenic 
markers and methods to generate a colour change when 
the chromogens are released from liposomes. pH-dependent 
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colour change seems not to have been exploited in a 
liposomal immunoassay, even though liposomes tend to have 
a low permeability to protons. 
As discussed in chapter 2, it would be useful to examine 
whether the Beer-Lambert law is obeyed at the high 
concentrations in chromogens which do not exhibit dimer 
formation. If not, this might provide another mechanism 
to produce an absorbance change on liposomal lysis and 
chromogen dilution. 
The question of liposome stability has been mentioned in 
the previous section. It may be possible to freeze-dry 
liposome preparations and reconstitute them prior to 
assay by adding a diluent (30). A similar approach has 
recently been used in the pharmaceutical field for 
liposomes carrying vaccines (231). 
An alternative approach to improved stability would be 
chemical modification of the liposome membranes. Several 
such stabilized liposome formulations have been made 
(232-234). Stabilized liposomes are less likely to be 
suitable for homogeneous assays involving release of 
their contents following their lysis. However they could 
be used in solid phase assays (section 1.6.8). 
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An improvement in stability and possibly homogeneity 
might also be achieved by development of novel "synthetic 
liposomes", i. e. vesicles composed of synthetic, non- 
lipid ampiphiles. The following two reports suggest this 
might be possible. Lamellar structures (not closed 
vesicles), formed from dihexadecyl-dimethylammonium 
bromide, were used to promote agglutination in the 
presence of antibody. This involved electrostatic 
interaction with an anionic antigen (N, NO bis(2,4 
dinitrophenyl)-L-lysine (235). In a second, non- 
immunological, application; vesicles composed of 
didodecyldimethylammonium bromide were used in a 
chemiluminescent assay for free cyanide ions (134). 
Also discussed in the previous section was the necessity 
to minimize the degree of batch variation between 
preparations if any application were to be developed for 
routine use. A commercial application would, in addition, 
require the scaling-up of the reagent preparation. An 
alternative to the reverse-evaporation method might 
be easier to scale-up. Various techniques to synthesize 
lipsomes were discussed in section 1.3. The optimum size 
of liposome preparation for a given application should 
also influence the synthetic technique used. The effects 
of size on liposomal immunoassays was discussed in 
section 3.8. 
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As far as the applications of liposomal immunoassays 
studied in this report, the potentially most useful 
studies are in the measurement of anticardiolipin 
antibodies. Their clinical value, particularly in 
cardiovascular disease, remains to be fully established. 
The liposomal assay which was developed might have a role 
to play in this research. Its rapid speed and ease of 
automation would enable the measurement of large number 
of patient samples. In addition, rapid colorimetric 
assays are more likely to be usable in the clinic (e. g. 
in out-patients) where there may be an advantage in a 
rapid result being immediately available to the 
physician. 
Although assays for urinary microalbumin are common, the 
liposomal assay has potential advantages over other 
techniques. The assay is much more rapid than 
radioimmunoassay. Rapid homogeneous assays for 
microalbumin are also available using immunoturbidimetry. 
However the liposomal assay has the advantage that 
measurements are made at a higher wavelength, so 
interferences due to non-specific light-scattering from 
the sample are less likely. 
From a wider perspective, there are a range of potential 
future roles for liposomal assays. 
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The use of liposomes in ultra-sensitive assays was not 
addressed in this project. Many alternative ultra- 
sensitive techniques are being developed. New labels 
which have high potential sensitivity include bio- 
luminescent labels, time resolved fluorescent labels, 
Fourier transform infra-red analysis of metal carbonyl 
complexes, and use of phosphors (10). In addition, 
coupled enzyme reactions can be used to produce an 
amplified signal. These techniques should not necessarily 
be seen as competing with liposomal immunoassays. In most 
if not all cases, these labels could, in principle, be 
combined with liposomal amplification to create even 
greater sensitivity. 
New applications may arise which make use not only of the 
characteristics of the marker in the liposomal assay, 
but also unique properties of the liposomal structure. 
The possible uses of liposomes in latex agglutination 
assays has been described in section 1.6.10. Liposomes 
might also enhance immunoturbidimetry in a similar way, 
as an alternative to other particle enhancement agents 
(discussed in section 1.6.1). 
As another possible application, Wallace and Wood (236) 
described the use of semi-permeable nylon capsules 
containing antiserum as a means to separate radiolabelled 
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free hormones. Liposomes may provide an alternative to 
the use of nylon capsules. It might, for example, be 
possible to develop sensitive assays for free hormones 
(e. g. free thyroxine), using antibody-containing 
liposomes incorporating pores of specific restricted 
size in their membranes. 
Recent analytical applications of liposomes, which have 
been described in chapter 1, include flow injection 
analysis, flow cytometry and electrochemical detection. 
Other technical advances are also possibly amenable to 
the involvement of liposomes. Several applications make 
use of colloidal gold sols, which absorb between 510 nm 
and 550 nm and can absorb proteins non-covalently onto 
their surfaces. These are often used in multi-assay 
systems. 
One such technique is the Ascend Multiimmunoassay 
(TMBiosite), which utilizes the flow of reagents and 
sample through a wick which contains discrete areas 
impregnated with specific antibodies to provide a screen 
for a panel of drugs of abuse (237). Replacement of the 
gold sol conjugates by liposomes coated in specific 
antigens (or antibodies) might improve the clarity of the 
colour reaction, if intense dyes were entrapped. 
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A non-immunological application of liposomes which might 
be developed using a simple colorimetric marker is the 
measurement of phosholipases. This was described in 
section 1.7). Another possible non-immunological area for 
liposomal assay development lies in the use of liposomes 
to study or measure the effects of lipid peroxidation 
(also described in section 1.7). Liposomes have been used 
to study this; however combination with a simple dye 
marker might enable novel analytical tests of this 
important biological process'to be developed. 
Although this project has concentrated on analytical 
applications, major recent advances in the applications 
of liposomes have come in the pharmaceutical field. For 
example, there is currently considerable interest in the 
use of liposomes to carry genes in the therapy of 
individuals suffering from genetic disorders. Clinical 
trials are underway in the treatment of cystic fibrosis 
using liposomes (238). 
Many of the difficulties encountered in the 
pharmaceutical use of liposomes are not found in 
analytical applications. For example, the route of 
liposomal clearance from the circulation is not a 
consideration. There is nevertheless a certain common 
ground, since even the most elegant pharmaceutical 
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application must first be based on carefully optimizing 
entrapment of often scarce amounts of material. The 
relationships of liposome size, amount of entrapment and 
surface binding of proteins were discussed in chapter 3. 
These seem equally relevant to the pharmaceutical field. 
The low cost and the ease of colorimetric detection of 
Sulphorhodamine B might, in some circumstances, make it a 
useful preliminary tool in assessing entrapment and 
stability of pharmaceutical liposome preparations. 
However it could not replace the use of the 
pharmaceutical agent to any great extent; since the agent 
might exhibit differing effects on entrapment and 
stability from those of the dye, e. g. by differing 
charge. Furthermore, the safety of Sulphorhodamine B in 
pharmacological studies would require examination. 
Perhaps the liposomal entrapment of this dye might be 
more useful in other fields. For example, it might 
provide a simple addition to existing methods in the 
study of membrane properties using liposomes. 
Returning finally to the analytical applications of 
liposomes, these studies have demonstrated some features 
and applications of liposomal immunoassays. The use of 
liposomes has some advantages over other techniques, as 
well as a few potential disadvantages. 
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It seems unlikely that any one immunoassay technique will 
replace all others in the near future. The wide range of 
possible approaches to the use of liposomes and the wide 
choice of possible labels that can be incorporated have 
been described. This variety makes it likely that 
liposomal immunoassay will at least find a place, for 
specific applications, alongside other recent approaches. 
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Appendix 1 
Light and Electron-Microscopy Photographs of Liposome 
Preparations 
Light-microscope photographs were taken of reverse- 
evaporation liposomes prepared as described in section 
2.4. A droplet of aqueous liposome preparation was placed 
on a microscope slide, covered by a cover-slip and 
photographed immediately to avoid drying. The greatest 
clarity of photographs were obtained using a blue optical 
filter. 
Figure A1.1 shows liposomes fractionated by Sepharose 4B 
gel filtration but not passed through a 200 nm 
polycarbonate filter to increase homogeneity (as is the 
case in the procedure for protein-coated liposomes, e. g. 
section 3.3.1). The magnification was x 640 (using x 40 
objective lens). 
Figure A1.2 shows the same liposome preparation using a 
x 100 objective lens (magnification x 1600). Using this 
magnification the image was less clear and some 
distortion of the liposome images is evident due to 
Brownian movement of the liposomes. 
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Figure A1.1 
Sulphorhodamine B-Containing Liposomes by Light Microscopy 
Light microscope photograph of liposome fraction from Sepharose 4B gel 
filtration, without subsequent passage through 200 nm filter. The magnification 
was x 640. 
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Figure A1.2 
Sulphorhodamine B-Containing Liposomes by Light Microscopy using 
High Magnification 
tr 
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Light microscope photograph of liposome fraction from Sepharose 4B gel 
filtration, without subsequent passage through 200 nm filter. The magnification 
was x 1600. 
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The figures show a wide range of sizes of liposomes with 
a few very large liposomes (i. e. several um diameters). 
In figure A1.1, for example, 200 nm liposomes would have 
a diameter of approximately 0.12 mm. 
Liposomes which had been passed through a 200 nm 
polycarbonate filter were visible by eye as small pink 
dots using a (x 40) objective (magnification x 400). 
Liposome preparations with surface bound protein 
(sections 3.3.1,3.5 and 3.6) and without surface-bound 
protein (section 2.4) had similar appearances with no 
visible evidence of clumping. These preparations did not 
permit clear light-microscope photographic images to be 
obtained. 
Using albumin-coated liposomes (which had been passed 
through a 200 nm filter, section 3.3.1); clear 
micrographic images were obtained by the School of 
Materials Sciences, University of Surrey, using an 
electron microscope (figure A1.3). The negative staining 
technique was used (239). A drop of the preparation was 
placed on the electron microscope grid, left for a minute 
and excess removed using filter paper. The grid was then 
floated in stain (2% potassium phosphotungstic acid), 
dried and viewed in the electron microscope. The 
magnification was approximately x 8,500. 
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Figure A1.3 
Electron Micrograph of Liposomes Containing Sulphorhodamine B 
Albumin-coated liposomes, after passage through a 200 nm polycarbonate 
filter, were observed by electron microscopy, using the negative staining 
technique. The magnification in the photograph is approximately 8,500. 
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The small white dots were believed to an 
artifact, probably due to background stain. It is 
impossible to say whether a degree of clumping was 
present or whether the apparent aggregations were due to 
the overlap of discrete liposomes in the field of view. 
The objective in obtaining these electron microscope 
photographs was to demonstrate the presence of liposomes, 
rather than to estimate their size. To estimate size 
reliably various dilutions and fields of view would be 
required to minimize artifactual aggregation (239). The 
diameter of the original liposome is usually assumed to 
be less (e. g. 0.71 x the diameter of the photographed 
disc) to allow for flattening of the disc on drying. 
A mean diameter of close to 200 nm was used as a basis 
for calculations of protein binding and dye entrapment in 
the discussion of chapter 3. Allowing for flattening, a 
200 nm liposome would have an approximate diameter of 2.4 
mm in figure A1.3. The photograph suggests this may be a 
reasonable approximation. However, because of the 
difficulty in accurately assessing size from a limited 
number of fields, such an estimate was not attempted. 
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Spectrofluorimetric Properties of Sulphorhodamine B 
The fluorimetric characteristics of a solution of 
Sulphorhodamine B (2 x 10-6 M in distilled water) were 
examined between approximately 240 nm and 700 nm. The 
emission and excitation filter band-widths were both set 
at 10 nm (except when either was set as unrestricted). 
Figure A2. la shows a scan of wavelengths of excitation 
allowing all emission wavelenths to be open. This 
indicated that the only significant excitation wavelength 
was 400 nm. Figure A2. lb is a scan of emission 
wavelengths in which the excitation wavelengths were 
unrestricted. This indicated that the only significant 
emission wavelength was 580 nm. The vertical gradations 
in figure 2.1a and 2.1b were 3 arbitrary units (as 
defined in materials and equipment section. ) 
Figure A2.2 shows the emission at the excitation 
wavelength of 400 nm. A single emission peak at 580 nm 
was found. The vertical scale gradations in figure A2.2 
were 27 arbitary units. These excitation and emission 
wavelengths were used throughout this study. A 10 nm 
band-width for both emission and excitation filters was 
also used throughout. 
318 
Figure A2.1 
Fluorimetric Scans to Determine Excitation and Emission Wavelengths of 
Sulphorhodamine B 
""". -. " 
N ý1 
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Figure (a) is a scan of excitation wavelengths, in which the emission 
wavelengths are open. Figure (b) is a scan of emission wavelengths, in which 
the excitation wavelengths are open. The scanned solution was 
Sulphorhodamine B in distilled water, as described in Appendix 2. 
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Figure A2.2 
Fluorimetric Scan of the Emission Wavelength of Sulphorhodamine B at 
an Excitation Wavelength of 400 nm 
a cý 
öö 
Fluorimetric emission wavelength scan of Sulphorhodamine B in distilled 
water. The measurement conditions are described in appendix 2. 
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There was a high amount 
excitation wavelength which 
of the instrument's optical 
by the apparent emission 
when the dye solution was 
(figure A2.3). 
of emitted light at the 
was attributed to an artifact 
system. This was demonstrated 
at the excitation wavelength 
replaced by distilled water 
The minimum scale gradation for the fluorimeter was 1 
arbitrary unit and for the manual spectrophotometer in 
these studies was 1 mA. Under the fluorimeter 
settings described, the dye gave an absorbance of 1 mA 
for every 4 arbitrary units of fluorescence. It was 
established that the minimum scale gradation could be 
measured reproducibly by identical readings of a water 
blank over 12 replicate samples. This indicated that 
fluorescence gave only approximately a four fold increase 
in sensitivity compared to absorbance measurements under 
these conditions. A large potential increase in 
fluorescence sensitivity could, however, be obtained by 
increasing the filter band-widths for the excitation and 
emission filters. This is demonstrated in table A2.1 for 
various filter band-widths. At least a 25 fold increase 
in fluorescence signal could be obtained compared to 10 
nm band-widths. This would have conferred at least a 
hundred fold increase in sensitivity of fluorescence 
relative to absorbance measurements. 
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Table A2.1 
Effect of Varying Excitation and Emission Filter Band- 
Widths on Fluorescence Signal 
Excitation Emission Fluorescence Relative* 
Band-width (nm) Band-width (nm) Signal Fluorescence 
10 10 900 1 
5 5 50 0.055 
10 5 225 0.25 
5 10 228 0.25 
10 15 2080 2.31 
15 15 4210 4.68 
15 20 6970 7.74 
20 20 11700 13.0 
25 20 16200 18.1 
25 25 23100 25.7 
* 
relative to 10 nm filter band-widths 
+ 
arbitrary units 
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Figure A2.3 
Fluorimetric Scan of the Emission Wavelength of Distilled Water at an 
Excitation Wavelength of 400 nm 
Fluorimetric emission wavelength scan of distilled water, indicating a large 
artifactual light emission at the excitation wavelength. The measurement 
conditions are described in appendix 2. 
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A novel use of liposomes as a solid phase material achieving separation in immunoassays is described. 
Antibody-coated liposomes were prepared and used as a particulate solid phase in a radioimmunoassay 
procedure for urinary albumin. The assay was compared to a liquid phase albumin radioimmunoassay. 
The potential benefits of liposomes over other particulate solid phases are discussed. The use of liposomes 
in this manner need not be restricted to radioimmunoassay but should also be applicable to other 
immunoassays using alternative non-isotopic labels. 
Key words: Anti-albumin; Liposome; Micro-albumin; Radioimmunoassay; Solid phase; Sulforhodamine B 
Introduction 
Liposomes, small synthetic lipid vesicles, have 
been widely used both as drug delivery systems 
and as model membranes. There has also been 
considerable interest in their use and versatility as 
analytical reagents. Assays usually involve the en- 
capsulation, within antigen- or antibody-coated 
liposomes, of an aqueous marker, e. g., fluorophor, 
chromophor or an enzyme. The liposomes can 
Correspondence to: S. J. Frost, Clinical Biochemistry De- 
partment, Hurstwood Park Neurological Centre, Colwell Rd., 
Haywards Heath, West Sussex, U. K. 
Abbreviations: Cho], cholesterol; cpm, counts per minute; 
DTP-PE, dithiopyridyl phosphatidyl ethanolamine; NETRIA, 
North East Thames Regional Immunoassay; NSS, normal 
sheep serum; PC, dipalmitoyl phosphatidyl choline; PE, di- 
palmitoyl phosphatidyl ethanolamine; PTA, dipalmitoyl phos- 
phatidic acid; SPDP, N-succinimidyl 3-(2-pyridyldithio) pro- 
pionate. 
then be used as the `label' in heterogeneous 
(O'Connell et at., 1985) or homogeneous assays 
(Freytag and Litchfield, 1994; Bowden et al., 1986; 
Umeda et al., 1986). In developing such assays it 
became apparent that antibody-coated liposomes 
have the potential for use as particulate solid 
phases in conventional heterogeneous immunoas- 
says. 
Despite the attractions of homogeneous and 
coated surface assays, techniques which involve 
separation, particularly radioimmunoassay and 
immunoradiometric assays, have remained popu- 
lar. Other particulate solid phase materials (e. g. 
cellulose) are not easily dispensed and settle out 
rapidly on standing. This may limit their range of 
application, in, for example, automated systems. 
Liposomes, prepared as described here, behave as 
liquids prior to immune reaction, being easily 
pipetted and only exhibiting slight sedimentation 
after standing for several days. It was' noticed that 
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these liposomes, after reacting with the respective 
antigen, precipitate more readily, thereby permit- 
ting separation by moderate centrifugation e. g., at 
2000 Xg for 10 min. This phenomenon was used 
as the basis for developing a heterogeneous im- 
munoassay for urinary albumin (microalbumin) 
and the results are reported here. 
Materials and methods 
Materials 
Purified lipids, dipalmitoyl phosphatidyl cho- 
line (PC), dipalmitoyl phosphatidyl ethanolamine 
(PE), cholesterol (Chol) and dipalmitoyl phos- 
phatidic acid (PTA), the dye sulphorhodamine B 
and human albumin standard were supplied by 
Sigma Chemical Company Ltd., Poole, Dorset. A 
purified immunoglobulin G fraction of polyclonal 
anti-human albumin antisera and normal sheep 
serum (NSS) were obtained from Guildhay Anti- 
sera Ltd., Guildford, Surrey. 125I-labelled human 
albumin (specific activity 16.4 yCi/µg) was sup- 
plied by North East Thames Regional Immunoas- 
say, London (NETRIA). Gel filtration materials 
and N-succinimidyl 3-(2-pyridyldithio) propionate 
(SPDP) were obtained from Pharmacia Ltd, Mil- 
ton Keynes, Buckinghamshire. Protein was mea- 
sured using a manual Coomassie blue assay (Bio- 
rad Laboratories Ltd, Watford, Hertfordshire) and 
cholesterol by a colorimetric procedure (`CHOD- 
PAP' method, BDH Ltd, Poole, Dorset). Other 
chemicals and AnalaR grade reagents were also 
supplied by BDH Ltd. Gel filtration was per- 
formed using 0.7 mm X 20 cm `Econo Columns' 
(Bio-Rad Laboratories Ltd). Dialysis employed 
18/32" dialysis tubing (Medicell International 
Ltd, London). Liposomes were filtered using 200- 
nm `Minisart NML' filters (Sartorius Ltd, Epsom, 
Surrey). Sonication was achieved by a Soniprep 
150 probe sonicator (MSE Scientific Instruments 
Ltd, Crawley, West Sussex). An LKB-Wallac 
Clinigamma counter (Pharmacia Ltd) was used to 
measure radioactivity. Phosphate buffer, 0.05 M, 
pH 7.4, was used throughout except for `L Buffer' 
which contained 10 mM N-[2-hydroxyethyl] 
piperazine-N'-[2-ethanosulphonic acid] (HEPES) 
and 145 mM sodium chloride, pH 8.0. 
Dithiopyridyl phosphatidyl ethanolamine (DTP-PE) 
DTP-PE was prepared by a standard method 
(Truneh et al., 1987), adapted so that the entire 
procedure leading to the preparation of liposomes 
was completed within a working day. PE, 6.9 mg 
in 300 µl chloroform, SPDP, 3.75 mg in 300 µl 
methanol and triethanolamine, 2.7 µl, were mixed, 
solubilised by brief heating to 30°C and then 
incubated at room temperature for 2 h. The organic 
phase was then washed once in phosphate buffer 
and twice in distilled water, centrifuging at 2000 
xg for 5 min and discarding the aqueous phase 
at each stage. Chloroform (1 ml) was added prior 
to the last centrifugation step to facilitate com- 
plete removal of the final aqueous phase without 
excessive loss of the organic phase. A white pre- 
cipitate which formed at the solvent interphase 
could be reduced but not eliminated by addition 
of a small amount of methanol. This precipitate 
was discarded after the final centrifugation, leav- 
ing a clear organic phase containing DTP-PE. The 
concentration of DTP-PE formed was estimated 
by the release of dithiopyridine as described previ- 
ously (Truneh et al., 1987). An aliquot (25 µl) of 
the organic phase was gently evaporated to dry- 
ness, immediately 1 ml of `L Buffer' was added 
and vortexed vigorously. The absorbance before 
and after adding 50 µl dithiothreitol (100 mM) 
was measured and the molar concentration of 
DTP-PE calculated as the change in absorbance at 
343 nm x 41 (dilution factor)/8.08 x 103 M. 
Liposomes 
The DTP-PE was immediately incorporated 
into liposomes by a reverse phase evaporation 
method based on that of Szoka and Papahadjo- 
poulos, (Szoka and Papahadjopoulos, 1978). DTP- 
PE (2 smol, usually approximately 0.5 ml) was 
mixed with 28, umol PC, 9, umol PTA and 26 µmol 
chol in 2 ml petroleum ether and chloroform 
added to a total volume of 4 ml. Sulphorhodamine 
B, 1 ml 0.1 M in distilled water, was then added so 
that the liposomes could easily be seen after pre- 
cipitation in the immunoassay. The mixture was 
sonicated for 2 min, then 1 ml of phosphate buffer 
was added and the preparation evaporated at 45 °C 
under reduced pressure until the foaming subsided 
after about 20 min leaving a liquid. The resulting 
liquid which contained large unilamellar lipo- 
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somes (LUVs) was 
filtered through a 200-nm 
polycarbonate filter to increase homogeneity, then 
dialysed overnight against phosphate buffer to 
remove unencapsulated dye. The DTP-liposomes 
were coupled to dithiopyridyl-antibody (DTP-an- 
tibody) within 2 days. 
Formation of dithiopyridyl-antibody (DTP-antibody) 
DTP-antibody was formed essentially as de- 
scribed previously (Truneh et al., 1987). The pro- 
tein content of the antiserum was measured and 
SPDP added in a small volume of methanol (usu- 
ally 1 ml) with gentle mixing to give a molar ratio 
of SPDP : antiserum of 10: 1. The mixture was 
incubated at approximately 23°C for 30 min with 
occasional stirring. The pH was then reduced to 
approximately 4.5 using 50, ul of acetic acid, pH 3. 
Immediately prior to coupling with the liposomes, 
50 µl of dithiothreitol (500 mM) were added and 
the DTP-antibody incubated for 20 min at room 
temperature. The DTP-antibody was then sep- 
arated from the other reagents by gel filtration on 
Sephadex G50 equilibrated in 0.05 M phosphate 
buffer, pH 7.4. The protein content of the fraction 
was measured by the Bio-Rad Coomassie blue 
method. 
Coupling of liposomes and antibodies 
Equal volumes of the DTP-antibody reagent 
and the liposome preparation were mixed and 
incubated overnight at room temperature. The 
mixture was then separated by gel filtration using 
Sepharose 4B and 0.05 M phosphate buffer, pH 
7.4, the antibody-coated liposomes eluting in the 
void volume while the uncoupled protein and re- 
sidual free dye were retarded by the gel. The 
liposome fractions so prepared have been stored 
at 4°C over several months without noticeable 
loss of immunological activity. 
The protein content of the preparation was 
determined by the Bio-Rad Coomassie blue 
method. The modification of this method for this 
purpose entailed solubilising the protein by the 
addition of 50 Al ethanol to 20 Al liposome pre- 
paration. The standard colorimetric procedure was 
then followed by the addition of 1 ml of saline 
and 200 µl of Coomassie blue reagent, incubating 
at room temperature for 15 min and then measur- 
ing the absorbance at 580 nm. It was also neces- 
sary to subtract a blank for the absorbance of 
Sulphorhodamine B at the same wavelength. In 
this case saline replaced the Coomassie blue re- 
agent. Correspondingly, 50 µl of ethanol per tube 
were also added to the standards to compensate 
for the small additional effect of ethanol on the 
absorbance of the reagent. 
Measurement of the lipid content of liposomes 
by simple chemical methods was complicated by 
the interfering intense absorbance of Sulphor- 
hodamine B. This was avoided by overnight dialy- 
sis of the preparations in the presence of a deter- 
gent (Triton X-100) against a thousand-fold excess 
of distilled water. Detergent has the effect of 
lysing liposomes, allowing the dye to be dialysed 
while the lipid is retained. Cholesterol was assayed 
after dialysis (allowing for dilution during dialy- 
sis) and total lipid calculated (mol cholesterol x 
2.42). 
Evidence of competitive label binding 
To establish, independently of the immuno- 
precipitation process, that competitive binding of 
albumin to liposomes was occurring, various 
amounts of albumin were added to 30 µl of lipo- 
some preparation and 100 µl phosphate buffer 
containing 1% NSS and [12SI]albumin. After 4h 
incubation at room temperature the mixtures were 
each separated using Sepharose 4B and the eluted 
0.5 ml fractions analysed for radioactivity. Con- 
trol studies made use of liposomes synthesised as 
above but not coupled to anti-albumin antibody. 
Specimens 
Early morning urine specimens from 39 di- 
abetic patients were frozen on receipt. Prior to 
assay they were thawed and briefly centrifuged to 
remove precipitated material. 
Immunoassay protocols 
A standard liposomal immunoassay protocol 
was as follows. 100 µl of 0.05 M phosphate buffer, 
pH 7.4, containing 1% normal sheep serum (NSS) 
and [125I]albumin were mixed in a 4-ml plastic 
tube with 30 µl of anti-albumin liposomes and 6 
µl of urine sample/standard (0-200 mg/1). The 
tubes were incubated at 37°C overnight, centri- 
fuged for 10 minutes at 2000 X g, washed in 500 
µl of buffer containing 1% NSS and then centri- 
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fuged again as before. After aspiration of super- 
natant the precipitated liposomes were counted 
for 300 s per tube using a gamma counter. This 
protocol was varied as appropriate experimentally. 
The assay was compared with a liquid phase im- 
munoassay performed using an established proto- 
col (NETRIA). Briefly, this involved an overnight 
incubation followed by polyethylene glycol pre- 
cipitation, centrifugation (2000 X g, 30 min) and 
counting the pellet for radioactivity. Precision was 
estimated by replicate single measurements of 
pooled urine albumin specimens. 
Results 
The liposomes synthesised were calculated to 
have a ratio of bound anti-albumin to lipid of 
approximately 72 µg : µmol. For use in im- 
munoassay these were diluted to an anti-albumin 
concentration of 43 mg/1. Competitive binding of 
albumin label was demonstrated by analysis of 
fractions from gel filtration (Fig. 1). Fig. 2 il- 
Fig. 1. Various amounts of albumin (0 ng X, 10 ng ", 50 ng -, 
200 ng +, 2 µg *) were incubated with anti-albumin lipo- 
somes and 1251-labelled albumin (see text) and the mixtures 
separated by Sepharose 4B gel chromatography. 0.5 ml-frac- 
tions were collected and measured for radioactivity. The lipo- 
somes and bound label eluted in the void volume. 
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lustrates, for comparison, the separation of lipo- 
somes not coupled to anti-albumin, free dye (A max 
565 nm), and free albumin label under the same 
experimental conditions as for Fig. 1. Free im- 
munoglobulin and free albumin elute with essen- 
tially the same retention time. No significant elu- 
tion of albumin label in the liposomal fractions 
was observed when free anti-albumin (20 µg) was 
also added to the preparation prior to chromatog- 
raphy. 
In the immunoassay procedure, the effects of 
changing the incubation time and temperature 
were investigated. The sensitivity as indicated by 
the dose-response curve was greater at 37 °C than 
at either 25'C or 450C. The effect of incubation 
time was assessed from the dose-response curves 
at 1,4,16 and 40 h. Sensitivity increased to 16 h 
but a longer incubation did not cause a significant 
improvement. Overnight incubation at 37 °C was 
selected as giving the best sensitivity for the assay. 
Fig. 3 indicates that the maximum binding of 
label depends on the amount of anti-albumin lipo- 
somes added to each tube. A maximum binding 
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Fig. 5. Comparison between measured albumin concentrations 
in 39 urine specimens measured using the liposotnal im- 
munoassay and the NETRIA RIA method. (y - 0.832 + 1.65, 
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TABLE I 
WITHIN BATCH IMPRECISION OF 'LIPOSOMAL IM- 
MUNOASSAY' FOR URINARY ALBUMIN 
Sample Mean value n CV% 
(mg/I) + S. D. 
Urine pool, No. 1 20.1+1.57 20 7.8 
Urine pool, No. 2 46.0+2.34 20 5.1 
(i. e. zero standard/ total counts) in each assay of 
between 10-20% was achieved using the present 
protocol. 
A typical standard curve is shown in Fig. 4. 
Within batch precision data for 2 levels of al- 
bumin is given in Table I. The correlation of the 
data obtained with the liposomal method with 
those from an established radioimmunoassay is 
shown in Fig. 5 (y = 0.83x + 1.65, n= 39, r= 
0.97). 
Discussion 
The liposomes incorporated antibody at an an- 
tibody/lipid ratio similar to that previously re- 
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ported (Hutchinson et al., 1989). Sulphorhoda- 
mine B dye was encapsulated into the liposomes 
for several reasons. The dye offered some ad- 
vantage in the immunoassay itself in that the red 
immune-precipitate could be readily seen during 
the aspiration stage. It also permitted, either visu- 
ally or by absorbance measurement, the identifica- 
tion and quantitation of liposomes during pre- 
parative procedures such as gel filtration. Further- 
more, dye was included for the development of 
homogeneous immunoassays, proceeding concur- 
rently with these investigations. Microscopic 
visualisation of liposomes was also made easier by 
the inclusion of dye. Prior to immune reaction, the 
liposomes appeared as mainly discrete spheres with 
only occasional larger aggregates. 
The method we used to synthesise antibody- 
coated liposomes was at least as simple as most 
methods for generating antibody-coated solid 
phases using cellulose, Sephadex or polystyrene, 
e. g. latex particles (Wide 1981; Collet-Cassart et 
al., 1983). Coupling of antibody and phospholipid 
amino groups is achieved using SPDP, a heterobi- 
functional reagent which avoids protein-protein 
cross-linkage. 
An alternative method of liposome synthesis to 
the reverse evaporation method we employed, such 
as detergent dialysis (Lichtenberg, 1988), may be 
more suited to the production of a large batch of 
DTP-liposomes which could be coupled, if de- 
sired, to a range of antibodies. 
The liposomes we prepared showed no loss of 
immune reactivity over several months indicating 
an adequate `shelf-life'. Methods have been em- 
ployed that increase the stability of liposomes 
using, for example polymerizable phospholipid 
analogues (Regen et al., 1982). This approach has 
the potential to produce very long `shelf-life' lipo- 
somes although the preparation would almost cer- 
tainly be more difficult. 
The assay showed greater sensitivity at 37 °C 
than at either 25 °C or 45 ° C. The phospholipids 
used undergo a phase transition between 37"C 
and 45 ° C, allowing greater membrane fluidity at 
the higher temperature. However, the data failed 
to indicate any increase in sensitivity due to this 
fluidity. A maximum (zero standard) binding of 
label of 10-20% was achieved under the condi- 
tions of the adopted protocol, which is lower than 
the 50% normally sought in a conventional radio- 
immunoassay. Our results, shown in Fig. 3, indi- 
cate that higher binding might be achieved by 
increasing the liposome/label ratio. This will be 
investigated in future studies once the liposome 
preparation can be scaled up. 
Albumin was chosen as the analyte here in 
order to develop and evaluate the use of liposomes 
as a solid phase in immunoassay. The present 
optimised procedure for urinary albumin corre- 
lated well with the alternative RIA method within 
the concentration range of 0-200 mg/1. A con- 
centration of 20 mg/1, or thereabouts, is generally 
adopted as the cut off point above which "micro- 
albuminuria" would be indicated. A clinically use- 
ful assay should therefore have a good dose-re- 
sponse sensitivity at this concentration. Fig. 4 
shows that the liposomal immunoassay has a near 
maximal dose response slope at this level suggest- 
ing near optimal sensitivity. The correlation data 
of Fig. 5 suggests that the liposomal immunoassay 
and the NETRIA assay have similar abilities to 
discriminate microalbuminuria patients from other 
patients using the 20 mg/1 cutoff. 
Above 200 mg/l, frank albuminuria is consid- 
ered to be present. There is less interest in measur- 
ing these higher concentrations by immunoassay 
since they are easily measured by less sensitive 
chemical methods. 
It is interesting to postulate the mechanism 
involved in the increased precipitation of immune- 
reacted liposomes. Microscopically after immune 
reaction the liposomes, previously relatively ho- 
mogeneous pink spheres, clump into heteroge- 
neous clusters. One possible mechanism for this 
phenomenon would be immune complex forma- 
tion, which may be similar to the reported aug- 
mentation of latex agglutination by liposomes 
(Kung et at., 1985). It might be predicted that 
such complexes would only form with large anti- 
gens such as proteins, which have multiple anti- 
body binding sites. Immunoradiometric assays and 
`sandwich type' enzyme-linked immunosorbent as- 
says are generally similarly restricted to large ana- 
lytes. However, although composed of a relatively 
simple mix of components, the surface properties 
of liposomes can be complex. The liposomes used 
in this study contain lipids of net negative surface 
charge. This charge is likely to be modified by 
r.. _, _, _ .,, ý-_ý.. Tý. ý _-ý--- 
J 
, ý 
213 
antibody and antigen binding. Liposome clumping 
has also been reported after incubation with other 
agents, e. g. high concentrations of calcium ions 
(Papahadjopoulos and Vail, 1978). Therefore an 
alternative electrostatic mechanism for the clump- 
ing, not dependent on large immune-complex for- 
mation, cannot be ruled out. 
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